{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# BlackSheep Cookbook Exploration\n",
    "\n",
    "The Black Sheep Analysis allows researchers to find trends in abnormal protein enrichment among patients in CPTAC datasets. In this Cookbook, we will go through the steps needed to perform a full Black Sheep Analysis."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Step 1a: Import Dependencies\n",
    "First, import the necessary dependencies and load cptac data."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "import cptac\n",
    "import binarization_functions as bf\n",
    "import blackSheepCPTACmoduleCopy as blsh\n",
    "import gseapy as gp\n",
    "from gseapy.plot import barplot, heatmap, dotplot\n",
    "import json\n",
    "import requests"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 1b: Load Data and Choose Omics Table\n",
    "For this analysis, we will be looking at results across the proteomics, transcriptomics, and phosphoproteomics tables."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#cptac.download(dataset='renalccrcc')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                                    \r"
     ]
    }
   ],
   "source": [
    "re = cptac.RenalCcrcc()\n",
    "proteomics = re.get_proteomics()\n",
    "clinical = re.get_clinical()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 2: Determine what attributes you would like to A/B test. \n",
    "For this analysis, we will iteratively go through the various columns in the clinical dataset, to determine if any of them have trends within them for protein enrichment."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#Data cleaning. We want to get rid of non_clear cell carcinoma, \n",
    "#as it throws off our analysis, and isn't what we are studying\n",
    "non_clear_cell_filter = clinical['histologic_type'] == 'non-Clear Cell renal cell carcinoma'\n",
    "clinical = clinical[~non_clear_cell_filter]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Rows Dropped:\n",
      "['S011', 'S097', 'S104', 'S107', 'S115', 'S119', 'S123']\n"
     ]
    }
   ],
   "source": [
    "#We also need to get rid of those samples in the datasets we plan to use. In this case, Proteomics.\n",
    "rows_to_drop = ['S011', 'S097', 'S104', 'S107', 'S115', 'S119', 'S123']\n",
    "\n",
    "#for i, item in enumerate(proteomics.index):\n",
    "#    if item not in list(clinical.index):\n",
    "#        rows_to_drop.append(item)\n",
    "proteomics.drop(rows_to_drop)\n",
    "\n",
    "print(\"Rows Dropped:\")\n",
    "print(rows_to_drop)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#Create a copy of the original Clinical DataFrame\n",
    "annotations = pd.DataFrame(clinical.copy())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#Convert columns that should be numeric to numeric\n",
    "annotations['age'] = annotations['age'].replace('>=90', 90)\n",
    "annotations['age'] = pd.to_numeric(annotations['age'])\n",
    "\n",
    "annotations['age_started_smoking'] = annotations['age_started_smoking'].replace('Unknown', np.nan)\n",
    "annotations['age_started_smoking'] = pd.to_numeric(annotations['age_started_smoking'])\n",
    "\n",
    "annotations['age_stopped_smoking'] = annotations['age_stopped_smoking'].replace('Unknown', np.nan)\n",
    "annotations['age_stopped_smoking'] = pd.to_numeric(annotations['age_stopped_smoking'])\n",
    "\n",
    "annotations['how_many_cigarettes_usually_smoke_on_the_days_participant_smoked'] = annotations['how_many_cigarettes_usually_smoke_on_the_days_participant_smoked'].replace('Unknown', np.nan)\n",
    "annotations['how_many_cigarettes_usually_smoke_on_the_days_participant_smoked'] = pd.to_numeric(annotations['how_many_cigarettes_usually_smoke_on_the_days_participant_smoked'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#Drop irrelevant columns\n",
    "irrelevant_cols = ['Patient_ID', 'height_in_cm', 'weight_in_kg', 'race', 'ethnicity', \n",
    "                   'ethnicity_self_identified','tumor_site_other', 'sarcomatoid_features', \n",
    "                   'pathologic_findings_in_nonneoplastic_kidney_specify', \n",
    "                   'other_immunohistochemistry_specify', 'other_testing_performed', \n",
    "                   'other_coagulopathies', 'exposure_to_secondhand_smoke', \n",
    "                   'tumor_tissue_collection_clamps_used','tumor_tissue_collection_frozen_with_OCT', \n",
    "                   'preoperative_IV_sedation_administered',  'preoperative_IV_opiates_administered', \n",
    "                   'preoperative_IV_antiemetics_administered','preoperative_IV_anti_acids_administered', \n",
    "                   'other_preoperative_IV_medications_administered', 'platelets',\n",
    "                   'local_anesthesia_agents_administered', 'regional_anesthesia_agents_administered', \n",
    "                   'IV_anesthesia_agents_administered', 'IV_narcotic_opiate_agents_administered', \n",
    "                   'IV_muscle_relaxants_administered', 'inhalation_anesthesia_agents_administered', \n",
    "                   'additional_anesthesia', 'other_medications_administered_during_surgery', \n",
    "                   'surgical_procedure', 'epochs_of_oxygen_desaturation', 'time_specimen_left_OR', \n",
    "                   'first_participant_temperature_recorded_in_OR', 'first_temperature_recorded_in_OR_units', \n",
    "                   'first_temperature_recorded_in_OR_celsius', 'time_of_first_temperature', \n",
    "                   'first_temperature_recorded_in_OR_fahrenheit', 'second_participant_temperature_recorded_in_OR', \n",
    "                   'second_temperature_recorded_in_OR_units','second_temperature_recorded_in_OR_celsius', \n",
    "                   'second_temperature_recorded_in_OR_fahrenheit', 'time_of_second_temperature', \n",
    "                   'Karnofsky_score_at_12months_follow_up', 'Karnofsky_score_at_24months_follow_up', \n",
    "                   'performance_status_scale_timing_at_12months_follow_up', \n",
    "                   'performance_status_scale_timing_at_24months_follow_up', \n",
    "                   'adjuvant_postoperative_radiation_therapy_at_12months_follow_up', \n",
    "                   'adjuvant_postoperative_radiation_therapy_at_24months_follow_up',  \n",
    "                   'adjuvant_postoperative_immunological_therapy_at_12months_follow_up', \n",
    "                   'adjuvant_postoperative_immunological_therapy_at_24months_follow_up', \n",
    "                   'adjuvant_postoperative_pharmaceutical_therapy_at_12months_follow_up', \n",
    "                   'adjuvant_postoperative_pharmaceutical_therapy_at_24months_follow_up', \n",
    "                   'ECOG_score_at_12months_follow_up', 'ECOG_score_at_24months_follow_up', \n",
    "                   'specimen_id', 'slide_id', 'Presence_sarcomatoid_features', \n",
    "                   'non_cellular_component_description', 'meets_required_criteria', \n",
    "                   'histologic_type_of_normal_tissue', 'findings_not_consistent_with_local_pathology_report', \n",
    "                   'minutes_clamp_1_to_collection', 'minutes_clamp_2_to_collection', \n",
    "                   'consistent_with_diagnostic_report', 'patient_medications']\n",
    "\n",
    "annotations = annotations.drop(irrelevant_cols, axis=1)\n",
    "\n",
    "#Columns we should either drop, or be generally skeptical of in our analysis\n",
    "questionable_cols = ['specify_distant_metastasis_documented_sites', \n",
    "                     'erythrocyte_sedimentation_rate', \n",
    "                     'renal_vein_or_vena_cava_thrombosis', \n",
    "                     'CO2_level_recorded_at_time_closest_to_organ_excision']\n",
    "\n",
    "annotations = annotations.drop(questionable_cols, axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#Determine which columns are binary and which aren't\n",
    "binary_cols = []\n",
    "non_binary_cols = []\n",
    "\n",
    "for col in annotations.columns:\n",
    "    #this is the number of datapoints in a column\n",
    "    if annotations[col].describe()[0] <= 10:\n",
    "        annotations = annotations.drop(col, axis=1)\n",
    "    elif len(annotations[col].value_counts()) == 2:\n",
    "        binary_cols.append(col)\n",
    "    elif len(annotations[col].value_counts()) > 2:\n",
    "        if np.issubdtype(annotations[col].dtype, np.number):\n",
    "            mean = annotations[col].mean()\n",
    "            annotations[col]= bf.binarizeCutOff(annotations, col, mean, \n",
    "                                                \"Above_Mean(\"+str(round(mean, 2))+\")\", \n",
    "                                                \"Below_Mean(\"+str(round(mean, 2))+\")\")\n",
    "        else:\n",
    "            non_binary_cols.append(col)\n",
    "    else:\n",
    "        annotations = annotations.drop(col, axis=1)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 2a: Binarize column values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "tumor_site_map = {'Other':'Other',\n",
    "                  'Upper pole':'Pole',\n",
    "                  'Middle':'Pole',\n",
    "                  'Lower pole':'Pole'}\n",
    "\n",
    "annotations['tumor_site'] = bf.binarizeCategorical(annotations,\n",
    "                                                   'tumor_site',\n",
    "                                                   tumor_site_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "histologic_grade_map = {'G1':'G1or2',\n",
    "                        'G2':'G1or2',\n",
    "                        'G3':'G3or4',\n",
    "                        'G4':'G3or4'}\n",
    "\n",
    "annotations['histologic_grade'] = bf.binarizeCategorical(annotations, \n",
    "                                                         'histologic_grade',\n",
    "                                                         histologic_grade_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "tumor_stage_pathological_map = {'Stage I':'StageIorII', \n",
    "                                'Stage II':'StageIorII', \n",
    "                                'Stage III':'StageIIIorIV',\n",
    "                                'Stage V':'StageIIIorV'}\n",
    "\n",
    "annotations['tumor_stage_pathological'] = bf.binarizeCategorical(annotations,\n",
    "                                                                 'tumor_stage_pathological',\n",
    "                                                                 tumor_stage_pathological_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "pathologic_staging_map = {'pT3a':'pT3or4', \n",
    "                          'pT1a':'pT1or2', \n",
    "                          'pT1b':'pT1or2', \n",
    "                          'pT2a':'pT1or2', \n",
    "                          'pT2b':'pT1or2', \n",
    "                          'pT3':'pT3or4', \n",
    "                          'pT3b':'pT3or4', \n",
    "                          'pT4':'pT3or4'}\n",
    "\n",
    "annotations['pathologic_staging_primary_tumor_pT'] = bf.binarizeCategorical(annotations,\n",
    "                                                                            'pathologic_staging_primary_tumor_pT',\n",
    "                                                                            pathologic_staging_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "pathologic_lymph_map = {'pNX':'pNX', \n",
    "                        'pN0':'pN0or1', \n",
    "                        'pN1':'pN0or1'}\n",
    "\n",
    "annotations['pathologic_staging_regional_lymph_nodes_pN'] = bf.binarizeCategorical(annotations,\n",
    "                                                                                   'pathologic_staging_regional_lymph_nodes_pN',\n",
    "                                                                                   pathologic_lymph_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "pathologic_metastasis_map = {'Staging Incomplete':np.nan,\n",
    "                             'No pathologic evidence of distant metastasis':'No',\n",
    "                             'pM1':'pM1'}\n",
    "\n",
    "annotations['pathologic_staging_distant_metastasis_pM'] = bf.binarizeCategorical(annotations,\n",
    "                                                                                 'pathologic_staging_distant_metastasis_pM',\n",
    "                                                                                 pathologic_metastasis_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "annotations['clinical_staging_distant_metastasis_cM'] = annotations['clinical_staging_distant_metastasis_cM'].replace('Staging Incomplete', np.nan)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "serum_calcium_map = {'Not evaluated':np.nan,\n",
    "                     'Unknown':np.nan,\n",
    "                     'Normal':'Normal',\n",
    "                     'Low':'Abnormal',\n",
    "                     'Elevated':'Abnormal'}\n",
    "\n",
    "annotations['serum_calcium'] = bf.binarizeCategorical(annotations,\n",
    "                                                      'serum_calcium',\n",
    "                                                      serum_calcium_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "hemoglobin_map = {'Not evaluated':np.nan,\n",
    "                  'Unknown':np.nan,\n",
    "                  'Normal':'Normal',\n",
    "                  'Low':'Abnormal',\n",
    "                  'Elevated':'Abnormal'}\n",
    "\n",
    "annotations['hemoglobin'] = bf.binarizeCategorical(annotations,\n",
    "                                                   'hemoglobin',\n",
    "                                                   hemoglobin_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "white_cell_map = {'Not evaluated':np.nan,\n",
    "                  'Unknown':np.nan,\n",
    "                  'Normal':'Normal',\n",
    "                  'Low':'Abnormal',\n",
    "                  'Elevated':'Abnormal'}\n",
    "\n",
    "annotations['white_cell_count'] = bf.binarizeCategorical(annotations,\n",
    "                                                         'white_cell_count',\n",
    "                                                         white_cell_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "country_map = {'United States':'US', \n",
    "               'Poland':'Other',\n",
    "               'Other':'Other', \n",
    "               'Ukraine':'Other',\n",
    "               'Vietnam':'Other'}\n",
    "\n",
    "annotations['participant_country_of_origin'] = bf.binarizeCategorical(annotations,\n",
    "                                                                      'participant_country_of_origin',\n",
    "                                                                      country_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "annotations['margin_status'] = annotations['margin_status'].replace('Cannot be assessed', np.nan)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "annotations['residual_tumor'] = annotations['residual_tumor'].replace('RX:Presence of residual tumor cannot be assessed', np.nan)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "annotations['other_immunohistochemistry_performed'] = annotations['other_immunohistochemistry_performed'].replace('Unknown', np.nan)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "alcohol_map = {'Lifelong non-drinker':'Non-drinker',\n",
    "               'Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women':'Previous_or_Current_Drinker',\n",
    "               'Alcohol consumption history not available':np.nan,\n",
    "               'Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women':'Previous_or_Current_Drinker',\n",
    "               'Consumed alcohol in the past, but currently a non-drinker':'Previous_or_Current_Drinker'}\n",
    "\n",
    "annotations['alcohol_consumption'] = bf.binarizeCategorical(annotations, \n",
    "                                                            'alcohol_consumption', \n",
    "                                                            alcohol_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "tobacco_map = {'Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime':'Non-smoker', \n",
    "               'Smoking history not available':np.nan, \n",
    "               'Current reformed smoker within past 15 years':'Non-smoker', \n",
    "               'Current smoker: Includes daily and non-daily smokers':'Current Smoker', \n",
    "               'Current reformed smoker, more than 15 years':'Non-smoker'}\n",
    "\n",
    "annotations['tobacco_smoking_history'] = bf.binarizeCategorical(annotations, \n",
    "                                                                'tobacco_smoking_history', \n",
    "                                                                tobacco_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "annotations['tumor_status_at_12months_follow_up'] = annotations['tumor_status_at_12months_follow_up'].replace('Unknown', np.nan)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "annotations['tumor_status_at_24months_follow_up'] = annotations['tumor_status_at_24months_follow_up'].replace('Unknown', np.nan)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "success_map1 = {'Complete Remission':'Complete_Remission', \n",
    "                'Not Applicable':np.nan, 'Unknown':np.nan, \n",
    "                'Persistent Disease':'Persistent_Disease_or_Deceased', \n",
    "                'Patient Deceased':'Persistent_Disease_or_Deceased'}\n",
    "\n",
    "annotations['success_of_initial_treatment_at_12months_follow_up'] = bf.binarizeCategorical(annotations, \n",
    "                                                                                           'success_of_initial_treatment_at_12months_follow_up', \n",
    "                                                                                           success_map1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "success_map2 = {'Complete Remission':'Complete_Remission', \n",
    "                'Not Applicable':np.nan, 'Unknown':np.nan, \n",
    "                'Persistent Disease':'Persistent_Disease'}\n",
    "\n",
    "annotations['success_of_initial_treatment_at_24months_follow_up'] = bf.binarizeCategorical(annotations, \n",
    "                                                                                           'success_of_initial_treatment_at_24months_follow_up', \n",
    "                                                                                           success_map1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "success_map3 = {'Complete Remission':'Complete_Remission', \n",
    "                'Not Applicable':np.nan, 'Unknown':np.nan, \n",
    "                'Persistent Disease':'Persistent_Disease_or_Deceased', \n",
    "                'Patient Deceased':'Persistent_Disease_or_Deceased'}\n",
    "\n",
    "annotations['success_of_treatment_at_12months_follow_up'] = bf.binarizeCategorical(annotations,\n",
    "                                                                                   'success_of_treatment_at_12months_follow_up',\n",
    "                                                                                   success_map3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "success_map4 = {'Complete Remission':'Complete_Remission', \n",
    "                'Not Applicable':np.nan, 'Unknown':np.nan, \n",
    "                'Persistent Disease':'Persistent_Disease'}\n",
    "\n",
    "annotations['success_of_treatment_at_24months_follow_up'] = bf.binarizeCategorical(annotations,\n",
    "                                                                                   'success_of_treatment_at_24months_follow_up',\n",
    "                                                                                   success_map4)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "annotations['new_tumor_event_after_initial_treatment_at_12months_follow_up'] = annotations['new_tumor_event_after_initial_treatment_at_12months_follow_up'].replace('Unknown', np.nan)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "annotations['new_tumor_event_after_initial_treatment_at_24months_follow_up'] = annotations['new_tumor_event_after_initial_treatment_at_24months_follow_up'].replace('Unknown', np.nan)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 3: Perform outliers analysis"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "First, we create our outlier tables for both up and down regulated gene outliers."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [],
   "source": [
    "outliers_up = blsh.make_outliers_table(proteomics, iqrs=1.5, \n",
    "                                       up_or_down='up', \n",
    "                                       aggregate=False, \n",
    "                                       frac_table=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "outliers_down = blsh.make_outliers_table(proteomics, iqrs=1.5, \n",
    "                                         up_or_down='down', \n",
    "                                         aggregate=False, \n",
    "                                         frac_table=False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Next, we take these tables, and split them in half.  This is because the second half of the table is the inverse of the first (1st: _outliers; 2nd: _notOutliers).  We will then create a dictionary {key = SampleID : value = list of outliers} that we will use later to find personalized medicines for specific samples."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "length = int(len(outliers_up.index) / 2)\n",
    "only_outliers_up = outliers_up[:length]\n",
    "outlier_up_dict = {}\n",
    "for i in range(length):\n",
    "    key = proteomics.index[i]\n",
    "    my_filter = only_outliers_up.iloc[i] == 1.0\n",
    "    value = list(only_outliers_up.iloc[i][my_filter].index)\n",
    "    outlier_up_dict[key] = value"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "length = int(len(outliers_down.index) / 2)\n",
    "only_outliers_down = outliers_down[:length]\n",
    "outlier_down_dict = {}\n",
    "for i in range(length):\n",
    "    key = proteomics.index[i]\n",
    "    my_filter = only_outliers_down.iloc[i] == 1.0\n",
    "    value = list(only_outliers_down.iloc[i][my_filter].index)\n",
    "    outlier_down_dict[key] = value"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 4: Wrap your A/B test into the outliers analysis, and create a table\n",
    "Note: compare_groups_outliers will break if there are duplicate gene names. Be sure to use the \n",
    "renameDuplicateColumns function if there are indexing errors"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [],
   "source": [
    "bf.renameDuplicateColumns(outliers_up)\n",
    "bf.renameDuplicateColumns(outliers_down)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [],
   "source": [
    "results_up = blsh.compare_groups_outliers(outliers_up, \n",
    "                                          annotations)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [],
   "source": [
    "results_down = blsh.compare_groups_outliers(outliers_down, \n",
    "                                            annotations)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Many of the output values from compare_group_outliers are NaN, so here we will get rid of the NaN values for visualization purposes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "results_up = results_up.dropna(axis=0, how='all')\n",
    "results_down = results_down.dropna(axis=0, how='all')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 5: Visualize these enrichments"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "First, we will determine which clinical attributes have significant enrichments, and save them to a list for both up-regulated outliers, and down-regulated outliers."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Drop Columns with less than 4 significant up-regulated enrichments\n",
    "#print(\"TESTING FOR UP-REGULATION:\")\n",
    "sig_cols_up = []\n",
    "for col in results_up.columns:\n",
    "    sig_col = bf.significantEnrichments(results_up, col)\n",
    "    if sig_col is not None and len(sig_col) >= 4:\n",
    "        sig_cols_up.append(sig_col)\n",
    "        #print(sig_col.head())\n",
    "    else:\n",
    "        results_up = results_up.drop(col, axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Drop Columns with less than 4 significant down-regulated enrichments\n",
    "sig_cols_down = []\n",
    "for col in results_down.columns:\n",
    "    sig_col = bf.significantEnrichments(results_down, col)\n",
    "    if sig_col is not None and len(sig_col) >= 4:\n",
    "        sig_cols_down.append(sig_col)\n",
    "    else:\n",
    "        results_down = results_down.drop(col, axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#Here we will link clinical attributes with significantly up-regulated genes\n",
    "sig_genes_up = {}\n",
    "for i, col in enumerate(sig_cols_up):\n",
    "    list_of_genes = list(col.index)\n",
    "    sig_genes_up[sig_cols_up[i].columns[0][:-9]] = list_of_genes   \n",
    "\n",
    "#And then down-regulated genes\n",
    "sig_genes_down = {}\n",
    "for i, col in enumerate(sig_cols_down):\n",
    "    list_of_genes = list(col.index)\n",
    "    sig_genes_down[sig_cols_down[i].columns[0][:-9]] = list_of_genes"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Then we will plot the results, to visualize what genes are significantly enriched for the clinical attributes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAZYAAALmCAYAAABhMrLKAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz\nAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjEsIGh0\ndHA6Ly9tYXRwbG90bGliLm9yZy8QZhcZAAAgAElEQVR4nOydd7wcVfn/35/Um+SmE9ILhFAjIIai\nFIMgAiJVDAEVbIiK/EBBBfkqAgIiiqKosSCgVOkiCAiE3iIYIPT0TgrpPXl+f5yzyWSzd3fvnLl3\ndnLn/Xrllbszp+3s7jxzzvOczyMzIycnJycnJylapT2AnJycnJyti9yw5OTk5OQkSm5YcnJycnIS\nJTcsOTk5OTmJkhuWnJycnJxEyQ1LTk5OTk6i5IYlAEmnSXq6mfoaIskktWmO/hqDpFMkPZz2OKD6\nsUi6SNLfm2NMTYmk4yRNl7RM0ofTHk8I/vu9Q9rjyAmn2Q1LqS9PyI9c0khJG/wPa6mktyV9KZnR\nJkdT38gkTZG00l+HuZL+Kqk+ZluNGquZ3WRmhwX0tdaPu/BvUZy2QseSBgk8MFwFnGlm9Wb2SgLj\nGStplf8c5ku6S1Lf0HaTQNKnJD3pf+fzJD0h6ei0x9UQkv4Q+U6vKfqeP5j2+JqSrWXGMsvM6oEu\nwDnAnyTtlPKY0uAz/jrsBewNXFhcQI5a+9xv8zfGwr9ucRqpxdlcMzAYmBCnoqTWDZw603+PdgDq\nccYrVSR9FvgHcCMwAOgN/Aj4TJrjilL8/TOzMwrfaeAyNv+eH5HOKB1N/VuptRtMYQYyQ9IF/olp\niqRTqqlrjgeAhcDukTZ3lvSIpIV+RvO5yLmekv4paYmklyRdWljeKvU06Z/ovtrA2H/tlyWWSPqv\npAP98cOBC4BR/mllvD/eVdJfJM2WNNP33dqfay3pKn8NJgGfrvYamtlM4EFgeGTMP5X0DLAC2F5S\nP0n3+WvynqSvBYx1syVBf83OkPSupA8kXStJ1Y6/6Jo22Jbv9xlJV0taCFxUYiy7RT77uZIuiDTf\nTtKN/gl4gqQRkXpTJJ0n6VVJy/177y3pQV/+P5K6R8rvJ+lZSYskjZc0MnJurKRL/FiXSnpY0jb+\n9JP+/0X+en9U0g5yT+OL/ed/W4nr0l7SMqA1MF7SRH98F9/fIv+ejo7UuV7S7yU9IGk5cHC5a29m\ni4B7gD0jbbSS9ANJEyUtkHS7pB7+XOH3cqqkaX7sP4zU3UfSc35ssyX9VlK7cmPw9QT8ErjEzP5s\nZovNbIOZPWFmhe/tUEmP+THNl3STpG6RNqZIOtd/nosl3SapLnL+GEn/k/vtTvS/g2q+95t9/yq9\nl6L3daikKUXHZhS+O76vWyXd4r8b4/37vFBuxjZN0qGRugMk3e+/6+9K+nLk3KX+Pd8iaSnwef+d\nfdm/57mSft6Y8ZfFzJr1H2DADkXHLgL+7v8eCazDfZHaAx8HlgM7NdDeSGCG/7sVcDSwAfiwP9YJ\nmA58CWiDe5qfD+zmz9/q/3UEdvVln/bnhvjxton0Nxb4qv/7tEJZ//rzQE/fz3eBOUBd8XuMlL8H\nGOPHuC3wIvB1f+4M4C1gINADeLx4LEVtTQEO9X8PxD3FXhIZ8zRgNz+2tsATwO+AOtyNYx5wSMyx\nFl8HA+4HugGDfNuHNzDuLfoq8X0p2Zbvdx3wbf++OkTHAnQGZvvPos6/3jfS7yrgSNzN+XLg+aLr\n+Tzuybg/8D7wMvBh3PfyMeDHvmx/YIFvqxXwSf+6V+T6TwR29GMcC1xR5jt2C/BD31YdcEA1vyf/\nub6HezBoB3wCWIr/7QDXA4uB/Qttl2hvLJu+3z2B/wD3Rs6f7a/LAH8dxgC3FL2XP/n3uQewGtjF\nn/8IsJ//rIYAbwJnl7s3+OM7+3PblbkOO/jr3h7ohTPYvyr6PF8E+uF+T28CZ/hz+/jr8kl/XfoD\nO1f5vd/s+1dmfBex5W/qUGBK0bEZwEj/96XASl+uDXAzMBn4gX/9DeDdSN1ngN/470zhPvfxSFtr\ncDO8Vv7zeQkYHfmt7JvEPd7MatqwdIqcvx34vwbaG4kzJIv8l3h90Zd1FPBUUZ0xwI9xN5S1RIyW\n/wBiGZYSY/sA2KPUFwt3w1od/TICo4HH/d+PFb74/vVhxWMp6msKsMxfh6k4o9EhMuaLI2UH+uvU\nOXLscuD6mGPd7Dr4cR4QeX078IMyP7g1ftyFf49X05bvd1pRexvH4sf4Spl+/xN5vSuwsuh6nhJ5\nfSfw+8jrbwP3+L+/D/ytqP2HgFMj1//CyLlvAv8u8x27EfgjMKAxvyfgQNzDTKvI+VuAi/zf1wM3\nVmhvLG5Wu9i3/T9gUOT8m/gHEP+6L+43VDAWFh037kZ8UgN9nQ3cXeq9FJXb35/bwhCWeR/HRj97\n/3l+PvL6SuAPtul+cHWJNqr53k+rcjwXEc+wPBg5d5z/XFr51939dakHtvOfQ/S++XPgz5G2Hivq\n61nccmLPaq9rtf/SWApbj3uyitIWd1EKfGBmyyOvpwL9JA1SxMkbOT/L3Lp8F+Aa3JNagcHAvn76\nvUjOMXwK0Af3ZNMGN0spEP27UUj6rqQ3/VR7EdAV2KaB4oNx73t2ZFxjcE9F4J6somOZWsUQjjWz\nbmY22My+aWYrI+eibfUDFprZ0qL2+8ccaynmRP5egfvyN8TtftyFf8VLNOXaKvd5DcTNFKodY502\nX3ueG/l7ZYnXhXEMBk4s+o4dgLvpVvMeivkeIOBFv5z15TJlo/QDppvZhsix4s+1mu/3WWbWFbec\n3B03OykwGLg78j7fxP2me0fKlHyvknb0SzVzJC3B+R0a+n1EWeD/bzCIQNK2ftlopm/77yXabugz\naOh7Us33Pvb9okqKv3PzIp9v4fddj/vs55e4b5b77L+Ee6B6W9KLko5MatBpGJZpuCebKNux+Y2z\nu6ROkdeDcMZjmkWcvMUNm9lq3NPjhyQd6w9PB54ounHVm9k3cMsq69j8hzMw8nfhQ+oYOdan1JuS\n86d8H/gc0N0busW4GwS4J4so03FPQ9tExtXFzHbz52cXjWVQqX4bQbT/WUAPSZ2L2p8Zc6xpUjzW\nKNOBoc0whum4GUv0O9bJzK6oou4W4zezOWb2NTPrB3wd+J2qC8OdBQzU5sEZ0c+1ZH8NDszsNdyT\nbtRHNh04oui91pnz61Xi97jl3WFm1gW3ZFeN7+1t3+8JZcpcjntvu/u2P19l29Dw96Sa733V17ME\ny4ncW/xDTc+Ybc0Ctilx32zwszezt83sJJyh/AVwZ9TvFEIahuU24ELvaGrlnU+fAe4oKvcTSe38\nDfsoXERIRcxsDe4i/cgfuh/YUdIXJLX1//aWtIuZrQfuwjl9O0raGfhipK15uA/m83LO9C/T8I2q\nM85IzQPaSPoRbgZVYC4wpPCjN7PZwMPALyR18ddiqKSP+/K3A2f569Qdt66aCGY2HTcNvlxSnaTd\nga8AN8Uca61yP9BH0tlyzu7OkvZtgn7+DnxGLhy2tb+mIyUNqFjTfV82ANsXDkg6MVL3A9wNYX0V\nbb2Au1l9z3/PR+J+W7c24r0UcwPuxlMIAvgD8FNJg/1Ye0k6psq2OgNLgGX+t/aNaiqZW7f5DvB/\nkr4U+Q4eIOmPkbaX4YIg+gPnVTkmgL8AX5J0iG+3v6Sdm+F7/xbQ2X9v2uKW54tXc6rCzCYD44DL\n/Hd9T9yM5KaG6vh74jZ+BlRY+tzQUPnGkIZhuRh3U3sa96O5EreW/XqkzBx/bhbuwpxhZm81oo/r\ngEGSPuOXew4DTvLtzQF+hnPyAZyJW7KaA/wNtya9OtLW13Bf0gU45/ezDfT5EC4S6x3c7GsVm089\nC4ZxgaSX/d9fxDlZ3/Dv9w42Tff/5Nscj3Ma31X1u6+O0biZ4yzgbpwj+pGYYw2lEIEW/Vduma0q\n/Gf/SdzNdQ7wLhUioWL2Mx04BvcEPg/3uZ9HFb8vM1sB/BR4xi+37IcLFX/BL/feB/w/f+Oo1NYa\nnAE4Aue4/R3wxUb+dkq1eQ3wf/7Qr/2YHpaLLnoeqNZYnwucjAso+BPuIbPacdyB85d+GfednYub\nTd3ri/wE57BeDPyLRvxezOxF3E34al//CdwyGDTh997MPsD56m7APcAuZPPlusYyChjm27gDuMDM\nHi9T/kjgTf85XgWM8p93MPJOnJrBP2X93cyqedpriv5/BvQxs1PT6D8nJycn69TcPpbmRm6Py+5y\n7INbEro77XHl5OTkZJVMGBY5PSTz67KFY//2Swf3F5UdK7cJ8n9yEVqnR87Vy20QmyjpFUn/Bb6A\nmzYvx/k1fsGm6XVOTk5OTiOpOQkMMxvL5lFa4PwBT+P8JBf5Yz/HRVR8vUQzp5jZOLkdwRMlXe/X\nDv8MTMJFpWyQ1Av4spnlwnc5OTk5CVHzMxY5IcX9cUtUJxWOm9mjOCdgOepxM5H1kobidtheWIgD\nN7N5ZvazJhl4Tk5OTgul5mYsJTgWt0v5HTkNnL3M7OUKdW6StBoXIXG2ma2XtBswvmjzWFn8Mtrp\nAGPGjPnI6aefXqFG0/D2zuF6dTu9lY6Y6nY99+Cy9sOD2hg9q8GIyZycWiWWNl6UtfMnVR1Z1Xab\n7YP7S5IsGJbRwK/837f615UMS2EprBfwrKR/FxeQE8c7EdjWb0TbAjP7I05aA8I2QrVYJi8Yz0H9\nDwlqY3RCY8nJyWkeatqwSOqJk2cZLslw2l4m6XtWRZy0mc3z+zD2xRmjPSS1MqeM+lPcRq9l5Vtx\ntK8bWLlQE7J6VXzliLbt+kO7htRaKvPtfgfGrrv3mtbUtY615ysRQj+37nWxUtpsZM6iN2PXPTDQ\nIAM8NfPR2HVHDz62cqEy3DL1nqD6IYQ+zAxo06VyoTLcPDWBwNIN1eyJrU1q2rAAn8WJ5m100Et6\nAqfD9FSlypI64tRorzSz9ySNAy6V9H9+eayOKqesITf2tFm7phq1jabhkAGH0UXtKxdsIrL8uYUY\nhSRI0zCE8mTK1y4R1q9LewSxqXXDMhoo1lu6EzhZ0mU4Oe16STOAr5jZQ77MTZJW4nbXX29m//XH\nv4qLJntPLn/CSpy+V00T+vQF6f3QJizL7o09JydNGuEOrjlqbud9DZPaherSafvKhSqwZPmk2HX7\ndNslqO9t62IlhNzIq3OeC6qfJqGfXcjnlpMqwc70NTNeq/qe027Ah3LnfU7jGNK5d+VCTUiInyCJ\n2VaWSdMwtGsfroq0ZvWMBEaSE4sMz1hyw5IB+rTtmvYQYpP1te7Q2VqIUQ4lNwoZJ3feJ4uk43Ay\nK7uY2VuShuASCr2NUxp9EpeFb3dcjocuOFnxn5rZbZF2euGUUM80szH+WEeceu9QX+efZpaYJH1T\n0L1VIikSUuHDffYPbuOVOc8kMJKclsQefT4W3Mb4OQ0JmTcTGZ6x1KSPRdLtOGnqR83sIm9Y7jez\n4XLJcB7D7W15HZeu4V1J/YD/4ozRIt/ON3EBAOvNbKQ/1hGX2/lxSe2AR4HLzKzSDsLau1A5OTm1\nSrDPY/XE56u+57Qful/uYylHRMLlYFzeh4ui581snaRncbmx74ocnyXpfVy64UX+8Gjgu8DNkvqb\n2Uyf/+JxX2eN3+eSikR/taS9nyGEvfoeENzGy7OfTmAk8Rjcc/eg+lMXvJrQSHJaHBuyO2OpOcNC\nCQkXXAIcYOOM4xA2ZYgsHN8Ht0w20b8eiMur8qKfAY0CfllUpxsuCdSvSw2kSNKFtCRd0t7PEMKU\nZXMrF6phcsOQkxoZXgqrRcNSSsLlWmCopP/hlqTujS5dSeqLy/54akQL7CScDH6hnb8QMSx+Se0W\n4BozKxm6k0u6hNOtfT31bbLrI8rJSY0MO+9rysfiJVxmAO/jbuSt/f8fxznZt1AzlNQFGAtcbmb/\niBx/GegNrPWH+gG7mdm7/vx1wDIzO6vK4dXOhcoQg3p8KO0hMG3ha2kPIaflEe5jefPx6n0suxyc\n+1jK0JCES0kfiHe+3+3rRI3KTkAnM+sfOfYT3CzmEkmX4vLcf7VJ3kXCHDbw8OA2Hp6+hQ5ns7BL\np3D31UPT01FmBhjee7+g+q/PfT523b7ddg3qG2D2ojeC22iJ7N7no0H1E9nUm0u6JEZDEi4XNFD+\nc8BBQE9Jp/ljp+H8NMUqcHcCt0r6K/BD4C3gZUkAvzWzP4cOvqlYuG552kOIzbsr56Q9hCBCDENO\neoTuP4J09yABmXbe19RSWI2TX6icnIxQA4YleGlq1fgHqr7n1O1xZL4UltM4enQeFtzGwqXvJjCS\nxrN//09Q3ypM3ThfCotPyFJY6Pcure8cQLtWW8GtLY8Ky2lKtq/vk/YQYvPMzMf41MDwDJhpsWD1\nktT6XrpmZWp9Q7qGIZQhHbZNewjhZHgpLBOGRdJ64DXc9HI9TqLlWX9uR1x48o64CLDXgG8DuwDn\nmtlRkXaux+3gv0PSWNzu/sKv9z0z+2yzvKFGMm52xdQzNUvWRSjTdH4vWzE5tb6zTtY16oB8xtIM\nrDSzPQEkfQq4HPi4T9T1L+A7ZvZPf/5g3O77ajjFzMZVU7BNQAZGgHUpJtsKZbuee8Su20qtExxJ\n8xO6HJVHZeXEZv3aymVqlKwYlihdgA/83ycDzxWMCoCZPQ4gaWSSnWbZMIQyecH42HX36zeSKSuy\nu/s+1DDk+VhyYpMvhTU5Hfyu+zrc8tUn/PHhOOHJhjjQ1yswCLg/8rqQaRLgETM7L1q5ViRdjhx0\nZHAbD0x7IIGRNJ52as2Onfql0nctEGIYhvX6CMN6fSSo/3fnlft5NC2hGnchUkZZzrq6kXwprMmJ\nLoV9FLhR0ha78EvwVAkfS5SyS2G1IukydfWCtLoOZtmG1UH1Z69c2GKXo9I0CkmQpsZd6kYhCfIZ\nS/NhZs9J2gbnR5mAk3vZqpkw94W0hxCb+asXB9Vv26p1LsmS0zLJDUvzIWlnnIbYAuBm4HxJnzaz\nf/nzhwNblUPkrCGjgtu4ZsptlQs1AW0C9xPs32k7vjD4+KA2/jb1rsqFcragrm5QUP1Vq6bFrtur\n605BfQPMW/x2cBtpYrnzvsnpEPGVCKdivB5YKeko4FeSfoULN34V+H9AzyrajfpY5pvZoUkPPAnS\nMgpJMGn+K0E5WSaseT/VfCwtmRDDEErWjUIi5D6WpsXMGoxZNbO3gFIqjXNxqsfRsqdF/h6ZzOhy\nyrH9Nh9mxbpVaQ8jJyd75EthOU3J8YOPDm7jrqn3JTCSxjNp/itBuk0DO/Zi734HBY3hpVlPBtVP\ni9ClKEh31tG1fmhQ/cXLJsaum4TaQ5pSQkA+Y8nJaYju9TsE1X9vySw+WPZeQqPJFmkahSQIMQyh\npG4UkiCfsVSPpD44CZa9gdXAFOBsf7qUNMvuOCn9dsAa4Dwze8y3NQVY6uu2Bu4CLjGz1f78v4H9\ngKejYcf+XC9gFk4eZkwTvNXESGu2kQTbdQ7TOWutVqnOWEJVclOXXg8g1IEe4ifp3XXnoL4B5i5+\nK7iNVMlnLNUhl/zkbuAGMzvJH9sTl+nxOkpLs8wHPmNms/zelYeAqL7KwWY2X1I9bs/JH4FT/bmf\nAx2Br7MlJwLP43LA1LRhSZvQWUfIjCPUqGSZtNWNc1JmXZ7oq1oOBtaa2R8KB8zsf5K+TAPSLEVM\nAOoktS/MSiLll0k6A5guqYeZLTSzR8tIu4wGvgvcLKm/mdVsiPKAHtXsBS3PjIWvx64bYhh27DWC\nHXuNiF0f4J15Vcm5bXW0a53uSnWakVmZn20kQT5jqZqGJFgqSbMUOAF4pdioFDCzJZImA8OABncV\nShoI9DGzFyXdDowCflmiXE1IumSZlmoUkmDqglfTHkJOmuQ+lqZH0m7Az4DDKhWtormTgNv937cC\nf6GEYakVSZeQ2UbaZF2zaWDHaoWyc3ISJp+xVM0EoFTOk7LSLJIG4HwzXzSzBkNNJHUGhgDvVBjH\naKC3pFP8636ShplZdjMb5TQJWQ1VztkKyGcsVfMYcJmkr5nZnwAk7Q28R8PSLNNxOVfON7NnGmrY\nO+9/B9xjZh+UKbcT0MnM+keO/QQ3i7kk9A02BaMGHxvcxm1T70lgJI0n62KAg3p8KKh+iM5ZEs77\nhauWVi5UhtWrpgePIQ55VBiZnrHIrHlXeCT1w4UVfwRYxaZw49b++FA2l2b5GnA+EJ1NHGZm70fC\njQW0ws1qLjGzVb6vp4CdgXqctthXgI8CdWb2g8iYdgduNbNyv+TUlsKyzH79RrJw7bKgNnI/TU4G\nqWZJviwrb7+46ntOh8/9KLi/JGl2w5JhUrtQbwz9dHAbu078VwIjaTw79hpBlzYdgtrIcmrm/t13\nC6o/84MJCY0kp5kJNyy3/aR6wzLqxzVlWDLjvG/JpGUUkmDV+tWsWh+WkyXL5IYhJzYZ9rG0SnsA\nOVs3da3bB//LyWmRbNhQ/b8KSDpc0tuS3pP0gwbKfE7SG5ImSLo5cvxUSe/6f6eWqltMzc9YykjA\ntAV+AwzATTtvBC41v7bnnf8XA11wvpy3cXIw0ySdCFwE7ALsUy6LZC2Q9ZDdnJycGCTkvJfUGrgW\n+CQwA3hJ0n1m9kakzDCcL3t/M/tA0rb+eA/gx8AInDvgv75ugwFSUOOGpYIEzPXAN8zsYUkdgTuB\nbwLXeumX3wBHm9mbvt7RuFDkacDrwPE0QsrliEC11AcDRPFCjcKIvgcyou+Bsesf3n5g7LrzV4Vl\nkGzfum1wdNThAXpfP+23MKjvC2dVkxaoNHfOfyWo729vs29Q/R8cHxZ08YU74rslT1nbJajv768N\n12ibOP/l4DaCWL8+qZb2Ad4zs0kAkm4FjgGiej9fA64tGAwze98f/xTwiJkt9HUfwaUpuaVchzVt\nWGhYAuYrwDNm9rA/tkLSmbj8K9cC3wcuKxgVX+a+yN8FY1P1QF5bnk7YZRKk6fz+c6CIo2Eo0A/6\n1yl3xq67f/9PBPX9zMw7Yte9Lqjn9Ll7iy3HzUepzXKZIzkfS3/cto0CM4Dip44dASQ9g4vQvcjM\n/t1A3f5UoNYNS0NSL7sVHzeziZLqJXXx568K7Twq6dKubU/atukc2mQmCZmtfbjzkKDZWto8M/Ox\n1Preo8/HgtsYP+fZBEaSPZIQL019c2wjDEv0XuX5o1cOgdIRasXTyTY4KayROPfCU37lp5q6W1Dr\nhqUhRMNvbrPjknoCj+JUjv9oZlUbnFqRdAlZxioQMmsJMQzd63dIVR05lNBluBB14awbhe23+XBQ\n/UkBS4FzV5V1AWSDRvhYiu5VxcwAouvZA3ApQ4rLPG9ma4HJkt7GGZoZOGMTrTu20nhq3bCUk4DZ\n7JFE0vbAMjNbKmkCsBcw3swWAHtKOhe3UTJzZHkfxz7dh6U9hCB26xzfvwTQpdP2set2bhe2/wfS\nDXcOMQyhhCgeALRt15+27Squ+DTI2jXhYum2IbFn2ZeAYZK2w6mZnAScXFTmHpzU1fWStsEtjU0C\nJuLUUrr7cofhnPxlqXXD0pAEzLvABZIONbP/SOoAXANc6etdCdwt6fmIn6Vjcw8+x2Xy273PR9Me\nRmz+M/2htIeQkwJJGIZgEvKxmNk674N+COc/uc7MJki6GBjn/c8PAYdJegNYj4ugXQAg6RKccQK4\nuODIL0fN77wvIwFTh4v86ou7WH/DvelCuPGncSHFnXFyLtOAH5vZO5KO83V7AYuA/5nZpyoMpbYv\nVI2yT78GtUWrYvqKecFjCFmOSjODZGjOeEg3PXALJ3gn/Iprz6z6ntPxW7/Nd943BjObBXyugdMj\ny9T7F068stS5u3FhzJngrCGjgtu4ZsptCYyk8RzZdkBQ/X91TNeeZzm1cE7GyfDO+5o3LDnpGYUk\nuHF5eGrcNNfq0ySfbbRwcsOS05T06BzuAF+4NJ1UM4tWh22yy8lpsdS4m6IczWpYJK0HXsPJsawD\nbgB+ZWYbfG76c83sqEj564H7zewOSW1x+VJOwEm7rMD5TB6MyOcb8AEuIdhUn4L4RqAPsAEXbvzr\nojGdC/wc6GVm85vszbdQ6tvWpT2EVDl1yAlB9W8I2NyZE5/LB38+qP75U/8ePoh8xlI1K81sTwCv\nRXMz0BWnRVOJS3CO+uFmtlpSbzbPOnmwmc33SbsuxEkUrAO+a2Yv++yS/5X0SEEjxxueT+Ic+zVL\nWrONJFi6ZiU7dQnzs+Rkk9D9VyFh9qEJ2gC+0XmP4DaCSC7cuNlJbSnMJ+o6HSeIdlG5sl4L7GvA\ndma22tefy6a89VGeA87yZWYDs/3fSyW9iZMjKCz8Xw18D7g3+A3llOSDZe+xX7+RaQ8jNtt02TGo\n/vwllbJkb72kuf8qdB9LTZCcVlizk6qPxcwmSWoFbOsPHSjpf5Eig4D7gR2AaWa2pIpmD8dt9tkM\nSUOADwMv+NdHAzPNbHxDmmFRmYQxY8Zw+umnlyyX0zChu69Xrlud6u73NA1DaJIwyG4+mJ233Tu4\njbfef6lyoRrG8qWwIKJ39adK+Fiq5XG/PPY+bilsUwdSPU79+GwzW+JnQD/E7SJtkFzSJZwknPdZ\nXgoMIatGIQmybhQSIV8Ki4eXYVmPMwbldqK9BwyS1NnMljZQ5mBgOU5O/2LgO76PtjijcpOZ3eXL\nDgW2AwqzlQHAy5L2MbM5QW+qCciypMvCpe8Ga4WlSe+uOwfVn7v4rYRGktPiSCgfSxqkZlgk9QL+\nAPzWzKychL2Xxf8LcI2kr5vZGkl9gUPM7O+RcislnQ28JulSXITYX4A3zeyXkXKvsWn5DR9VNiKP\nCkueQT0+lIjmVVrkhiEnNfIZS9V08D6UQrjx34BqszZcCFwKvCFpFW528qPiQmY2W9ItwLeAx4Ev\n4AxNwXdzgZk9EPY2mpdRg48NbuO2qVu4nZqFI7qEPfFnncE9dw+qP3XBqwmNJFskMctNUxU7EdZl\n13lf81phNUR+oWKwXc/wkM3JC8YnMJJ47NY7LAvjhLkvxK6btvM+tP+QvkMNMqRulIO1u5b/3+eq\nvud0uuT2XCssp3EcOejI4DYemJbOJG3PToNS6TcpQrNXhtC/wzap9Q3pBg+01JnaZuRLYckQ2Zlf\n4FYzu0LSWNzmyFXAGuBrZp3GSiwAACAASURBVPY/X6ce+AVwqD+/ACf5/IKkPjhl5L1xu/Wn4CLD\n3vF1uwBvAneb2ZlN/w5bHrPXNRRrUT1pKgxPXppeLMeLs55Ire+c9MnDjZNj4878EpxiZuMkfQkn\nwfJJf/zPwGRgmJeG2R7YRS4a4G7gBjM7CUDSnkBvoLA54RKg5n+9M9ZkNxveHu16Bbfx/KyxwW3E\nZfmKKan1ndPCyWcszcpzwHkAkoYC++KMzgZwmy6BSZI+Aaw1sz8UKhZmOb7uR3BG5t/AiOYbfuP5\nR7duaQ8hNvcuej24jTEJjCOLhOaygXzWk2lyw5IYHbT5zvvLzaxYMz66s343XJKuUuETw4H/lurE\n7/b/BS5i7JCwITc9O70VP+d82qxZvy7tIWSWrBuF3w4ME3I8c3p8IcerB4X1DXDOtASEJEPIJV0S\no9xS2E2SOuGyRe4V2M83gQfMbHq5/TO1IumS5URfobvmB/X4ULCgYIhuVJpyMmmTZlTYiYOP4YnB\nx8Suv8TWxK5b4JzgFsJIMOd9s1NT4caSlplZfYnjY4FzgfHAFTgxyuP9UtgjwA6FpbBInUNwsvoH\nlWjvJuBAnJR+PdAO+J2Z/aDM8GrnQmWIPt12oV2rsOeXrUJQMCdTtG3XP6j+2jUzg8MJl551VNX3\nnM7X3J+HG8fFzNZKuhCYKGkXM3tT0jjgJ5J+5HfwDwN2Be4DLpP0NTP7E4CkvYGOZnZKoU1Jp+F2\n3ZczKkEcN+gzQfVv+ec3gsdQt0d4yHIcQo1K2qQZkZY2y84PyyUz8Ddh+4/en/Jw/L53+HRQ3z07\ndmHBimo0b5uQPCosMYp9LP8uvuF72ZZf4GYwXwG+ivOXvCdpBZvCjU3SccCvJP0AF4o8BTi7Gd7H\nZtw97Z/N3WXN0CbjhqUlU395WJKxDy5PaCAxyLJB30i+FNYiyC9UDHp0Hsbe3cLkOR6ant3ghZwW\nS/hS2BmHV78U9od/50thOY0jdCkN0ps1tW3Vmhc/aJmy91nn3j4nB9U/Zs7NCY2kZWLr86WwnCYk\ny0tpkvhcYLKvnHTIDUPKZHgprCrD4hNoXQ3sh5OiXwNcaWZ3+/O/Bj4LDCxEZ3mn+M+BmTg14zeB\nL5rZiki744E3zGx05Nj1uFz2i3HTye+Y2aOR872AWcCZZjYmcnwKsBQX6TXX9zWnlCS+pFOA7/uX\ny4BvmFl6Soc1TojSbPe6zjwSqDLbkkN+c1ouWQ43rmhYvDTKPThplJP9scHA0f7vVsBxwHTgIGBs\npPptBQ0uSTcDo4C/+te7AK2AgyR1MrPlkXrnmdkdkg7GZXAcFjl3IvA8MJotN2UfbGbzJV0GXACc\n1cDbmgx83Mw+kHSE7yNMxnYrJkR+/MhBR/Lm8pmx6z+xXbpCjKEcNSgsOun+af9KaCQ5mWNrNizA\nJ4A1RdIoU4Hf+JcHA68Dt+Fu9mOLG5DUBuiEm+0UOBmXj2UXnJG6pUTfzwHFAeWjge8CN0vqb2al\n7lpP0rBRwcyejbx8HpdBsixHDDyiUpGyPJhhB/RH+x8cVL93++6x635u1npu79c6qP8QQjNI7t11\naEIjaX7+0feUyoXKcOLsm+LXDdgcWeAfU+8NbiNVsutiqcqw7Aa8XOb8aJxRuBe3b6Stma3150ZJ\nOgCnTPwOEHUWjMIJSe4EnElpwxKVb0HSQKCPmb0o6XbfRqlEYUexuUpyOb4ClLzrR3fe79ZtNwbW\nD6yyyZwCSUQdDhr3aOVCTUQ5ZYZqCJlx9O22a6rLgF9Z8lxQ3ycG1P3PgvQk+2sFW5ddy9Jo572k\na4EDcH6W/YEjgXPMbKmkF4DDgMKv6TYzO9Mvp12LE4+8wm9UnGdmUyXNAK6T1N3MCjOan0u6Epc+\neL9I9ycBt/u/b8WlHY4alse99P6ruIyTld7LwTjDckCp82b2R9wyGaQYbnzYwMOD23h4+r9j131u\n5uOx6+7Yq6b1PSuSh+PnpEZ27UpVhmUCsHELrpl9S9I2wDjcjKIrLvUvQEdgBZsMS6GOSfon8G2c\nJMtoYGfvWAfo4vv4s399HnAXbjnrBuAj/vhooLd3vgP0kzTMzArxrAdXm7de0u6+vyPMbEE1dXIa\nz7qS+qA5WWDJ8kmp9Z35tMIJsFU774HHcEtc3zCz3/tjHf3/o4GvmtktAF4kcrKkjiXaOQAnxdIK\nN0veveAf8TOHC9lkWPC5VX4NnCrpU7hd853MbKPPRdJPcLOYS6p9w77eIJzh+kIh6VctEzLbSJvl\na1fysa7DKhesUeYufiu1vvNothbO1jxj8bONY4GrJX0PmAcsB36MC0H+eqTscklPA4UdfQUfSytg\nBnAaLnJsZpHT/UlgV0l9S/R9KfA94Clc4q4od+KWxCoZllclFT6m23EzpJ7A7/xMa52ZZXvNpkaZ\nu/gt9upbcqUxE+ShzjlpkeUZSy7pUj2pXagBPYYHtzFjYXjCrTj06Bw+W9m96+Cg+mNn/Cd23ZZs\nWHp13Smo/rzFb8euGxqNB+nONklA0mXhMR+v+p7T494nckmXnMaxf+cwra00Cc3HkjZZNgx1dYOC\n21i1alrsugf2j59Db8f6/jw1M3404B59PsYefT4Wuz7A+DnPVi7UhFiGc+TlhqVK2gTkZ0jiUeL4\nvnvHrnvn7JeCxg+wbk28TY779RsZ1C+E5bxvXxcWIn5i7/jXHeDvU++KXTc00VbPDp2Dkm2NHnws\nowcfG7v+Nq1LuVqbhz5tuwa3EZKTZW3M30sU25p9LE1BAxIxvwLO90V2wEnBrMSFDl+H2ycz2Z+f\nb2aHSvoOTjZ/Hc7382UfwjwEuN/MNq4hSboIWGZmV/m/v+brAFxgZg80yZvFraGFGJd3dtkV59aK\nxxXddmXYm+k8edclIJv/1o7xc8mMH/Qh9pgWP1HY2SkKAW5IeZn6nvdfCao/vHv8Jcz3lswKkhJq\n36Zt7LoFkjAOQST41ZN0OPBrXAbeP5vZFQ2U+yzwD2BvMxvn76VvAoV1zefN7IxK/TW7YSknEVNI\nS1zIGGlm4/zrkcBTZnZUUXOv4HTAVkj6BnAlbtNkNVxtZldVO+64T+y1Qlqz6mmrwiO5d54RdoNb\nHTyCdEh7GW7lyqmp9t/SSWrGIqk1bh/hJ3FBVC9Jus/M3igq1xm3xeOFoiYmlkkZX5I0ZiyVJGKq\nxsyiO/eeBz4fPrzkCU1zukuP8LXyNxbGXyuH+IZ10vxXGNH3wKC+06QlZ5DMSZcEl8L2Ad4zs0kA\nkm4FjgGKn1wuwT2cnxvaYRqGpZJETEMcGMku+Q8z+2nR+WJplqFF2Sj7ANEZypmSvojb6PndyK7/\njUQlXcaMGcPpp58eY9g1MKVOkZDljFogNww5aWHrq19Aj96rPH/0yiHg9BanR87NoEh0V9KHcer0\n90sqNizbSXoFWAJcaGZPVRpP6s77qESMmZXzlJZaCiu08XlgBE5uv8Bm0zfvVynwe5x1Nv//L4Av\nF7dbK5IuWaZXh24sWRvfP5ST01JpzIyl6F5VTCkLtfF+5jetX43bZ1jMbGCQmS2Q9BHgHkm7mdmS\ncuNJw7CUk4hpNJIOBX6Ik8GvajndzOZG6v8JuD9O3zmVWbV+NZ3adEh7GLE5ZlDJZ5mquXda/tXK\niYdtSGxrygwgGh45AJfTqkBnYDgw1m8Y7wPcJ+lo7+deDWBm/5U0EdiRCvfrNAxLOYmYRuGnb2OA\nw83s/UbU62tms/3L43Cy/zVLEpsM09pP0q1dfSr9JsULSyamPYScFkqCPpaXgGGStsNF256ES1vi\n+jFbDGxMfBQNnvKJFRea2XpJ2+NyY1UUkWt2w1JGIub75WuW5OdAPfAPb2mnmdnRVdS7UtKeuOng\nFCKyNLVIljcZdmzVPu0hBJH7WHLSwiyZGYuZrZN0JvAQLtz4OjObIOliYJyZ3Vem+kHAxZLWAeuB\nM8xsYaU+c0mX6skvVAy2D8x3/0CPvpULVWDnd5psi1KTEionA2Ehy6EbNEM2Z4Zm3oTUs28GW4UZ\n+36i6nvOgBceqylJl9ywVE9+oWKwTZcdg9uYvyQ9Aeq9+x0UVP+lWU8mNJKcjBF8o5824pCq7zmD\nxj1aU4Yl9aiwnK2bfh17Zno5LDcMOWmRoPO+2Wk2wyJpmZnV+7+H4cLbdgEW4eKjf2xmT0o6Dec7\nKWz+eNXMvijp5zg5/jXAROBLZrbI78ovyL20At4HTjaz94vaaofbbf8nSTsDfwX2An7YmB34aXDk\noPiSJgUemBZ/OeiQAYfFrturTWeWb1gTuz7AsF4fqVyoAaYtrTqmoyS9O3YLqn9wwIztf6tmVy5U\ngbcWTa9cqAF26jYgqO9X58RPbZzE/qesJwvLDUsjkFSHyzB5bsFpJGk4bh9K4fHwNjM7s6jqI8D5\n3hH1M5yuWMHhv3GPi6TLgW/h8sVsbEvStsAESfcBC3HSBfEV9pqREKOQBCtsbWp9r2cD3dp2il2/\nW4/tgmYdoTvv/xMo3R7ip8gyR/XcPdX+Tx1yQuVCZbhhyp3BY8iylyKNpbBTgOeikQhm9joVQn7N\n7OHIy+eBzxaX8TpknYEtHlX8DGYiMNjMXgTelxTuIWwBhOS8H9TjQ8H9967rHtxGXEJ9kDMXxTcM\nfbvt2mLzwfwtQBU6CZIwDKHkM5bGUY2kSyHzJMCvzeyvRee/DNwWeV2Qe+mJC12+oLhBH4O9PSWM\nTkNEZRLate1J2zadq626GavXhS0FQbqyMOcMOSl23TYJqBuvXB9+/eLiw9hj06XT9kH108w7n1aq\nBYB27cOW4fp0Cn8YmbYwvip2EiQVbpwGqTvvJd2N23Tzjpkd7w+XWgorlP8hTqz3psjh6FLY93FC\nagVp54KRWg18vZoY7AK5pIvj6im3xq6rISfx7Jo5Qf2H5GMJZXjnMAHQ/0x/KHbd3Xrvy269961c\nsAwT5hYL1VbP4C69g/oOSfS17zY7BSX6Oiig71phfSO0wmqNtCRdNsZwmtlxkkawuUBkSSSdChwF\nHGINr1HcB0TnsQ0aqZZCaIrZQwP9DLNXV23Lt2CHDn2CggcAHp3xcOVCDTBhaXzndyhJJKsKYe6K\nLXRZG8XE+XG0Zh1dOm0fNNvbqWvYjGeb1p04YuARses/OP3ByoUqkM9YGsfNwPleh6bgZ6ko6eIT\n1Xwfpwm2okzRA3BRYzk1wNtr5tOzXZfY9T9Yv4LuKWYiTJM3ls1IewipsWT5pOBlxKyT+1gagZmt\nlHQU8EtJvwLmAkuBSytU/S3QHnjEr3tHM5kVfCwCFuOySjaIpD44EbUuwAZJZwO7VlLsTIvjB1ej\nUtMwB3bbibumllNtaDqOG/QZxq8Iu0G+PPvphEbTeNJ0frcK9O+EsmzF5MqFmpA0/Uu1QJajwvKd\n99WTX6gYZFlAE8Kj2tJ2AOekRvBTwRtDP131PWfXif+qqelN6s77nK2bHTuHRRalTW4YctJi/YZW\naQ8hNrlhyWlS1tg6Fq8t5xLLaYi6uvCU1KtWhaWkzkmPLC8m1aRhicq/lDg3HnjDzEZHjl2Pyx65\nGDcF/Y6ZPerPjQX6AquAZcCXzextv5nyUuBEnBz0783smiZ7Uy2UZetWUd+mLu1hZJLcKLRsNuRR\nYc2DpF1wemAHSepkZtGct+eZ2R2SDsbtPYku7p/ik9acjtMOOxqXhnMgsLOZbfCSLzVJ2vLpIXRq\nnV0BypycNMnDjZuPk4G/4cQrjwZuKVHmOaChhf0ngbP939/AiVVuACf5kuxQkyOrshwAr8x5JsiB\nH+q4b183sHKhMhy+7R5B9bOcmnj04DApvVum3pPQSFom+VJY8zEK+CSwE3AmpQ3L4UBD3+jPAAVv\n7FDcrvzjcFkszzKzze5iUUmXMWPGcPrppwe/gZbGv3qP5m8dRwTV//TcUh9zdaxeFbbBcdyATOiU\nNgm5YUiXfCmsGZC0NzDPzKZKmgFcJ6m7mRW2B/9c0pXAtsB+RdVvkrQSl4b42/5Ye2CVmY2QdDxw\nHXBgtFIu6RJOiFGoBUbMSO/mmuUl0LQJVaWG9NNS51FhzcNoYGdJU/zrLsAJwJ/96/OAu3By+DcA\n0SQep5jZuKL2ZrBJ+uVuXH6WmmRU4JIEwG0pPX1+uM/+TF0etsqY5j6WnGyStlFIgiw/yWbCsEhq\nhYve2t3MZvpjBwMXssmw4J3wvwZOlfQpMyunAHgP8AncTOXjQHr5byvw5uq5aQ8hNpIYUh8mZthS\naamzjSTYo8/HgtsYP+fZBEYSn3wpLHk6+uWuAr8EZhaMiudJYFdJfaMVzcwkXQp8DyhnWK7ALZGd\ngwtDLisDkyYhmfjSplfMVAMFFq5fnmre+dAllSw/OYdK169ZHV/KJ1QnrFv7+MnhaoUsR4Xlki7V\nk1+oGOzf/xPBbUxfOS+ofr57PicFgq3CU30+W/U958A5d9SUFarVGUtOhLd3ji/fXWCnt+LLeH8n\nINHXvm23Ze81rWPXBxi98LGg+iEM710cB9I4pi+PbxSTWEJMezknJz4WbptSIzcsGeDERYuC23g1\ngXHEYbat4r62YW2MrlykZlm8LH4GhySiwtKkJS8jJsG6DC+FNalhkWTA383sC/51G2A28IKZHSXp\nNNxO+Kjv5FRcVBfAIJxMy2JgAS71cPHx+Tj/yP1mNryo/xOBi3AbKvcpjgyTNAh4A7jIzComGkuL\ntH0svwzIIJlEzvs0WbouPZ2z3HnfsslnLA2zHBguqYOZrcRtbixOhF0qw+OesFED7H4zuyN6svi4\npCEN9P86cDwwpoHzVwPhqd6amK71Q4PbCHlyDmHNhnWp9JsUUxekNdfLPi19xhHKhrQHEEBzLIU9\nCHwauAO3qnELRRsRmwozexNcyGsxko4FJuGMX02TllFIgh079Ut7CDk5mSSfsZTnVuBHku4HdmfL\nHe6jJB0Qef1RP7tpMiR1wqU5/iRwbplyuaRLIE/OfDTtIeTkZJJ8xlIGM3vVL1WNBh4oUaTUUlhT\n8xPgajNbVmo2UyCXdAlnr74HVC5UgTRTE+dkk61C0iWfsVTkPuAqYCSbHPBpsi/wWa8t1g2X936V\nmf025XHl5OQkQNpGIQk2ZNeuNJthuQ5YbGavSRrZTH02iJltXIqTdBGwrJaNyllDRgW3cc2U2xIY\nSeNZtDbchTWs10cqFyrDu/P+G7tulnPeh6YMgHB16Jz4bMhnLOUxsxnArxs4Xexj+aaZxdnVtVOR\nDMw5wDrgN0Av4F+S/mdmn4rRdqqkZRSSYFiHPry7ck5QGyGGIZQs79pvyUYhVCvszQ/CsneGyNkU\nyPLaey7pUj2pXagjBx0Z3MYD00q5t5qeUJ0vCNP6yslJieDpxl19Tq76nnP8nJtranqT77zPAP1a\ndUx7CLFZuX5N2kPIyckkG8oEFtU6uWHJAH+eckflQk1ISIra+tZ1CY4ke5w65ISg+jdMubNyoRrl\nwP6HBNV/KsVQ9SMGhunzPTg9fN/1+uAW0iP1pTAv+/JLM/uuf30uUG9mF3nH+tdwqYM74dIKX2hm\nb/iy7YArcSmHN+DkWb7lfTpIWu/rtAEmA18ws0X+3L9xmSafNrOjqhhqvmYYg1GDj+WRhROC2kgz\n0VeWnfc5qRI83bil3ylV33NGz7qpbH+SDsf5uVsDfzazK4rOnwF8C2fPlgGnR+6z5wNf8efOqpDn\nCqiNGctq4HhJl5vZ/BLnry7oeEkaBTwm6UNmNg+4DOgM7Ghm6yV9CbhL0r7mLOZKMyvIw9yAu3A/\n9e3+HOgIfL1J310CTBsR9uQHMGhcOk9/s9ctZXiXQbHrr7S1qeZj6V3XPajvLHNvn5OD6h8z5+bY\nde/oe0pQ3wCfnX1TcBtpklRUmKTWwLW4DeEzgJck3VcwHJ6bzewPvvzRuBxYh0vaFTgJ2A3oB/xH\n0o5mVnZCVQuGZR1uE+I5wA/LFTSz2yR9GjhZ0p+ALwHbFd6kmf1V0pdxmSGL76TP4Xb+F9p6tBZC\nn6shLaOQBGvKf/8q0ppWPD9rbCJjiUNLDhwIMQyhZN0oJEGCSyT7AO+Z2SQASbcCx+BWeFxfZksi\n5TtFuj8GuNXMVgOTJb3n2yurjFsLhgWcNX3Vb1isxMvAzsAOwLSiCwIwDmddN96NvcU+BPhLYwZV\nK5Iunwpc7wV4KIE13zgc3rZ/UP2JrOQLg48PauNvU++KXXeffh8P6vvFWU8E1U+T/t13C6q/fcc+\nset2a90hqO8564pvC40n7YeKxmyQjN6rPH/0yiEA/YFo7PkM3Cbx4ja+BXwHaId7OC/Ufb6obsUf\ndU0YFjNbIulG4Cygkk6YIv+XMurR4x0k/Q8YAvwXeKSR46oJSZfnFr6dVtfBXLc0XB04TT9Flg1D\nKDM/CPON5YTRGK2wontVMaVM1Bb3MzO7FrhW0snAhbgUJlXVLaYmDIvnV7jZyF8rlPswblbyHjBY\nUmczWxo5vxfwT//3SjPbU1JX4H6cj+WaZIfd9CxZPintIcTme532SHsIQYQm2zosQLPqzvdfDuob\nYNmKycFt5KTD+uSijWcAURmGAcCsMuVvBX4fsy5QQ4bFzBZKuh0XfXBdqTKSTgAOA75rZsu9Q/6X\nks7wzvsv4hzym+WyNbPFks4C7pX0ezNb27TvJqfAX9aG39iaW6E0SULChW+oXCRnKyZBdeOXgGGS\ntsPlwzoJ2CwyQ9IwMyuEX34aKPx9H3CzpF/inPfDgBcrdVgzhsXzC7a8j5wj6fM4h9LrwCd8RBjA\n+Thxy3ckbQDeAo6zEjHUZvaKpPG4i/o3SU/hfDX1XgrmK+XC6NKMa79q0OeD+v7Z4peC6n+9e3yt\nrk/XDeaHV+4cu/68K58IjooLCX4Y3W33yoWaiNA9MBBm2NKMCmvXfkBQ3w922z+oPsAhc9OVUkrK\nsJjZOklnAg/hwo2vM7MJki4GxpnZfcCZkg4F1gIf4JbB8OVuxzn61+G2c1SMyEl9H0uGsLjGJXSz\n1PGDjw6qD/DUovh+mnmL3+bCIfFuMlNsVex+C1zWa3HsuqERdWnnbQ8xLklsrgwxLmlGlQE82ju+\neGsCRiV4IesPAz9f9c35jOl/r6lt+rlhqZ7ULtSAHsOD25ix8PUERtJ4QvOxzFq5IHgMITf3UB9L\nSN76+o7bBfUNYT6WDh0GB/W9cuXU2HW7dNo+qG9I3TcZfKP/XSMMyzdrzLDU2lJYzlbG/NXxZxsA\n7Vq1STUqrHPb7Oq0hRJiGELJcsBKUmRZ0iXYsBTJprwJnGpmK/y544C7gF3M7C1/bIgvF12b2cfM\n1vjz9wLbmtlHI31chMuZclXk2BRghJnNl3QdcBTwvpkNj5S5Hvg4sBioA24xs5/4c38BRuCeLN4B\nTjOzZaHXoylIa7aRBKd12Z37V6d3gwrlnXnjUuu7c7uwvRwQlpOlfeu2QX2HGIetYMYSTEtP9BWV\nTbkJOAMnBwAuHfHTOIf5RZE6Ewt1okjqhgsXXiZpOzOrdh5/PfBb4MYS584zszsk1QFvSLrRt3tO\nYXOlj3g4E7iiRP2cAC6echPjEpD9T4sRfQ+sXKgM42Y/Fbvu2g3rgvqG7OZkCTUKfbrtkrp/LJQ8\n5/0mnsLLpkiqB/YHDsaFrF1URf0TcHtQ5uKM0eXVdGpmT/qZUDkKMrvLfZ2CURHQgRoWmQy9uUHY\nDS6EC4eczF6tuqXSdxKkdd0A5i95J7W+s06oUTiw/yFB6sxJKDPnhgWQ1AY4Avi3P3Qs8G8ze0fS\nQkl7mVlhx9dQvyMe4Bkz+5b/ezTwE5xhuYPNDUsh7LhAvyqH9nNJF+IkYK4xs/cjY/4rcCQulO67\nJd5TTUi6pHlzC+XSKelGBoWS5owl66Qpm781JJir2SfdKkjCsHSIGImn2KTHNRq3mx7cTs7RuJ31\nUGIpTFJv3M3/aTMzSeskDTezgoPh6hI+lmooLIXVA49K+lgh9bGZfcnriP0GGEXRrv9akXTJMln/\ngb+/elFqfWedNPOppG0UkiD3sWxpJHriRMyG+3wrrQGT9L0y7YwCuuMUNAG64JbDLkxgjJjZMklj\ngQOAZyPH10u6DTiPynIyOY1k9qqFQfW/0GV3zo+5h6bA5QGzptXrW65IQ4/Ow4Lqh+TR2XnbvYP6\nBnjr/bCNwWnToqPCGuCzwI1mtjHXiaQncDf1hryJo4HDzew5X347nGhkIobFL9XtC/zG+1WGmtl7\n/u/P4Hbt5yRMq8Bw/puWvMYpXeIn2woxKgBzF7fcr0WaCdaybhSSYEOGF0mayrCMZssIqztx+jQ/\nKy7sHe+DiMgzm9lkSUskbSHvXKL+LcBIYBsvz/JjMyssyRV8LO1wUvp34UKMb5DUxf89HvhGI95f\ns/LVIZ8NbiOt9Mb96noGtxFqHELIemRRTnZp0c57M6svcWxkiWNRVeHhReemUELj38z28n++UOLc\nkMjfoxsY22klB+38JeFiQs3ErA0rUu2/e/0OQfUH1vdKaCTNzzbtu6bWd2g+FAiTvg/d+Z+msvLW\nsJSW3flKvvM+Ezww7YG0hxDEq3PKJpuraV6f+3zlQk1ES86HEion06djdkPcC7ToGUtz0NDufkkD\ncNkndwVa4XKunGdma3za4ceBo83sn76d+4GrzGysV/s8GxgK9DKz+c39vqolVK8KwjSrPlj2Xuy6\nO/YawY69RsSuD+nufm/JpDnjSFNOplZYp+zOWTJhWCixu1/S1Th/ye/N7BgfNvxH4Ke4CC9wSWp+\nyKbEX1GewRmisU089mA+2jVsKSpN1gXmvE+bNEUou9YPDeobYPGyicFtZJEsp/MukF2zkh3DEqWw\nu/8TwCoz+ytsDBs+Bxeu/GNfdjzQVtInzWyztMRm9gqAD22uae6ael/aQ4jNpPmvpD2EzNJSjUIS\npG0UkiBfCmsminb374bLY78RM1siaRpuo2WBS/2/RuW7z0mG3l3jJ/kqkGbIb8iMI+uECFgC9K/f\nJqj+B6uWVi5UhhARAjhhqQAAIABJREFUzzQVtQvk4cZNT6nd/d+g9GxR0eNm9pQkJDVam6NWJF3S\n9rGE0KN9l1T6zck2aRoVgEE9PpS6ccmuWcmOYSm1u38CTrQyeqwLMBCYCEQ3UPwU52tplFxsrUi6\nDOvUN62ug1lvWZ7QZ5vBPcPSKvfp1J2pC15NaDTNS+j+o1ogy7+crBiWUjwKXCHpi2Z2o3fe/wK4\n3keMbSxoZg9LuoTqhStrivrW7dMeQmzmrcy1ttIiq0YhCbq122J7XeZYn+E5S2YNixeqPA74naT/\nw4UbPwBc0ECVnwL3Fl5IOgv4HtAHeFXSA2b21SYedotjpy4DWGPheUXSIlc3js9uvSuKZpRlwtwt\n9kVXzer1a4L6rgXyGUsTU2p3vz8+HafzVercWCKhxGZ2H5E81F4J4JotKtYgWd4gmWWjArB3+/SW\nIbMebhxiGEKZvGB8an0nheUzlpymJMtaYVOWzU2l36T4/ZTbU+t7QKewqKqcbJPPWHKalLSMQhLU\nt63LtPT8oB7xlZUhLGx14eqwyKicbNMiw42LZFYmA18ws0WR8+fgMkD2NrPF/thInJ9jMs4n8j5w\nspm9L+kY4BKcoV4HnG1mT/t6w4CrgV2ARcASnILxk5H+7gW2NbOPRo5dBHwNmOfHeYGZ3SfpIFwS\nst2Bk8wsu3fuGqdtq7a0bdU2dv1WEsN6fSRoDO/O+2/lQg2QZshpS95Dk9Nyw42jMis3AN/COcgL\njAZeAo4Dro8cf8rMjvL1Lvf1foyL8rrPO+V3B24HdpZUB/wLONf7SZA0HBgBPOlfdwP2ApZJ2s7M\noiJHV5vZVZJ2AZ6StC0wDTgNODfg/TcbRw46Mqj+I3PC15vXrpkZq96l7XbhrrbLYvd7Sft0Zzvj\nBhwbVH/EjHti1z1kwGFBfQM8OuPh2HW7dNo+qO8lyyfFrhu6dyuJEP0nU8yACbAuw6YlqaWw53BP\n/wBIGgrU4zS7LmBzw1IoI6Az8B64DI+R053YZLBPAZ4rGBVf9nXg9Uj5E3B6YHNxWScvL+7PzN6U\ntA7Yxsv0IykTy5hZdt5fvmESrI5f/3Or01VHDjEMoYQYhSQIMQyh5LO1Fu689/tHDmFTrntws5Vb\ncLvkd5K0rZm9788d6HfR9wSWEwkP9uHDlwPbAp/2h3cDXq4wjNHAT3CG5Q5KGBafMGwDblms2ve2\nced969bdaNW6U7VVt2DN6hmx62aZZetWpT2EnJQ4blDJgM2quXtaKe3Y6tijz8eC+gYYP+fZyoWa\nkEw89TZAiGEpyKwMwWl2RbW4TgKOM7MNku4CTsTJ28PmS2HfB64EzgAws7uBu70P5BLg0OJOJd0N\nDAPeMbPjJfXGaYM97ZfR1kka7mc1AOdI+jywFBhlZlU/BtTKzvssc2z9TmkPIbPU1Q0KbmPVqmmx\n644aHLYM+M7q9ysXaoC96vrzhcHHx66/e/s+PJ1xEc+WOmNZaWZ7SuqKk5//FnCN948MAx7xu9/b\nAZPYZFii3IdLWbwZZvakpKGStgEmAAdFzh0naQRwlT80CuiOUzUG6IIzbBf681eb2VVkmNBNepDe\nRr07loQnq/plAuNIi1OHnFC5UAOM6rM3N0zZ4ufRbNw2Nb1lwLQ5dcgJQZ9dEp9bS52xAGBmi/0u\n9nsl/R63LHWRmW1cjpI0WVKplHAH4HS9kLQDMNHPOvbCGaQFwM3A+ZKOjvhZOkbaGA0cbmbP+Xa2\nw82eLmQrYWi78LzxaTFt4WvBIbtp5p1PM9w4Jz3SNOgF1le/uFJzJOK8N7NXJI3HzRROwknbR7nb\nH3+BTT4WAYuBgozKCcAXJa0FVrJp2WqlpKOAX0r6Fc6PshS4VNIQYBCwMX+smU2WtMT7VEoiaW8/\npu7AZyT9xMzCE4w3EU8ufiftIcRmr74HBOeNf3n20wmNpvHkhiEnLbK8j0WNcDm0dPILFYMkVGZD\nZhw5OSkRnEFw9OBjq77n3DL1nprKWJjvvM9pUnKjkJMTjxbtY8nJKUf3+h0qF6rAB8veS2AkOTnZ\nIstLYTVhWBqSh/E+lDeBt3HO/HHAV8xsbaTur4HPAgPNNmWVknQ4cDEuSmyVb+M8M5vmz5+L8++s\nA9YDvzCzG5v2nbY82reJL+eSk23S3Mdy4uBjgvoG+MfUeysXakKSDDf298NfA62BP5vZFUXnG5S5\nityfAaaZ2dGV+qsJw0J5eZiJPqy5NS7a63PATb5sK5xkzHRcSPJYf3w48BvgaDN70x87GrfnZpqk\nM4BPAvuY2RIfMh0WtJ9TktXr1tK9rnPaw0iN0CyOWU7WFWIYQgk1CkcMPIIjBhbHIFXPg9MfDOof\nkosK8/fOa3H3vBnAS5LuM7OovEE5mastMvhWolYMS5TN5GEKmNl6SS8C/SOHD8ZJu9yGCzse649/\nH7isYFR8/fsi9S4ADjazJf7cYuCGBN9DohzU/5DgNtLSPZLEotXxtcLSJjT4oH3rfMaWE48El8L2\nAd4zs0kAkm4FjgE2GpakZa5qyrA0IA9TOFcH7Av8v8jhgnTMvcBlktr6ZbLd2LSBsridzkBnM6u4\nLTcq6TJmzBhOP/30xr2hhNimTXwpmbRZuPTdoPp79zuIvfsdVLlgGV6a9WTlQk1EyIyjb7ddg8UY\nQzS3enUNU02Yt/jtoPohbNdzj+A20k4W1pg7fPRe5fmjVw4B9zA+PXJuBu5eWi11ksbh3AZXmFnF\nnbO1YljKycMM9eeGAXeY2asAktoBRwLnmNlSSS8Ah+GUkDciqSdOObkjTp7lj1QZOpxLuoQTOtvq\noLapqsymGdWWthBjqGEI2bkOYZsUR9QPCeq7FmiMj6XoXlVMqVDkxtzPBpnZLEnbA49Jeq3Sg3mt\nGJaS8jD+XMHH0hcYG9mBfzjQFXjNS7l0BFbgDMsEnIz+eDNbAOzpnfX13qeyXNL2halhrXPX1Psq\nF2pCQiK76tq0o22r1gmOJicrpLl7PW3HexIkuBQ2AxgYeT0AmFVtZTOb5f+fJGks8GG8YkpD1Iph\nAUrKw0TPzZb0A+B8nMbYaOCrZnYLgKROOL2wjjhhy7slPR/xs0RlYC4HrpU0yhuaLrhIiIYsfosm\nJNz3sIGHJziS5idNOZmc9GhfN7ByoTKsXjW9cqEKJLh5/SVgmJe7molTQTm5moqSugMrzGy1127c\nH3d/LUtNGRbYQh6mWDnxHuAiSR8HPgV8PVJvuaSngc+Y2W2S/h9wo/epLMBFPfzYF/89Ll/MS15C\nZi3wi6Z8XyH06DwsuI1QX0dcJq+qOktBTfLxQD9DTjZJwjCEsj6hGYuZrZN0JvAQLtz4OjObIOli\nYJzPqtuQzNUuwBjv1G+F87FUXKPNJV2qJ79QLZBchDInJsESK4cO/FTV95z/TH8ol3TJaTns2GsE\n62x9UBuT5r+S0GgaT24YctIiyw/9uWHJANNGhO9jGTQufmRVqCzLyB5hfoo0Q25D6dChVLaI6jmk\n1/DYddda+JaEhxLY6JdFasHHkku6BCLphzhn0npc+PbXgZ8B2wODC1kfJd0DHGpm9ZG65+Cc8b39\nRkckjcTtbZmEc9rPBa40s/v9+TNwkWfrgWXA6dWsG6ZFiFHYGkjTMCShzhyXbu078d8lk4PaSDtk\nOSc+LTWDZCJI+ihwFLBXJPKgnT+9CBeF8LSkbkDfEk2MxkU9HAdcHzkeTYG8J3CPpJVm9ihws5n9\nwZ87GpekMNvhS01IqAjkfv1GJjOQFMijulomNeG8z5fCgugLzDez1QBmNh+cFAhwKy467GngeOAu\n3K56fJmhuOiu83AyLdeX6sDM/ucjIM4EHi1IuXg6UeOO+dDc45Bemtkk1I1bKqFLgBA2Y2nbrn/l\nQmVYu2Zm7LqhS4jDu4fVh3QVGyBfCgvlYeBHkt4B/gPcZmZP+HOPAn/yUi8n4SQL/i9StyDp8tT/\nZ++84+0oyjf+fRJKQoBASEKHQKR3BARRKYqKoiICgmADQRSk/QREUWmioCjVgkBAQZSioAgSurTQ\nEkIH6V2K9E7y/v545+TuPXfP2dmdc3Nyc/f5fM7n3i3PzOzOzszuzPs+L7CCpLFm9myLfCbjAxAA\nknYH9sW/jjbNI8wqki5T36zeQLuNEXMN63YRkrD8mHWS+Pc/d0tlbrensVIGhlS8+eajXct7VkE9\nsCTAzF6T9H7gw7io5F+CIyT4Gsi1wBeB4Wb2SPiSaWA74PNmNl3SX4FtcBXPPPQimtmJuJPkl4CD\ngK/mlG2WkHRZau6BG/P+if/d2e0iJCFlYKhRIwW1VVgizGwarkx8laQ76N3J/xl33Dk4y5G0Oq4f\ndmkYbObCF+tbDSxr4bFdmvFn3GFylsXEx//V7SIMWoyef/kk/qvvvJnEnxXm+mt0B/UXSwIkrQBM\nN7OGa/iawKNAw87yGtzq66wm6vbAwWb200xaD0vqM7kaBqEf4oG9kLRcJr9PA91xS69RiG6vMzz/\nyv3J+deoUQW1VVga5gWOD1Zf7wEP4Osa5wIEU+M8CfztgOZIPH8L+28EPixpCm5u/CywZ7AIA9hD\n0sdwKZcXyZkGq9EZpMqXDxs6Z9fly2vU6AamdcAPqVuoJV3iUd+oClh70Q8lp/H82y8n8VO852sR\nysGJDjhIJkusrLXIhtF9zpRnrqslXWqUQycUgru1TjP56WuTBpehGsLCwxbsYInKoR4YBidmhbWt\neo2lRr9iIC/eLz9mHV559/WkNAZr5774gqsUn1SAJ1+8qwMlGXjohGJCt5+7eo2lA8hEegRYBDc1\nbmiur4cvsv8VWMnM7s3wVgGOx4PXCPgDcLiZmaSvAeuY2R6ShgATQro7A4cDXwEWzErE1Ogs3rNp\nzDPHwPZl6RYG66DQCXR7UOgEpg/gZYpZZmBpRHoEkHQw8JqZzVi0l7Q97tOyHcH0WNJwPOjXt8xs\nYgjydR7wbTJmx3J75N8CcwJfD4POP4ATGAAWYUuMqi5E2EC3/EnmGjLLPGIDDvPOs0xyGq+9kaY1\nVqN7qL9Y+hmS5sU1wzbBB5KDw6EvAdeZ2UQAM3sjBLS5it7+LMcCCwFfNHNTCzObFNKeCVeQhoHs\nZDh2zvl5adob3S5GZSw8csUk/n9fvrf4pBaoB4XBjYFsFTYgBhZgS+BfZna/pP9JWtvMJuO6Ybdm\nTzSzByXNG8INgw8+9wAbm9l7ZTKdVSRdvjFu6+Q0Tn7k3A6UpDyeeedllhk2pit5dwJDNKTbRega\nxiRGz3zu5fs6VJLySDVzB7pu5l5PhfU/tgeOCf//OWxPxtdUWt39xv7JwIr4Os11ZTKdVSRdujUo\ndALvTn+X+994qtvFqIxu6nV12zm0mwNDjXoqrF8RFvU3BVaVZHjMZpO0P3AX8JGm85fF12deDdNc\n9wI/As6W9Akzq1dEZyK6/dY3kNFtEcqBjNnhuau/WPoXWwN/MLNvNnZIuhr4EHAm8H1JHzOzy8Ji\n/nHAUdkEzOz6ENzrn5I+YmaPzcTyD2qk+uDc8Wp6VdUddHcwct7xlblvvvt2cv7LjswL3xSPe5+9\nObkMKai/WPoX2wM/a9p3HvAlM7tG0udwSZgT8a+ZP+LWXr1gZhdKGgP8S9KHgQPw9Zd5JD0BnGxm\nB/fjdQxKpPrgdGI6qEZ38PJrD1bmzjX3Esn5d3tgSMU0m9btIlRGLekSj67dqI8snh7z/t9PDu7w\nxjUGF2YBB8lkc9OlRq0W3ec89r87Zinz1oHwxVJjAGPzJZt1Qsvj4scv7kBJagwmzBYOkvVUWI3+\nxPpzju12ESqjE5b4t4/7TBJ/9Uf+0YFS1KgxczGQZ5O6NrAUSLisAUzFy/cw8GUze0nSOOBCM1tV\n0sbAlcA3zOyUkOZahBDEZvYLST8HPgO8AzyIe92/JGkHMmGKgdWBtc3stv663hT86ZXq6rwNHFV8\nSr/gf9PSdMIAdk6cah7YM+3dwxyJMe/fSwht3Ik1lnfefiI5jW6itgqrgHYSLpJeM7PGsdOB3YGf\n5CRzBx62+JSwvR0+IDVwKXCgmb0n6UjgQOAAMzsTtyhD0mrABbPqoDLQ8eCrTyen8b9XZ3nVndkS\nKQNDKgb6oNAJ1FZh/Ysb8C+KPDwGzC9pYTyY1yeBixoHG1IvAZNw0+VmbE/f6JSzFAaypMtAHxRW\nXXj9JP6d/53UoZLUKIN1F/tI8UkFuPmpf3egJNVRS7r0EyQNBT5KzxdJHs4FtgGm4NNgrQzgdwL+\nkrP/i8DnWuQ/S0i6DGQsO3qt5DQeen5KB0pSDfXAMDDR7UGhE6jXWDqP4ZJuA8bhWmCXtjn3bHzA\nWBH/8vhg8wmSfoCHPT6zaf8HgDfMLPeTYFaRdBnIsAH81lWjRjdRr7F0Hm+a2ZqSRgIX4mssx+Wd\naGbPSHoX2AzYi6aBRdJXgS2Aj1rfV4DtiJwGSwlVOn16Wuf6+PrLJfGXmJQ2HTVirrR4Ks/8etvK\n3C2+fysfXeLjlfnXPp9mdrrOQmn3/ronr0jidxPrLbZREv/QadU93w8akra+88Sbzyfx9xr5/iT+\ngY+ekcSH+oul32BmL0vaE7hA0m/anPojYKyZTcvK4Ev6JO5hv5GZ9dJuD4G/tqFJa6w/MGTIkKTB\nZa9HF0jK/wuLrst5T3fHNmqNkeP4xIE3JaUxp4Z2qDQDC90WoXzhnVfTMh9afWB5bdpbSVkvMFda\n7L7T37yPrw5PU3dORe3H0o8wsymSpuJfF9e0OOf6FvQTgLmBS8OAM8nMdgvHPgI8YWYPxZSjmzGw\nVxy7bnIa3bLwWXb0Wiwx96ikNC5/YmLxSbMhuq1x9uDzk7uWd/UoNrMPBvIXSy3pEo/6RlXAQF+8\nT8VXx30hiX/6I+d1qCQ1ZjKSJVZGzDMuus95/Y1HakmXGuXQ7SmRFDz0/BSWGrVaV/LuBFLvfbe/\nOmoMXNSL9zX6FQO5c1p9kQ2S57u7iYF872sMbAzk2aRuSrr8CnjUzI4J25cAj5vZN8L20cCTuMf9\nvcAw4FXgRDM7PZzzNeDn4bxhwO/M7Ffh2NLAqcAY4H/Ajmb2RDj2L2B94Foz22KmXPAgxepzp8XE\nGMxYeqFWfsHxePSF2ztQkhrdQO15Xw3X41ZZxwQLrdHA/JnjHwT2Bh40s7VgRnTIv0oaYmYTwnl/\nMbM9gvbYfZLONbPHgV/gAcJOl7Qp8FPgy4Hzc2Ae4JsMANy3YrpC8Ar3dkch+NH3Xu5KvrMD6kFh\ncKP+YqmG64Bfhf9XAe4EFpW0IPAGsBLwYpZgZg9J2hc4GpjQdOwFSQ8AiwKPAysD+4TDVwLnZ869\nPIhYDgh0a1DoBK558vKOLODXqDHYMJDXWDCzrv2AR4Cl8C+H3YDDgE8BGwL/xj3v72ziLIA7UAJ8\nDTgh/L8UcBswLGz/Cdgr/L8VbtW1UCadjXGl5Hbl2xW4Jfx2LTo38V50jT+Qy15fe33tAy3vwfAb\nUnVA6hCuw6e8PoiLTd6Q2W7lm9JsVvdFSXcBDwHHmlnDs+q7wEaSpgAb4esw75UpnJmdZGbrhN9J\nBaenCol1kz+Qy57KH8hlT+UP5LKn8rtd9tka3R5YrscHkdXwqbBJwAZh33UtOGsBWZ2Ov5jZKsCH\ngaMlLQJgZk+Z2Vbm6zM/CPvqCf8aNWrU6Gd0e2C5Dtfx+p+ZTTOz/+FTXRvgXy+9EAJ9/QI4vvmY\nmd0A/BHXC0PS6GAUAB6H5dR+KH+NGjVq1GhCtweWO3BrsElN+142s4aK3HhJUyTdgysZH289FmHN\nOBL4uqT58DWU+yTdDyxMJlCYpGuAc4CPSnpC0ic6cC1FU2WzMn8glz2VP5DLnsofyGVP5Xe77LM1\nakmXGjVq1KjRUXT7i6VGjRo1asxmqAeWGjVq1KjRUdQDS40aXYakEd0uQ40anUQ9sNToGFI6SDm+\n2MnyzCxIWkHS7yPOW1zSOpLmCttjJR0BpIX49LSWSOAOT+C+ryAIXzvu/JIOqJr3rICgSVijCfXA\n0kHEdjBt+AtI+kFF7maSLq2ad5k0UjpISfNK2k/SMZI2DQPKt4AHga9ULPdQSTtU4QZ+7MCwuqSJ\nku6UdLikhSWdB1wOtJVBlrQ3rgxxPDAphMy+BxgORMfBlbSupC0ljQ7bq0j6A70tK1txF5a0pqQ5\nwvZoSYcCD0RwV5V0kaTbJB0saYykv+AKGW2D5YXn5URJ50v6mqThko7E63yp4qtum3blNhP4m0gq\n1EyStIGkrSWNDdurS/oTcG3VvGdrdNv1fyD+gNWBibhT5+G4OfN5wBPAPhH8JXFzxQuBb+CCmEcD\nz+LqAe24mwL3A68BZ+CaaLcAtwJbRZa/chq4MOhzuJ/RZOCrwAu47tuiEXn/LeS5e7hnF+ONc50I\n7vy4T9IJwMdxFYbvAI8CF8yEersRlxFaAfeXehIXNB0Wwb0bGBX+Xwp4B1i/5HP301Bv54T6+kF4\nZv4PmKeA+51QTzeHet4hbB8PLBGR96TwrK4S8nsc+CUwPIJ7ebjfnwaOA6bgrgOLl7j2ym0m8DcK\ndfAScFqow0nAVGDbAu7P8ZeAs8L9+zHw3/AMFNb9YPx1vQAD8ZfSwQT+lcDBwCdCh3x7eGgXieBO\nwX105ga2BF4haKKVKH/lNFI7SOCOzP9DcaHR+SO5F4RO4ZuhY7oUuBpYcybV221N248DQyO5k5u2\n74zh5dz74eH/UcBbwAoluKPD/+NCvW1YIu+8a58jkju1afu/ZTvklDYT+FOAjwEjgK2Bl4F9S9y7\nhgbhgsCbwHJl628w/bpegIH4S+lgwvl5DW3uSG5zB/VghfJXTiO1g8zhTy7BzRuU5puJ9XYvLim0\ndvjdk90u4D6Lv603fr22K96720qUPbXe7sWll1YPv3uy2wXcqcB8+Bfn/M3bkflXbjPh/ClN2w8R\n/PgiuLdWve+D9VdHkKyGYZLWokcQ8zVgdUkCMLPJRQmE8AAN/jPAPI3Fb3Npm1ZYQNJWvZPq2Taz\nv0aUPyWNJSQdl9kem902sz0L8l5DUuP6BMwXtuV0G9WG+24mn2mSHjazVwvyyyK13p7Gp38aeCaz\nbfgUYyvs17R9a1SJe2NZSY26ETAus42ZbZVPA7zesmUfm902s30L8n4O+HVm+/nMtgEfacNdCLiL\n3gKyjTUpI3KdJaHNAIyU9NmmfZ8JVY+Z/b0Nd7ykxvHGfZ9xvpk1pzvoUXveV4CkK9scNjNr18Eg\n6RFgOn2Vmhv8ZdtwW8nZNLg7tcs7NY2w6NyOfHpB3kML+NPacKcBr9Nz34bjsXsag9L8rbiBn1Rv\n3Yakj7Y7bmaXt+HuXMA9pWq5ZgZS2kzg/7HNYTOzloYjkjZql7aZXd3u+GBEPbDU6AokrQSsGDbv\nNrP7ulmeWMgjlX6JnrLfA/wp4o25MSjvha/xNLjHmdkfKpRjQQAze7Ho3E4h5Lkdva/9z2b2UgR3\nKG5wMaPOgcvavUjMipA0BsDMnut2WWZl1ANLRaR0MIE/B7A5vRvaJWZWGDNG0gp4PIhs3ieZ2f0l\nyl85jZQOUtL8wF+B5fAFWAGr4qbKW8VMbUlajd6D0l1FnAw3ZWBYCbgCuARfDBa+xrIZsKmZ3duG\n+xU8oum+uDWd8LWZn+NWTVGDSzCt3RMYhrsLvI7f+yMiuDuQX29/iuCugC+gX0Hva98Y2KTdcyNp\n0cB7IcNdEzdA2NTMninKP6RTuc0E/vuAXehd9yebWVtz6zBV+iPcsk74fX8PF8Q9NCbvQYduL/IM\nxB8eNvlp3EJpL9wE93TgKWDFCP5iwH3AVbiFyzG4ddN9wGIF3A1C3ocAn8Otug4JeUdZZ6Wkgfua\nTAE2AUbiYQ42xdcMvhKR9zHhmodm9s2Bm44WmVqPDPfsIdxs+XzcF+JKIhaBO1Bv55Jjmgp8ATiv\ngDsJGJezfxwwKbLe9sI76OUy+5YHLgP2LODuiA/km+FrHqPxL4jbgB0i8j4H2C5n/7bAuQXcCcD/\n5ezfB5gQee2V20zgfwBfl/lJqK+tw/9PAesWcPfBLRCXyexbFn/BKDRTH4y/rhdgIP5SOphw3mnA\n3jn79wROL+BeDGycs38j4OLI8ldOI7WDxN8y+5ipAnMB9xRwj8Pj8QzJ7BsCHIW/PfZ3vd1X5Vjj\nuqscazpvMjAmZ/9YCqzrcL+j8Tn7l42st5Rrv7fKsabzKreZcN5FwEdz9m8CXFTAnUIw1W7aP4Ym\na7P6F+5NtwswEH8pjSyc066hFTXS+1PyTk0jtYOkjalmu2ON9FsMSnMUDUodqreWnXdEx35rlWNN\n57U0EQbuSqi3mHuXcu0tO9/YjjmlzYRzUp75dve9tD/SYPjV5sbV8HrFYw282ebYGwXcdmsQMXmn\nptGu7O2ONTAsrJE0W/cId9hsh3csZz7dzN6T9HZE3qn1NlZSnlmu8LfXdlhJ0u0tuG0tmjJ4p82x\noutPeebArz3PlDzm2vNMfRvctpZ8GaSWP+WZb3ff2x0btKgHlmpI6WDAG1qez0FMQ1uyyY8ky108\nIu/UNFI7yKz/Q96xdmj2Q8nmXTQoQXq9/R537MvDyQXclSLSL0LWBygLAfMW5S8pz09H+DpNESbQ\n+h6dVsC9HtimzbEYpLQZ8Gf+lzn7Y575NSS90oI7LCLvQYfaKqwCJP243XEzO6SAfxruGNaK//U2\n3CQ/ktQ0VKDmamaPFuVfFZKuov1926SAn1RvKZC0vpkVCkUWpJHiAzS+gPtg1XLNDKS0mcAf0H48\nAw7dnourf+V+ROoz9VcalBROzOEflvl/027fz5Jln5j5/8CS3MmZ/2+omP/nMv9HSaFkzm9r+RTB\nvzjz//4luadk/t+xS3UXJd/SgrtV5v8Fu1H+gfarZfMrQNLEzP8HVuCflvm/7ddDDm7KcI8vm3cH\n0pgxjSXphgp5fzrz/y/KEOXS/I3/NyubcWq90XsqqNXUTsvsM/9XnT7JfnFdVZL7uxkFkapIvS+S\n+X+7kty1M/+MngxbAAAgAElEQVQXScfkIrHNQEZCR9IxJbkHZf5vqW5Qowf1wFINKR0MwBqZ//cq\nyc12UBtWyDs1jU50kFXxycz/R1bgp9ZbyrzxEEkLBgfNxv+jGr/INNTi/7LcKgHZUq69E/PtKW0G\nel9/O12zIm7Z+z4oUS/eV0NqQ+l2I03uIPGXksb/MxqbFXuwN6yLRI6lkZnlGRV0Cqn3btkgPqjM\n/z2JtxcjHIm/NTfuVXYh3YgzfBgeLOqGkGNdZ2Z5RhUNDJE0Hz31Nl8TN29xOouGAKboLYbZ4McI\nYIq+YphYsQAmdLfNDQ9GI4373suAxCJEZwcb6sX7CpD0Eh45T8CHw/8zUNDBIOlZ4M+B/8Xwf5bf\nUiFY0ht4xD8B4+mJ/tcQYlw9ovyV0+iAGOBh7Y6b2Q/bcJ/A1YSFe0M3d1B5Vj9Zfmq9bVRQ9mQx\nQkmrWAuJGknXtM/eWr6Jh3vXXG9GT523VRjutgBmSpsJ/Ddw6X/hkjYN+Z3G9a/dhntl++LP2uKl\n3UA9sFRAagfTbausmWHZ1a6DjOTvb2ZHNe1Ltcbr94Eh5HOemX2hIndyu04uMo1NzeyKitwVrY3m\nWQT/bDPbtiL3GDPbu8WxJGvImWEVJ2kzM0sKDz7boNvWA7PzjwiZkAJ+oUxJG24ly6NOpUGJAF6d\n5lPSYqsf6q2yzEcKt0P3LrXeUq49Ke+QRuU2E/jXdrP8s8uvXrzvX8R6VLdC1cV56MzCekoaqYuc\nKfwqC/NZpNZbt9fQUu5dar11ewokpc1ANcOGBuqF/YB6YOlfdLORdXuRv5uLrQO9c0xFtwe2gYz6\n3nUA9cBSY1ZFyuDQ7QaeUvaBrj3Vza+lGrMI6oGlf9HN6aBONNJ+6yAlrV+w76/Nx0ugX++7pD5+\nFE37DmjD7WM9ld1nZn3uS875fdwEmvY9XpRGG7SN6Chpj4J932/D7WOS3LTvhJgCFqDf6l5SHz26\npn2PJOY9+6DbizwD+Qfs1W4f8PEC/jbt9gFfa8M9st0+YNWI8ldOA7g8Zl8bfp+FTuLl4zdstw/4\nfj/XW17Z2y5a4+tVo4CpwILh/1F4HJtC2fqI/KMWjsnI0rTb18lr70SdZ86v3GbC8SPa7QPW6I/7\nPth+tblxAvJMQyVNMbO1EvhR5qYtuLdbhB9LShqShgHz4FEbN6bnDW9+XE+qrYqvpPXwCJbfxcPy\nNjA/HoQrxg+n8n1rwy+sN0nb42GNPwRkfUrmA6aZ2cfacBsRKxcDnqTnvr0C/N7MCt/WJY0FFsV9\nOLal970/2cxWbMOdCx/crgnlz3Iva8cN/C/iUi4b43XfwHy49lxLAVBJn8BVE74EnJk5ND/eka/b\nLu+mtPqj7qea2RptOIvgCshnhGvI3rvfFt27wYja874CMh3MMk3e1/Phcb2L+JsDnwIWV2/5+vnx\nWNrtuN8Cvo17P2c9recDrossf0oa36Sng8x6kr8CnBiR/Qg8LO4c9JZYeZUCay5JGwAfBMaot/z9\n/EBb5d/AT6o3XOL96VD+o5vK3s7rHTM7FjhW0nfMrKrG26eBnYAl6B164FWgpWNpwO64TtdY4C56\n19tvI/K+Cb9HS9C7nl/FIyy2w7PAncBbIe8s93sReSe1mcD/JrAbsLx6hw+Yj4yOWAt8Avgafu1Z\nJ9xXaTP1N5hRf7FUQHAwXAb4Kb0bxqvA7ZYTjKqJvwawJnAo8KMm/pVm9mIb7kh8KqVP3lYsp9LJ\nNFI6SCQta2YPleRshL8x70bvzvBV4B9m9p8CflK9dQqSPohPgc14sTOzP5Tgb2tmZ1fMe28zKyvC\n2BFIGmZmb1XkVm4zgb8gsBD5z/yzkWX4gpmdV6rggxT1wNJFSJrTzN5N4A8FFqZ3B/XYzEojpYOU\n9D78DbqZ//EI7tLWj3FfIvLfChfBHIu/+TdkQQoDTkn6Iy6jcxs9C+VmBZIkTWnMBWxJ33t3RCtO\nE3+9HO6fIrmfA36Gf7GWvfb1cYXmpUPeDW5MoLFGGkltJqTRCOyWvf6nInhzA1+g7707NKU8syPq\nqbAEpHQwAetJOpi+Da3QQS9Y4hwM/BfXgAI3sy2zxlI5jVYdJBD75n0ucAo+b93WEikHc0s6ib4N\nPEqzqQP1dhTwGTO7p0yhA9YBVra0N7q/4dNKt1Ly3snl51emb71FDSz4FODnzeyOMvkGTAD2p0K5\nM6jcZmDGNPBh+LRe9plfOYJ+AfAyXv6YUNiDFvUXSwIkPUD1DgZJ9+Jiir0ampnFrNM8AHwg5tz+\nSEPSPSR0kCmaWJKm4lNhzfetaK68wU+tt+vMrJKHt6RzgD3N7Okq/JDGnWa2akXuvXi9TS88OZ+f\ncu03mtkHqnAzaVRuM4H/ALCBmT1XIe/K932wof5iScN/q3ZOAS+b2cUVuY/jb08pSEnjTjz4U9UO\n8gJJu+Jv3zPe/qxYvh3gPTP7TcV8Ib3ebpH0F+B8epc9xvdmNHC3pJuauG2VlZswSdLKZnZ3CU4D\nd4UyRK0r5OBmSWfS99r/3poyA1dI+inuo5TltjV8aEJKmwF4AohaR8zB9ZJWq/i1NqhQf7EkQNKx\neOdapYNB0s9wa6bmhlYY30HSKbj89z+buG2l4zuVhlxKfE3cWqh0Bykpz4nPrEC+PXAPxjvG5kEp\n1vAgtd4m5Ow2M9spgpursGwllJUl3QEsj4c7eJue6aAYM/XLgLWASfS+9nbxVLL8P+bsNjP7SgQ3\nT/bfrI3cf04aldtM4J8MLAdc2MQvjAMk6W7gfcDD9L7v0dPPgwX1F0sa5gfeALILzka813hjWmCd\nJn7MWsFj4TdX+FVBShoHV8wTADNbMoHekFDfL5sk8eKRSfVmZl+PzCePe3WwTlvOzC6TNA8RptJN\n2LJq/rhVVGWY2ZcTuB9OyTsgpc2Af2E/jT8DZbF5Bc6gRP3FMsAhaYSZvd6NNPI6SDN7NZI7HA8x\nu7SZfStYiS2XOM0xUyBpeeA3wMJmtqqk1YHPmtnhEdxdgF2BUWY2XtJyuJNd20BaOemsDyxvZn+Q\nhzseUcKabwn8Xl8pd3gdGlv/oZ5OBBYxszXCtX/azAoHLEljgMOBxc1sC0krA+uZ2WkxeXcSkuY2\ns9IL8JI+hN+7CeF65jWzhztfwgEOmwXc/wfqD5+OuBy4M2yvDhxUgr8wbhl1cdheGdg5krsBcDfw\nWNheA/h1yfJXTgPYBbgZeDBsL0c5SZezcOeyxr2bh3hpkHmAg4CTMnlvMRPr7WpgvWx5G2lFcG/D\nvw6z3DtK1ttBwMXA/WF7cSLjiOAOlpMz9bY87nkfm/dVuJPqlLAt4K5I7j9xB9WpYXvOCtdeuc2E\n89cD7mh65qNiuOCm0v/I3PfFgOvKlH+w/GoRyjT8HjgQeBdmLEJuV4J/GnAJ/oAC3I97tcfgGNwj\n+IWQ91Qgeq66A2nsjse+eCVw/4Ob78ZiOXO/i8a9ewOiBQQn4CKXHwzbT+BvwrFIrbd5zOympn2x\nzpVvm9kMgU65eGTZaYOtcS/01wHM7Enip3b2BNanp97uxzvrWIwws+sbG+Y9bKxfyVhzf5npgfsu\n5c2OT6N6mwE4DtiC3s98SzmaJnwe+Cw99/0p3HO/RhPqgSUNKR0MwGhzD+pGQ3uPEg3NzJoXwEv7\nBiSkkdpBvhOmYSzwlyFeMn68edjixsDwJvGDEqTX2/PyULeNsm9NvHXc1ZK+DwyXtBlwDv4WXAZv\nhw69kf88JbhvNdVb2fWdF0JdNfLeEngmkvu6pFEZ7rq453wZJLUZYIj1da6N5b/TdN9TgoLN1qgX\n79OQ0sGAN7SFMvz1iTf/fTx4vlvwxN4TKGtCm5JGcwf5bcp1kIcC/wKWkHQ6sBGwcyT3nbBG07hv\n4ynnsJZab7sDJwErSnoStxLaMZL7Pfw678B11y4CTi6RN8BfJZ0IjJT09ZDeqZHc6yTtDwyTtAl+\nLReWyHsPfCpqRUmP4vdt+0jud/FnZFlJV+NTeFuXyBvS2gz4M78e/swPBb6Df/XE4GxJvwMWCGtl\nO+FfvzWaUC/eJ0DSsngH80HgRUIHY2aPRPLXBo4HVsX9QsYAW1uEXb+k0cCxwMfwt/WJuPR7tLNj\nShqShuAd2scD9xJcYTf6gQqLnx8M/OstXrNpM3ydYeVQ5g1xufSrIvlJ9ZZJZwT+Blz2rTsZclHG\nGffeIo0eQme6K73r7XdW0mFSrjcnM3upJG8uYKWQ993Zr6dIfuU2E/hj8emwhhL1ZcAeZvZ8JH8z\net/3S8uUf7CgHlg6gJQOJkwhrYA/qPdZog7SQEKwChpHb1mWGEc7wlvr+vh9mxTbMTSlUaneJC0A\nfIW+ZS/U+5K0BS4p0ixJUtr8NUyBZfOPcS5NgqT58a+zcU1579uKk+EOweXzm7mFPiRN6XS1zYR7\nkC1/VYfL2Rb1VFgCmjsYyaf5YzqYwB+KL8KOw+vi45KwOAfFZfDP+Aa3kXe0B3dKGqkdpKTf474I\nd9NbsylqYMGnUYaGvD8S7lusg2NSveHTV5Pw6ayy0ijHAFvh1lBV5XC+gd/7aSF/4fcuxrn0k+TX\n26jI7C/CrcqqXPsFoZxVuEBamwn8pfDpvAYfiHMQlUvvHwq8Se/7Hus/NWhQDyxpSOlgwOeb36rI\nPx+f6/5HxbxT00jtID9ERa0xSafiJsJ30XtQinVMTa23YTFv6C3wOG6anDJVcAAeIKuKLMsJeJCw\nqtc+T4kBuBnjzGy1itwGUtoM+IvLH4BLK/C/C6xS5et4sKEeWNKQ0sEALGHV5SDeKjuF0OE0UjvI\nG3EfivsqcNc3sxg12lZIrbc/hsXbZlmQmCmR/YGLwuJ1JSke4CGCuXAFPAHcVnZNJYM/BYOB5muP\nKc8lkjY1sysq5g1pbQbcsqvMvc7iQVyxoUYB6jWWBEjaB3iNah0Mko7EnQonVsj7S7hj4EQqaCal\nphFMRQ/DnQVLd5CSPoy/fT5Jeb2rU4CjrZoIYyfqbXfgJ8BL9JhYm8WFO5gY8u71xm1mh5Qo/1q4\nJVmz3lfMOsd6uKPfVZTUygr83fCQA6/S+9pjpuE+h8vzG25aXnYaLqnNBP6X8WnASygphBnu+wT8\npSjLrfoFN9ui/mJJwzt43PYfkGlkxM+5TgL+FhY136XcOsVqwJdxjaTsdFCsZlJqGj/BO8hhVNMq\nOxU316wypXE6cIOkZ6gmBphab/sC76s4JTLKIoKZFeC3eAjpKvfuEPxZW6ACF1yfbbmK03C/Aj5M\nwhoLaW0G/Cv5G7juV/aZj3EM/h1wBWnlHxSoB5Y0pHQw4EGTNqDaOsXngWXLmmt2MI3UDvLx2MX2\nHJyKD4hVG3hqvd1F9SmRyyR9vOobd8D0hLfksWb2/oS876b6NNx/cCmYlGmSlDYDvr40zirohOHh\nGlKmUAcN6oElDSkdDHhDq7pOMRV/66waVyM1jdQO8m5Jf8Cnw8rG9Xgs1iy5BVLrbRpwmzx0QNkp\nkd2B/SW9TbU3boDLJe1E33sX0+FfnrjO8Q4wRdIVlJyGA57CY7JcRIVpuICUNgNwOy7DUmVguVIe\nQ6j5vtfmxk2o11gSIOlvwCpAlQ6mESZ2WVxQsGw8lKtwy6ibm7hlzI0rpyHpVWBE4JXuIJUW1+PX\n+IDY3MBjzY1T6+2refvN7PQYfiqUFsvmRWAkPrCWXueQlKuOYGanRHAPa8H9YUzeIY3TqNhmAv8K\n/JlvXieJMTfOUzGOWlsbbKgHlgSkdjCSftyCX7iQq84EjEpOoxtQQqCtwO/2wLA4PX4kjbz/PZPy\nztUGM7OqMehnKlLaTODnhicws8tTylWjN+qBpUZlpHSQQU5mJ/o6qu3a2VJ2HpI2xAOdNTsZxliF\nHQl8EV+raHTmVuZLM6SzHn3v3Z8iuYvgzpRZ7vWtGb246+NWZc31vnwE9334+lZzuVONGWYa5Np6\n4+hd/j90rUCzKOo1lgSkdDCBvzzudDWO3g9qoVWWpK1ws8+xId/Sc/UpabTqIIHYN+8LcAufaymp\nyhw0xnah732L/WJJqjfcqXQf4FbKK0pvCaxQcfEYmDEdtDIe2yV77wsHFklH4JIs9zZxPxWZ/QTc\nF6fKtZ+L37szKnCBtDYT+J8DfobL7pd95v8IjKfvfa8HlibUXywJkHQvOR2MRQpBSpqKm44282+N\n4D4AfMbMyioadyQNSfcBq1ftICXdZmZrVuReD1xD3/t2XiQ/td5uNLMPFJ+Zy70Y2MbMXqvCD2nc\ni6sWlLaIC/W2hpm9VTHvlGufbBF+SgVpVG4zgf8A8Hkzu6NC3vdQUS1isKH+YknDy5YWSvc9M/tN\nRe5/UwaVDqTxEB4BsOqb98UJVmXzmNkBFfOFivUmV9YFtw76OS4hE+VYKul4/O32Ddyi7HKqO9nd\nBYymmjXfw1SIwyQPQQxu1fVT+l57SwfDINoIcEGwqvob5a3ZGkhpM+DPfOlBJeBOYBHKhVgYlKi/\nWCog08FsiwshRncwgd+wwNkT7xyaG1pL88UwfQUev2QRXO+rlGVUShqZDnJxPKxrqQ4yWCUZPgVR\nyTpJ0uG4zP5FRec28VLr7co2h63ddEwrg4EMudBwIFizGR4tci36et63tGyS9KvAXRK3irqMEubC\nkq5pX3xr6WAYrNgadZ7HjbFmq9xmAr+xhrUpLrXf/My3NF+X9I9Q/vmANYGbqGiJOVhQDywVkNLB\nBP7DtG9oLef6W1hEZbmF6wwpaaR2kK2skjL8lnPvwcS5cd9Kmzqn1lsnIJfqf6txneF+zG0emrmI\nm2vR1EA7y6ZWZsIZbqG5cDeR0mYCP8+8PctvaebeynoyQ56lrSi7AjOrf/Wv9A/v2IdmtofiU1Sx\n/M8CIzPbCwBbdPu6Ist+BLBAZntB4PBI7iRg3sz2vPjXV5n8l8KFNBvbw4ElI7nD8Bg0je0h2bQi\n+IflXPshkdzdcri7drs+S1z7Mjn3fVy3yzUr/uqY9wmQdIQ8tkdje8EwTRPL3z2H/+1I7uk53Njw\ntJ1I43K8YTUwHJ9eicWhZjYjpKx5JMJcB7pmSPq8PIJhY3sBeez1KKTWG7C5ZSInmtmLxFtVDbPM\nwn34v0zMevApvOzC/XQgynABdwrNxmofgetfxWKLnGv/TCR3txzut0rkndRmwvmn5PBjwwufQ+/7\nPi3sq9GEemBJQ0oHA7BLDn+XSO7qOdy1SuSdmkZqB5n37MUak/w4Z1DKdZxrgdR6Gypp7saGpOHA\n3G3Oz+L1zFoPkt6PB44qgzkso+9mbpkXm/9wy0TMDP+Xqbeh8vDCAEgqI0LaaxpULiQ5Z4m8Ia3N\nAKydw4/VTmu+7+9QTYB1tkc9sKQhpYMBGCJpxpxxmG+PfVCHSFowwx1FeSu/lDRSO8jJko6StLSk\npYKV1ZRIbsqgBOn1dgauubWzXLPrUlxxOQZ7A+dIuiYsiP8Fj2hYBi9ImjEQyqN5xupVvSFpjQx3\nTTxwViz+DFwq6auSvoLLz58Zyb1U0lmSNpL0kcAr85ULaW2mwc9+7S5I/OD2XMYIoOETUwf9ykFt\nbpyGRgczAV9Y3In4Dga8UZ4t6beBvxvwr0ju0cD1ks4N29vgUvZlkJJGo4N8KmwvijtMxmIP3Enx\nAnxBdiIQO6Vxi6RfAifi9+07uF9DLJLqzcyOknQH8NFQ9sPM7JJI7s2SVqQnZvu9Vj5m+7fwgFsn\nhu3ncKfHGOyDy84/GraXAraPzdjMjmi69qPM7J+R9P3wOt6Hnjr/XWzeASltBjzy6Q2S/hL42wFH\nRXJ3A86UdAJe/sfxENc1mlBbhSVC0ub0NLKJsR1M4A4BvpnlAydbpG6TpJVx80nhwY9KB75KSUPS\nnKR1kJUQLKt+CHyMnvt2uJm9XiKNyvVWBQqKwuox9e4FqxBCoLFWkJ3aieTNDayEX/tdlhZ6YaYi\ntc2ENFan55m/zEr6tUiaF+87Xy08eZCiHlgGGCTNb2avZOz6e8EiJLxT0kjtICUdbWb/px6fjGZ+\nocpstyDpWjP7UMbsecYhCsydJR1iZj9WgoCmpO3N7CxJub5C1kZ+XtJGZnZ1diqnids2DIGkq81s\nI/X4Ic04RIH/kaSzzGx7SVPIr/Mkb/wYSBphZq+rx1mzuQwtnTQl7WhmZ0jK9fWx6qGOZ1vUU2EV\nkNLBBP7ZZrZtmFLIa2jtIiH+CdgCn/rpkzdxURBT0tgItyLKswQy3GKpHf4S/p4QUc5ekHSMme2t\nHoe13pkXOKql1puZfSj8na9s2cOgMgS42MzOLssPaKyHjanA3QwPI71NXvGAovg2m4S/oyvkvV/4\nu3UFLpDcZsB1yjbHVQvynvl2TpoNK7rS9T5YUX+xdAGSFjWzpyUtnXfczB7N25/hC/dbeCyhDJXT\nCB3k1lU7yLDgeqqZtXW2zOG938xuVRfl/sO1325mq1bk/9vaeKlH8IcCu7f7OingbmmRmmot+JPN\nbI3Ck/O5F5nZJyrmndRmQhoCFjWzp4rOzeEOBfY0s1+V5Q5G1FZhFSFpiKQ7q3BDAxkKnGJmjzb/\nIviGS1pURkoa5uKHZS2ZsvxpwKJhjaYM79Zw33Yxs6ubfzFppNRbKMN0YKqkQhmSFrhU0nclLSlp\nVONXIv9pQKXpwsDduwo3w79bHi6hCvedVlNREfykNhPSMDw4XJX8p+FOvTUiUE+FVYSZTZc0VdJS\nVd76zWyapDckjbSMT0YJTJK0rpndXIHbiTQulfRdfGprxqJ5zBpPwEPANZIuaOK3fRMP922MpLmq\nLDqn1lvAosBdkm6id9ljOp7GWsru2WIRN4XZwLWSjsVNf7P5txSCzOASSXvTt95ihSBHA/dIuqGJ\nHzPYvYYPyhObuFFx5DvQZgBukrS2FejCtcD1wSKs+d5VSWu2Rj0VlgB5mNN1cVG6sh0Mks4G1sf9\nILL8QqVbSXcDywOPBm5jnaBorrkjaSgxTKsSwtRK+h2wNr4ukL1vZcLTptRbVyNvKl8Q0mKm2JQQ\n1jjwK0dgVEJY40waldtM4N+BW8Q9SO9nvtCAQPlac2YzQWNuoKEeWBKQ2sEoIURuylxzJ9PoBpQe\nnrbbA0MdhbAiUtpM4I9vwX8wpVw1eqMeWAYwwpzzwvTuoEpN76SkkdJBagCHqVVa5M3cKISxb9wh\njbnwSJTj6H3vjojkp4Q1TonAWDmscScRFvHHNJWhcEFf7v/zBfreu0M7X8qBjXqNJQEpHUzgp8RO\n/w7eSP9LjzCe4bE2YstfOY1WHSTxYVorh6lVenja1LDOR1E9euc6pEch/Bsuw1I6PLASwhoHHE3F\nCIykhTUG0tpM4H8bOBR4gd7P/MoR9AuAl/HyVw4tPRhQf7EkQInhgZUQIjfk/YGYc/sjDSWGaVVC\nmFp1JjxtSr1dZ2YbVuSeg5utVo5CKOlOq27uXDmsceCnXHvlsMaZNFLDSj8AbGBmz1XIu/J9H2yo\nv1jSkBoeOCW08eP421MKUtJIDdOaEqa2E+FpU+rtFrnWVOnonbhV1d3BoqxqFMJJkla2ChI+pIU1\nBrhZ0pmUiMCYQemwxjlIDQf+BPGCnc24XtJqFb/WBhXqL5YEBJPPSuGBA/9nVAiRG7in4Dpd/2zi\nRstLpKQRLGQqh2lNsU6SdDAVwtNm+Kn1liLLkmw4ECyblgcewMtfxrLpMkqGNW7i50ViNGsTgTHD\nrWzNlkmjcpsJ/JOB5YALm/iFDqfBivJ9wMP0vu/R08+DBfUXSxrmx2O2ZxecY2RNGmhMC6zTxI9Z\nK3gs/OaiekyIlDQOrpgnAGa2ZAK9YRm0X2ZfGV+QpHozs69H5pPHvTpY4y1nZpdJmoemOCURiA5q\nloOfJnAxsy8ncD+ckndASpsB/8J+Gn8GymLzCpxBifqLZYBDQVyvG2nkdZAWqfgqj4GyF7C0mX0r\nWIktlzjNMVMQjAd+AyxsZqvK1XI/a2aFUSgl7QLsCowys/GSlgN+a2Zt49nnpLM+sLyZ/UHSQsCI\nEtZ8S+D3+kp5oK6hsfUf6ulEYBEzWyNc+6fNrHDAkjQGOBxY3My2kCtrr2dmp8Xk3UlImts8QFpZ\n3ofwezchXM+8Zpbn0zW4YbNAfOSB+sOnIy4H7gzbqwMHleAvjFtGXRy2VwZ2juRuANwNPBa21wB+\nXbL8ldPAo/bdDDwYtpfDZfdj8z4L+H7m3s0DTInkzgMcBJyUyXuLmVhvVwPrZcvbSCuCexv+dZjl\n3lGy3g4CLgbuD9uLA9dGcncCJmfqbXlcOj4276uADzbKDzOk92O4/wS+BEwN23NWuPbKbSacvx5w\nR9Mzf3wk98e4JEzjvi8GXFem/IPlV2uFpeH3wIHAuzBjEXK7EvzT8MBFi4Xt+4nXcjoG+ARuNomZ\nTQXKihumpLE7sCHwSuD+BzffjcVy5n4XjXv3Bt5JxWAC8A7ewYEvyJaJWZ9ab/OY2U1N+96L5L5t\nGSkaSXOQo9ZbgK3xUMqvA5jZk8RP7eyJe6436u1+vLOOxQgzu76xYd7DxsbhGWvuLzM9cN+lvNnx\naVRvMwDH4cre2Wd+k7aMHnwe1wtr3PenqBWPc1EPLGlI6WAARpsrBDca2nuUaGhm1rwAXto3ICGN\n1A7ynTANY4G/DD5YxGC8mR1Fz8DwJvGDEqTX2/PBg7tR9q2Jt467WtL3geGSNgPOobww4tuhQ2/k\nXyZm/VtN9VZ2feeFUFeNvLcEnonkvi4X3Gxw1wXKBstKajPAEOurLBHLf6fpvo8oOH/Qol68T0NK\nBwPe0BbK8Ncn3vz38eD5bsETe0+grAltShrNHeS3KddBHoqHlF1C0ul4nJdcLakcvBPWaBr3bTzl\nHNZS62134CRgRUlP4lZCO0Ryv4df5x14JMSLgJNL5A3wV3lY4pGSvh7SOzWSe52k/YFhkjbBr+XC\nEnnvgU9FrSgPb/w08V9738WfkWUlXY1P4ZWN0ZLSZsCf+fXwZ34oHtb6/kju2XKdugXCWtlO+Ndv\njWZ0e7cs+cwAACAASURBVC5uIP9wK6TLcAujJ4Fr8cXoWP7awHV4w7gOf8BXj+SOBs7EveafxT3Y\nFypZ/spp4F+7u+Bv3OeG/1Uy/zHA53Arp7FNx1Zsw2sErXoulP8RYOOZVW+ZdEYA8+Xs/2rCM3Ve\n5HmbA7/CpzM3L5H+UOBbuKn2+eH/IRXKORJYIGf/jgW8ufB1jTWBuZqObRqRb+U2E/hjcVXo58Pv\nz/hXUCx/M+DnwC+AzarW8+z+63oBZodfSgeDfzWuAqwKzNl0rPKDCxzYgeuqnEZsB9mGP7ng+ELA\np/H58tFNx1bp73pLKXsBN8qAoSCNqIX8Ftyzu3jtUdz+ajOBv38C94bUuptdfvUaSwdgZq9bvpnt\nXhHc98zsLjO703wxM4sjE4qVF4J2ZqZRJr5IHtqumZjZC2b2TzO70Myebzqc58SXl0bleitAmfWe\nZnTC/j9l7n+5xLxTrj2K249tBsoZcTRjWGLesw3qgaV/kdLIUvmpeaemkdpBpvC7ed+hM4NDt/Lv\nZr114r51s+67Xe+zDOqBpX8x0BvpQG0o3bzv0P0Xgm6i2+Xvdt3XoB5Y+hvdbGTd/mJJzb+SrHqH\nkFr263ITlYZKOqOAe0Bi3tBP9RbK/4UC/qQW3CGSipSN8/TjZjYG80tBx1APLBURGsq2BafldjAl\n8EgC95zEvFPTaNtBSlq/4X8haXtJR0maoR9mZusm5N3WHyb4YbTbV1hvkj4taX9JP2r8GsfMbI88\njplNA8YE0+5cmNnEiLyHS1L4f7ykTwU/oga+VpRG4I4MsipZfL9N2aZR4IxoZt9qsX86cGwB93Pt\njkfikUR+oV6cpBEt/H8q66jNbqi1whIg6d9WQpk1hz8W915fDHgTl6K/xdrEypB0PG0+161EJMKm\ndO+3xEh+ki42syihPkm342anq+Emw6fhelsbteG0Ve+1eIXbPrFgJN1qZu+P5P8Wl5XZBPdB2Rq4\nycwK/XCCH8TawN/pHbO9jCr1LbhCwkhcVmcK8KLFKQxfjnuQDwWm4hLyl5rZfm2JPfyDgNeAvzSV\nvzDcgaTD8Of7gpi8mrht1ZctXpn6p7gQ5xu4xMyawD7WJoKmpCH4ov4OwLq4z9TcuLn7Rbi00H9i\n8h8sqB0k03CppO/St5G1lW8PjmnfA0bhncKzuEXJlsB4SecCR7dorLekFlrSq/QMTo3P93ka+61N\nJMU2nbvwRhqL98zM5KFujzWzkyUVORkeHf4Ow9Vtp4Z8VwduBD7UjixpRdxMdWRTRzU/5Sx6Pmhm\nq0u63cwOkXQ08YrWT4XfEKrLgQwxszck7QScYGY/k3RbJHeUmb0iaWfgdDP7YRjkowYW3KkT4P8y\n+wwoDHeAO1eOlPQ2/iLVkJ0fFcH9TPg7FpfyuSJsb4Lrl8Xe/83N7MCgGPAs/jxcTvsImlfifk8H\n4ppw0wGCisAmwM8k/c3MiqY5Bw3qgSUNjfgbu2f2xci3fwrYxXLUaMOUxha4I9Z5zcfN7PRqRe2F\n0/C33f3M7L8h34fNrM8UUQ5uxp0T8+aTFyhRhtcl7YdPH2wU3grnbEcws01CWf8M7Goh4JKkVXGv\n7iKsgN/bBejpqMBlRXYpUfY3w983JC2G607F3DvM7BBIVqUeEuRQvoQrJUO89P4cQZV3G+BHRSc3\nw9LCHYyuSrQQqkDShXgEzKfD9qK42nIsGn3ep4CzzOx5SUXTNh/LMWtuvECeB5wnqe2zO9hQDywJ\niOyI83gt3w7NtY/OL0ojdA4H4OquM962LSLuu5l9R9L7gbMknQ+cQLw1zD3AN/M+/ZUfvKsVvgjs\nGNJ6WtJSQOx00IqWieJnZndKKvxaClMwF0jawMxuKFHWZlwoaQHcA3syfu+iZFkkbYBLoswLLCVp\nDfwefLtE/vsChwD/DNe+LJAXRCsPP8FfDK41s5sCN1r2Pbz47EqPWOlVwMnhuW0LM5sm6VNZrpn9\nKzbvgHHWO6zzf3GF5lhcLOlO3Dhkd0mjKZADyhtUGpA0r5m91u6cwYh6jSUBYfF5X2ApM9tVHltj\nBTMro73UnObXzWxCxHkT8Sm47wK74cGvnjOzaKui8JWwB/72Ot7MFiugNHS17jCz+3KObWlmhYNi\n5vxKcUEknYVPPZ6Bd+o74nExto/Mdwz+hTKOzMuVRUSAzElrbmCYmUXpVUm6EV+T+buZrRX2VYql\nrooxRVIQ1ohGAH8Iu3bEhS13bc2awf0JvqbYmHbaDrjezA4qkf8JuBPnWXjdbwc8YGbfKZHGWOB/\nZvaepHmBkeYK0aUh6TGLiHo62FAPLAmQxz2/FfiKecCn4bisQ5m1huY0ox7UxmJzmOdfPey7ut3i\ndxN/CLC+mV0fphPWMrOLSnC3NleZrYSwPrAH3qjHy4Nn/drMPhbBHYZrXDXefP8N/MbM3orM+3r8\nDf9WMmbNZtZn6rEFfyguJzOO3gNTTEjnG83sA5KmZAaWqWa2Rkze4fz18K+ekWbW+Or5RkznqoRA\nXa3KGlv+sJazVrAua3z9TLaSoX0lfZ5M3ZvZ30pwSweYk7Rvq0PADyLXiAYV6qmwNIw3sy9K2h5c\nvl1SoS17aGC5h4iPjdH49H5a0qfxBeElIrmY2fSw6LxBmFqIVvcN3D2AygMLrqS8Hr7ojpndLynq\n2s3srWCZdVHel1ME5inzZZeDfwBv4QrFLS34WqATqtSNmCLng8cUCQYhMTgZNylurEvcgb/9x4Ys\nni5pnJk9AiBpHOXuwfzAi+H/qsYLk4FXLUQulTSfRUYuxVWg7wAaYZKfws3q20UuPQKf9syb7qtd\nNnJQDyxpqCrfvjAeYOvFpv0Cru97ei4OlzQSt845Hm+w+0RyG5god3j7q5X/dK1kEZfBW2b2TmMc\nVom4IJI+izf0uYBlwvrKoWb22cgkLpT0qdgvtBwsUfYtO4PdcH+OxfEAZRPpbfwRgyFm9mjTO0ys\nQ+mI8JUKuEmWpDLrA/sD/5Z0P/68vo/4cAdHAZPlJs8CNqakAYEyoZ2B8fh9/C0QG9p5OTPbXtI2\n4AHmIl4GJwPnm9mtOeX5RnThBxHqgSUNP8Zjiiwp6Ux8/vhrEbwL8TWBPiaikq6KyTizjvMy8RHw\nmrEvPl8+TVJjGsmsjblxBlUt4hpIiQvyY/xr5yoAM7stvDnHYi/g+5LewZ0pG2avsVEYL5b0cYtw\nZszBdDPrZVYtd858oUQaKTFFUgJ1YWaXSloBWAm/b3ebB1qL4Z4h6UrgA4H7owprG7vT+0v3P2HN\nJBZVAsx9Hff3ycM6JfIeNKjXWBIhDzq0Pt5QJllfpd3+yvd0YC8zeylsL4j7vpRegO4GQoe4K/Bx\n/N5dAvzO2jiHZrh56xS3J3xFlEKY4z8DnwZ5lxIDk6TrcF+KV8L2SsA5ZRbvQ0d6HNBYj7oM2CPm\n2QtrCifhz+xzhEBdjamtCP4Q4JP0XV86LpK/cg737zHcwO9V92XXaSR9EvchWxmf/toI2NnMLo8t\nQ41i1F8s6RiGT2nNAawsCTP7d9lEJI0qMY0EHtzopcaGmb0oaa0K+X6W3uafUV8Ncrv97AL6VfjA\n0HZaJXylHB0WcH8TfmVxp6QvAUPllnh7Ej+FSJj62AFYxswOk0vJLGp9wxW3wtHABrh1XNk3syOA\nf4R1sRVw66qo6JOS1jezSWb2LCXl3SUtbWaPmtkDwKZhGlXZZygSF+Bv+6XXlyT9Hn/DvzvDNVyF\nIBZXq0LkUklDzGy6mf1L0q24k6VwX65nC7hDgW/ga5j/MrPrMscOMrPDS5R/UKD+YkmApCNxf4y7\nyDSUorn+7MMY3uDOx50DBXzRzG6MyHsqHjXxxbA9CrjazFYrUf6f4RIVZ4Zd2wO3mtn3IrgnhzI3\nHDa/DEwzs7ZzzvKQuhsCu2cbaBnIzbx/QO+vncNKWIX9Bq+vTc1spfC1N9Ei9ckkXYJ/dZRduG/w\nt8TXKuYDtrJIORBJU4CbgAPKDgiSHsAX7n9hET4nbdK5o8wz1sS9B3durNzphC+mneld9ycXpSlX\nJviWVfBfCs/6PPi9/zLezvYNx/rIA9WoB5YkSLoP/3Io5UuQfRgl/ROX5bg4zJsfY2YfjEjjK7jE\nxLlh1zbAT8wsKshVSON2YE3rkagYikcwLJxWUJrZ6dq4wcG9+BfLjA7aIvW+MmkNxRekC7WqMpzJ\nZra2Kpr8SjoNX0u6mIyxhrUxN1ZfjbdNgYcIookWofEWOtU98bf0w0rW9XzAoSHf71T5qg7p/AK3\nxrui8OS+3NOAn1a05MtLbxRuSNHKyjJ77gfwZ24qHiWy2XCmHTdr0j8H8GtcRWB7fPq79EzB7I56\nKiwND+Fv7SlOaotZsKE394QeHkMysz/IxQgbnvZbmdndFfJfgJ6FyZEleNMkjTezBwHkHtxRlklm\nNlnSD3A5jPH0dLhGz/W0hKQ/4dZV03BflJGSfmlmP48s+7thQGos4I6h3LTOw+E3V/jFoFnjrY+F\nURHCC8AxcufYGyT9Gr+GwjUec3PcfeSKC5dLegK/5gY3dn3qGnwqz+ht+BDjy3EKcKOkJ/E20+BG\nv/EH45bP4n3XbcBzcv+tVr4m4JncGAaX3YBbJF1M7xeadgP7XJnz3gN2latZX4ErKNRoQj2wVEDm\n7fMN4Da5+WT2zbXo7XNZSX/HG9YSkuYxszfCsTKaQ43pMyvJa+CnwJRgqSN8veTASO5+wJWSHgrc\npXHrmbYIC89H42/8m5rZ1ArlXtlcSHEHXF32ALyjjh1YjgP+BoyVe4NvDUR7f1uP3td8vmmvRXBm\naLzJ/VcaMiT3Fa1LZSEXj/wePhV4YplpJUmb4qbOJ+N+LFWm8n6F+4BU8eE5FbcmrMJtYGSo+28A\nE8zsx2rtF9aMUfjU73P48xJbhlskfdIy8jNmdqikp6i2Rjjbox5YqqHx9nkrfRceYxp6c9yJIQBy\nB8GoB1XSXrgsyXl4x36GpJPM7PgYPoCZnRXeANcNaRxgZlGmp2Z2eVg4XyFw742cEpwE/AxXK6g6\nDztnMB7YEp9GfFfFQoIzYGZnhgXcj+Jl39LMop0U5aKXf8Q7KiQ9j1/PXRHcjfF1qUdC3ktK+mrM\n1JRcMeAR4MOx9ZTh/hn3+fiSZXTWKuA/+HRplbp73CLl7dtgDrlSxLb44BoFSbvhL0M/x63Ayjwv\nO7bYfzKRGnGDDmZW/yr+cHPfwn39lPft+NpCY3sEcHsJ/iK4rAfAGGArYJVI7or4V8Jx+BvwAbgw\nZAx3TOR557U5tifwJP610vhauqbEtY8H5g7/bxzSW6AE/3pgk8z2xrjmVQz3VlxPrrG9PG4wEcPd\nLPK8A3P27RLJ/WrB8Qm4jPx+4b7tCewZmfYJuBXcNvh01mfxGDxlnvttwrP/67C9bLtnJcM7Exgb\ncV5UG8icv0iZ8wfLr168T0CeRUh2Qbhimrua2UkR590BrGvBEkru9HWzRVjsSPomPp0i4EjcqfMu\n3FrrKDM7pQ33AHzR8s+45zi4GeZ2wJ/N7GdF+ceg7H2UNIdFWjsFC6F1cH+Kf+HmqiuY2aci+Ul6\nWda0npG3LwUplkpFXHmwrj4wsx9GpJ1nbGAWEaBsZqHsvZP0TzP7dH+WaSCingqrALk22JdwOZHs\nVNh8lPOgzk0+8rwJ+EJoQ4BvS3xxNAZ74AGOhgOPAu8zs2eC2e2VBensjL/V9VoXkPRLfHDqyMBC\nwZSi3A9kFXoH6Do0Mu3p5sq2W+FBxo4PpryxeEjSD/HpMHCF31jp+VsknZLh7kCFhfwC9Fvc9pgB\npA03OXRveIHamaa6t845Bpe6d/Wgko96YKmG63GP5dH0RDUEDxgVu5CYCzP7XbvjkpYxs4fN7Jdh\nfeRDeGP4upnFdo7vmhsLvCHpQQvz9eZOlkWfsNPxUMqPNu1flOoLsqWgFqGBSyTxbng5+Ao9Ab/K\nGD/shMdD+St+7/9NhOFCwLdwWZI9M9xfl8g7BinTEEUD+qV555jZx4sSlpT7JW4RkvsZ/BE3U/8E\n/iKxA+VFPNsh6t6pvEPzoEI9sFSAmT0KPBqsklbGH8Z7zOyhGH4we7zH3LplOD4ttTbukXyEtY/t\ncS7wfkmXm9lHcYG8spguac7w1THjjSu8DRapte6Nm6v+B2gE9loKFyPco0JZWqHdm2NKaGDwQWA3\n3O/nYbleVHRYWXMfiEK/kxbct/GAZtEx7iug375Y6G09Nwz4AvHm9lnZlGHA5+l5hmLxPjPbRtLn\nzOz0YHp+Sck0SkEtHJolRTs0DzbUA0sFSJoff1N+Pz1x19cIlkY7W7Gz3qlAYz7+WNxs+UjcSmkC\nvpDeCkMk/RhYXjlxIiwiJkhI38L5T2T2L0TvWOZ9YC6JsTwuBLg4fu1P4Os7UX4swYfkdGthbRPQ\nTta+cmhgADO7O6wVLRW2H6bEFF64/u/SV/MqxgdnC+Aw3OBgDiJ8UCrgnARuWzWEnE70aklXxyRs\nZn/Jboc1l0vLFW9GuIiXgnXeM3g9dAp5gpRbAQ3Zlp/jBjozHJpxeZgaGdQDSzUch39dbGc9XusC\nfohbvhQtRg7JLDSvk1ksvDYsLLfDdvh6yhxUjGdhZo+12P8kbm1VxJ+Omw1XgnmI2jGS5jKzXGVZ\na68cXDk0MICkzwC/oLrs/jm4VPvJxMvVN3AM3lFV0RkDZjh0toyAaWZHtOHuhb+8vIqXfy3ge437\nbWZtvzrDS1UDQ/CXq0WrXAf+MrB0Sc5JYS3wh7ip/7yUl97fCp9CNjxE84xAYWa2fgG9kkPzYENt\nFVYBkv5jZsuVPZY55xxcFmOCpAm4o9st4U34TIvQrJK0ubWJelfA3RkYZcFTXe4JPR/+9ry/mbX0\npZH0Kvnz0HMAc5lZ1MuKPMTt2njnkI3nUmqKSCVDAwfOrbiH/1XWI+kSrYGlEL2zTDkz3CuBj1pF\nnbGQRuUImA3rNUmfwNd6fog7GkZZQkl6nB5v//dwo4VDzKzwq0XSi/Q8O0NwxYfvWUIk0rKQqxW8\nDw9uBq7196CZtYyJI+klfC1MuCr00mGNElUMKz27o/5iqYaUOWxwpdRjJR0EPI/LczyOzzcXiTju\naGZn4ErKKzUfj+yYd8Olzxt41swWD2ssE2njpGlmvb6S5N7n3wa+iXuzx+Kp8BtCyS8vuQjl/wFL\nmdkukpaS9GGLVGYG3jOzl9U7vlOZN6x/SPo2fr1ZxYWYxdz9gYvC9FGUzlgOUiJgNi76U/iAMlWK\ninraUFZesnSG0lLhK3l0Zvf0Kl9scifiI/Avh83DmscG7Uzkm7ARsGojb3n4iSKH0WSH5sGGemCp\nhuvkWkGHZRtHMEEtnCIKb9dfC53ysng9PGFm/43Ie0T4m6dRFNtQh5hZ1iz6nFCut2I/7cNU1N74\ntN+fcJ+aaFNr65FFGWFmrxed34QJ+Nv6BmH7CfwaYgeWJNl94Kvh736ZfbFBzn4CvIYvXsfqjDUj\nJQLmrXKtsWWAA8MzGPP19Gv8C7MKzgfWjl2DK8BpeP03vO7vx6OYxg4s9+Fraw2rxiUpsORs9TUW\n2uuJeccGPWwW8NIcaD88DPA5wIO4pMq54f9zcS2jIv68qecAG8bsa8F9oMX+IcBDBdzRuMbYQ7iF\nUOH1tkhnA3yd6rGwvQbBmzqCe0v4OyWzb2qJvOfBO/ibw+9wfDptZjw7t3QgjVfxweBN4JWw/Uok\ndwg+QCwQthfCFbqLeJMTyjulKjcnrZtz6v62EvyrcWOZq8LvdTxQ2t+Bv7fgnASs1uLYCNz8fIeZ\n8fwMlF/9xVIB5lZf28hj3K9Mj87Wg9nzJK1i+fpRF4RF+gtwOY/Xw/nL4r4Z2wK/p0cSPw/H0/cN\nMm9fHiZKOtzMmoUXD8WnwtrhUVzEbwLeQHfOzqRY/JTOMbgvwt8Db6qkj7SnzMA74cuqMZ0xnkiT\n12CRdoiZ7UcJranA3dTMrgiLv31gcTpYl6l6WONGPqWNNuShCrJYNmIGrPn8lgG5rL3hw+KSWkaY\ntIiQARm8Lo/a2qj79fHw3LEotdAf8Gvgh5JWA+7En/9hwHL4S+ap9MQ0qkE9FZaEMJA82OaUP5LT\n0ZvZRyV9Cl+X2FAeV+Jd/DP9n7heU67IoKQNcPPGMU3mxvMDQyOLvh9wsjz4U0NdeA1cXLPtGg9u\nidWYcqtkldaAmT3e1LnFTpX8GJdiWVLSmbgUzdci85wml46vgo1wqfTP5Bwz4nxpdgf2l/Q2vvgd\nihUV1nhFM7s3Z5BoJNLOp6nhyDsMt+S6HX8hWh2PH/+hguyfo7czcBm8SefUBfbFX0bGy8M8j8Ed\nZKNgEUYGOZzbgG0lzYtLAS2KX9M91qHYMrMbaquwfoQSdcNapLkRLnq4G27y2sCrwD8sMhphSGtZ\nXBoD4O4SX1zJkHQu7iR4Am5psydueh0Vcje8ta6Pd46TLCLee4Z7NP62eQ69LdJSlXf7FZJ+b26s\ncGXOYbM4P5o/446hd4TtVYHvmtnXCnj9pj9WIb056FHVLht2IGvVOBeuuPB6zMBeIx71wNKPiGlQ\nkhanx1kOAIuTUF/aXAGg39Cu/GFQOhbv3A24AdjH4tUHRgf+x/AOYiLueFZoACDp88AVFkyMgyHB\nxmZ2fmTeE3J2m0XqTUk6AhfrfClsLwj8X87UYpazNPBSpsyb4P5Ij+Dm5rn+PJ2GpNvMbM2ifTm8\nv5pZO8fddtxJVuwfEpvW7rhJfvbeb29mlWRx5GGi1zOz70ecuyFwMH2dW2OMNgYV6oGlH1E0sEg6\nErejv5ueaSBrN18t6R+0sf4qmOsuhXZfXJIm4RYxDX+A7fCQtx/oVP5typXXOUZ/HUoaXeYLJ4ff\nJ6+Iur4R+LyZPSV3yLwMN4JYHdduK5qCbDj2tUTMF5eks/CvtDPw52hH3FBk+yLurIDUum+RZtTA\nJ+leYB/6+g+lCs/OdqjXWPoXRW+hW+Jy7WVCG/8ioTxl0e6tQ9Y75voZkqK1woL/wF5Nb55HR341\n5OmZFT7Lco/7U3ERyunAtmZWxsy4gaGS5m7UWzAkmLuAM9zMngr/7wicamZHy+PYF6ktNJC3ttNA\n7BrP13EhzL3C9r8ZWL4YQyTJwhtxMMaINttuGpyH4GsmsW/XL1tFp+TBhnpgSUBwLNsBWNY8VOlS\neOCfmyBKHuIhfI43emCpsvjYT7hS0vfwuCyGf3n9MxgiYMXOgqs3BpVw/ouSYt86b5HL9J8Y8v4O\ncYvDP8GjL94rFwI9Cl+QL4szcCHOCSH/nfCokO2QtVLYlBAC2symx1pnmVmsgnK7NN7Cwwv/KjWt\nLuES4Gy5wrXha43/ak/phezg/B4+FdnsANkKV0r6OT6AZ51bqwjBztaop8ISIOk3uD/Bpma2Unjr\nnmgRkiyBfx5ujXU5vR/UQvNLSQ+TL1/esfnedlMEIf9WKJx3ljQVXxd5MWyPAq62uEBlI3Apko+F\nXRPxBem2jpbN01WJC9KfJLM+ZGZtFXYlHYtbEz2NR05c3jyk8qK40cU6JfLONZk1s5bxaCSdbWbb\nygPE5T030YHGqq4LBu5QYOEmbq52XQv+ENyashFWeiJwsnXG+RJJB5rZT1scq2w0MdhQf7Gk4QNm\ntrZCkKjw1l3Gm/rv4VcF2Y5oGB6ydVSZBFK+uMysrZqwpM3MrJ1y7dHA9cE6jFD+n8SUOwwg35M0\nr5m9FsMJGNtkot1r2yJ8cELHeImZfYxyb8p74191iwIfylgyLUJJfxoylmx43W9BcUySxtTXFiXz\n6oVW64L/z955x8lSVdv/uy7BS7oExfBEJAo/MggqSUUFRURBBERARBRMiPoeKupTMYuKKCpBAQVR\ngoggguQMguQkKIIoBgxPEAUJsn5/7FN3avp2V53q6pmeudPr8+nPvV3d+1RNT0+dc/Zeey0ipVYX\nuy9BFb+PsW5/E3WmLKQd3rcJ8sZEUH13JGpf3c69xQScb77EaMfSAqkguwnRDbyBQnX2nEFTjBtc\nz2W26/oRyu9vteOqGTuHEbcm0RAq4Hzbt2WOvQmhzLu47eUlrQvsY/sdNXEfq3rdSWYm4/ynA7u7\ngfDlREIhxHm67Zdnvv9pQPE7vtr2nxuc6w4ijdmkLljE3kksxvoudkt6NdFLtbDtFdVcmbpu/Eoi\ngLo4l1btFGcqRjuWdvgqIUT4VEmfJhq1sq1bFTpVnyW698tf1Np0lsY3yRVFyKYNi213XJWXmPGe\n24G/k76HGhMrrMOX6aNrv8HE0TMdkvBv4GaFm2K5D6Yv868BYFHydMqQtBNxY76I+B0dKml/21Uq\nD2U0rguW8Duadcl3w8cIL6CLIJoXJa3Qcswyeq601d65dMZgNLG0gO3jFRLsRb53O9tNbFKPIf5Q\nvkx8Wfck74YM47ugiyLkTg3ODcGOWoAxeYxlGZy9cJ3FbTkt8h9STwCZaRH337Wfg57pkISfpMdQ\n0FEnWYDoPs9dNX+YEAz9cxprWYL6XDmxSDo0nfMh4AZJ2XXBUrrxLuAiST+hf2XnbsrUg8REOpfO\nGIwmlhaQdJzt3YmVd+exHCxi+/xEn7wH+LikS4kbbiUGlO/ttuPq2eQ3YOxHUK37SYv8LqXDnHZY\n72awvueVdy3bdQyw3gNL+9n+St2xGpTrJI8D93nMOK4OszpSX3+j3o4aQu4Hgn3XWResy6cXO+nf\npsfCjFGEm+biWylTS5qdmHG9UOW+2cq5dCZhNLG0w5rlJ2n130SH6t+J5fKr1APye+CpVQHqYkdc\nRpPV3wB2XFX4Tc3rbdIibyO69p9JSOafQ2hwDQp1u62+U5iE5H7nJPKmLseqUNgsPCLpxcAOko4t\n07cr8FNJZzPe6KpWfr+YTHtNjDWxhUXCjrbH3bgl7ZhxzWXsS+y6HiF+hrMJq+dc3CLpPsIo7RLg\n8nKtzBXum7R0Lp1JGBXv+4CkA4APAYsQqYFihfsocKTtAzLH2YhYaS9F/HHMAb5gu6eni6Kx7wbg\nb+F/wAAAIABJREFULOKPa7xbVUYdoeg16YWqHpS6WkYD2ulRhN5Tm7TIhCCjgHsZYynMbUkpTNs9\nd5qSdgHeQIg9Xlp6aQngP4lllnt9NxA1tRWIG+vpxO7vlZnxhTWvgEtcsubNiJ2HlFH3edXEDlRH\nLAeJ/bg5IV76SkJqp1LSpssYjZ1LZxJGO5Y+kAq7n5X02dxJpMc4PweITFh289sGhHzKNkRa4vsE\no6rJCuFaxuxllycK6CImuN9Svb3fv8sxE/04y5GvsNwtLVILhcbWvsSkBDExf832RbljZKAqHQL9\npTCvIHpYnsL4+tiD1BhNdcETth9PE8Qhtg8tCBhV6KBKN6oNlCbGFTVePn8JIiVUFbs1cQPvlM+f\nw5jCc8417EFKoaZDvwC+avvYBmMsR0womxPf2VuByzJj2zqXzhx4CpjCTLcHsHr6d4Nujwbj9G12\nld6/CeHB8gvg1X38HIcDryw935qQVWkyxmbE7ulnwLYT/LlvQ3is75k+q/WIrve7yj9HxjgHETe1\nhYjm1L8CuzWIv5yoS/wQeBewPaGyO1nfv6uAXQhvkBXTsVsyY0+nD3M2oiHyxYTY6ItKjw2ABWti\n1yVSgPekf4vHa4GlM8//RuB6guSyJLEIegmxSHpjg5/jifT5vaaPz+BEwlr6lvR8ERqYjM2kx9Av\nYDo+iHQXwIVdHhc0GOcqwhq17IaXe4NYlqgrXAScC7ygj5/j2i7HshwOibrMReln3rKPcy9L5KrP\nJDxOLqj77NL51u1yfB2iaz/33Dekf7cnpFiWoZkD5UaENfRyBLPvlNzPP91Mf0XUlxq5P5bGWIMg\nXuySnq8IfDAz9iRip3hUGuOrxKp/Mv5uKiegmtifASt0Ob4CYZuQO8666e/mRGKSPBbYKzO2lXPp\nTHqMUmF9wPbe6d/WzCw3pM1K2pMouM4mKKI7uUGDWwf+KukjjFe6rUtrbEMUTx8APmz78j7PfTzx\nx/0qohi/B2EmVYWn276x86Dtm1LTXy4WSv++Evi+7f9rQl91SmES3vVN9bsOInZ2fZMkHI2k7y49\nvxv4XGZ4X1TpovlW4/1MgLnS8T39TJTkZIDrJfUrJzPH9m+6xP5GUraXiqPnqTDo25z4zr+QmGjr\n0Ldz6UzDaGJpgcRo+antB9MNegPgk7Zr890J/dBmjwJuJladLwe20nhr4CYdyLsQdYGieHtJOlaF\nHxNMrL8BH+i8ITc4/5NtH5VYRhcDF0uqE9is0gKr1AnrwI8VEugPA+9IvRxVFNRxSI2RO3q8MvMJ\nzut8v6/NpJLO17cviO3vpJvj8m4gieKk6OA+bJEZjJzMw32+Ng6SriGUqK8gaisvdL6v0cfo07l0\npmHECmuB1Ci1jqTNCPrpF4EPOdOTRH2YXSkcJHvCE6x+PKjzKwlcJurrV4E/AD+wvXJFzP1016QS\nob+1dM6501hLEymo/6Si7Bz3sIPuEtvNjyWXGfUVQh/sR4xnw2UX09XCF0RhHfBFGkqiSDqEqC1d\n7jH5/9zrfU+Kvd75/TadYzwE3NntJULrbrHMcZa1Xbczrorv27l0JmG0Y2mH4o96G+Aw26dJ+nhu\ncPpS7trkhA1u3KfY3qHmPcsSxchO7aOeaq3l86dd1upEauAON3NB/JSkJQmWzaFEMf29NTFV8ua1\nPjWSXmL7ApU8OTp2XLk39ydUkp9RuEPmrtDmEBT1rUrHcr1UCrTxBfk480qi5DT53UnUpL6QPrMr\niMniCqLOUKXYsByxgFpd0k2l2Ctdb69Q4P9lvq8OjyosFwra/MXExNqTNqzx8kkQ7D6A5dP3YCSb\n34HRjqUFJJ1BNDW+jGiMfJgQ9Vu3Ju6rVa97AJpTOStoSecQdY7/oVTnsP2BjPG3IVhlvyZWbysS\nQpBDN0LqNalKOtD2x9TemvgVwJHETQniJrW3a6TzBwVJnyNo3Y19QSRdZfv55e9HsfNucP5nEGmg\nTQgLgKdW1VhKcQsT/TebEIzIjYkekjVyz51xjittb1zx+ikEm65QT9idIIT0dOdMvWO3MlYDLK9G\nXLUQm6kY7VjaYSfgFcAXbd+f/uDm9nlIWtrJb6QDbyO+3CcRKaCJED7KWTH0U+co8CVgC9t3wtxC\n5k8I6nEt1M5Bsg5daw1ODYxuaZhl+6dpFVukRN6bmxKR9BzCsfFptteStA5BFf9Ug0soUq1l6wQT\n9Ns69C2JotiqrE1MDJsS7LQ7geOq4kpYhNixLZkefyDqhYPE7JrXV+5YdByoaDitwn8DOxALxxOA\nU93MrmHmYZAUs9Fj/AO4rsfxJxOTy4UEVfgtZPL525674z0/S/+eTaTz1gd+nTn+JR3P1XmsJv76\nnGMT8bMTxeQ56Zq/RchzbDVJ34mLiVRUY4r5gM6/KOF78/P0+BTwpIy4cwl6/BEEE+7/NTjnkUTq\n66fAgUS/1EC/7w1+91cS9bji+aZESi5n7BUJxY2riEXhepP1e5tuj9GOZWLRdSfiKLIeDhyucOPb\nBbhV0gc83kd+4OfuQD91jgK3SjqT+AMzoQj886J+4fpi9Kzyjk4hMzNZ38c32/6KpJcT2mx7Ev0o\n50zCuRe1fXVHbSeroC1pN9vfVQ+9OOfJ4Wxj+8OUzMUSu7FObeAuogdkVYIR+FdJf3HeTm15gon1\nKyJ1fC+Qo2s2EXg78J30vRfwf2Qyu2zfLek0Yue1O/AcQl5phA6MJpaJRZ2Y4QbEpLIlkULK8W0v\nYl8FnOneRdPKOolC3mNVhxzFA0RHcxPMJiTvC5bYX4hGw23JK0aXHSRNpBWzHCQzUDepFq+/EjjG\n0dswYTrsHfhrShsWvRCvY6wYXIeC+dQP5bfAAcw7iXQ7Ng629wFIPSMvINJh70wEkFts71ER+4r0\n+a6Z4v4bWEvS/xG7hVo17waoU6a+AVi36H2x/Y/aAaWVCBml1xDiqScQVtjZFPWZhlHxfgKhHgJ7\nkg5kzE72BKIXphENU9J3ieLnKcTNsXFvhKQLPUF2q6o3y0LSGkRdYB4HyYr6VPF6T0aapK1s99x9\npOL9M4nUxrpEIfwi29nK1IlivqrtY9LNdXFHo2Jd3EpEamgTQqPtbmBX5/dS5FzbPJ+9xvS6diII\nGwXmAGvYfl7m2E8ilAeK4v0LgD/bXjszvtDq2oT4G3iy7aUyY8taZ73es5btW7oc71sVPBXvbwJO\nI9QSxt00M3eKMwqjiWUC0YuZlb6odzHW2FX8EopGtyyGTlp17UKkckykc75v+8HM+E8TRdQTGe+E\n2Jo+2WtSHUR8W0aawqpgPeAuB+niycAzbWeJQSosjjckFIWfo/DmONn2phnnfZ3tkyQtRnijZP2u\nmqDbZ6ewb16PMAT7aOmlB4ELqybxFP9lYjJYlUj/XFE8XCPXL+ndjBX8HyNRjdO/N1fsuruN1Zct\ntFrYUqcWgp43yqrYmYrRxNIn0k3iJttrVbxnGXfh6ae+h55osnpVNFnuBryH2AGtQmg/HZoRe2H3\n07enT+bQnfuNVzQIvsodjDTbqzcY/9WUehls/7hB7A0E0eE6N6TsSrrEdq2NchvUfHYL2X4s/X9p\n4Fk5E2qaHK4gSAc9ZYckrWn71o5jB6fYy233TPvV7VLTe04idklTxRZ6LnJ26TMFoxpLn7D9hKQb\nVeHT3m1SScezJo4qTn66Me4JrEzQPZ9n+8+KLvJfEMX4up9hQtJgxfATGP/nYlJJuAvI1ktLfSAb\nEXplAO+WtInzLRAetW0l3au0+8jFuZL+h3l3ibmNgjmo+uzOTd+dBYmdx18kXWy7LlVU2XtVwnGE\ntFE5tnLsEs7vjO2CfrXOJrx3jHpL6xmD0cTSDs8g2FFXM/4m0USvqwpVnPzXAV92h7GW7Yck5Tb6\ndfuDf4BQPW7LdpnIYnhbRtorCaroEzC3p+Z6ooidg5MkHQEsJemthHT/NzNji99N2fHS9Oi96RNV\nn/2Stv8h6S1Ebe5jim74yTh361iH1tnCBCMLor72WMbY2cSYFpgsAsiUx2hiaYeJzq1WrTz/2Dmp\nSPq87Q/YPj9z/A3To0gDbUP0NrxN0sm2D2p8xWPoyjKStGJOkZvqP9K2jDQIP49il7BkxvvnwvYX\nJW1JFHJXAz5q+9y6uJQ+3c39K0LnoorhtaCikXcnSpTjAaLNTrU2VmHF/B3C+lqEIOQenX8L8wyc\nrJVL4ywRhwfa6DiqKxTwFGimmc4P4GkEu+VVhLTFIMfu2ezV7TWi5tNk/LMJNlPxfHGiiW0R4Laa\n2L7MskgeMAQLrOp9y0zg72wXwnTq28RN6m7g9Q3i3wss1+e5s5rxasaYTex4vgEcXTwyY3ckGE7f\nSM9XAk4Z4Gdb25jbJpbYeaxWev4cuvgKVcSvRexO7yEUwq8F1hzQzz6QBt/54THasbSApJ0Is6qL\niNXToZL2t/2DQZ2iyznfDrwDWLkjhbEEwbJpguWBsnDkY8CzbT8sqc5nYivb75e0PdHwtiOhJPDd\nmrhZiaHznG6pOCfqpitqDoku3M3XozYFmPopLiMKwBsRn/EHnKlsnDAHODv1YZxAqDLflxl7jqQd\ngB863Y36wHHA7YRtwicIIdMsurntkyntaGzfRciVAAMpQDcRIu1ETippIZfk/m3/UtJCVQEdOBJ4\nn+0LYe4O6JsEa60t6ppMZwxGrLAWkHQj4Z745/R8WeA814hQdozxbKIf4jyFT8aCThTUbpx8Rcfw\n0kSR8IOllx6suhn3OPf/Eoq1p6VD2xLWtV8iXDJ7Ki9LutX2mpK+Sax4fyrpxrqfXdJqwHYEi+3w\nztedQd1MN+YCs9PP8AdnFmAlXesGPSsV46xDmK7tANzriv6KUsyDRKPj44QHTK1RVpcxrre9vsZs\nGxYi+jsGwearpYmnWtZmxOR+me1Tq97fEbtBKfZyl6jtvViUHfFHp9hCoWJX4m8mS/+t23c053ub\n3jcInbcZgdHE0gKSbnapMSzl0G90frPYW4G9ibTPygpRwMNtv7QiZo6j+LpMt9f7mFyeS/yhi7hJ\nXFN6rSf9MzGrtiN6cZ5H1CzOcL4XzdYekBJy+tzPy72xSvo68G2POUH2e96nEzu11wNLuIFCcMvz\nXm37eZIuIXavfyJUtVsTAOpo4pK+QVDav58O7Uzoy72zV0wp9qPE51XUwLYj+n+yb8yKBs13Mvad\nvYRI62U5OUo6ldCGKyam3YANbW+XEXsxITJ7hMdo5re4ouVgpmI0sbSApC8QfuvlP7Kbbb8/M/4G\n4qZ8VemLenPVxCTpDNuvknQ3sXLrlPAeGLuobvWq8WZZixE311yzrCUJR75sX4yKsVYj+lhWyXz/\nbURu/h6Czde0MfXtxO96WcIe+kSXVANqYrv2sLim+NwxxlsIxYV1iKbYxQkCwTw7wKbI+J3fCqxV\npPHSpH6z7TUzxv4FsL6TFEraoV9ne1BeK6jGhyh9Zw8kJiaIienAXguojtif295I4y0HbrC93iCu\nfX7CqMbSArb3T2mZTYmb05FN0gLAI7YfVZKpkrQgNcwS269K/+aYM7VFz5x36pd5J1Gn2Rv4L4Ih\ndUbm2EcT1gE7pee7EzfJnr4YpXN3+q7/iRpttA5s3eC93fBs4D3uj5K9f+n/s4mFxbXkSd4DYPtb\n6b8XM1iaMtTXOe4gfudFL9azCDJADn5D/MyFxtaTCPWEQaLr5yHpONu7A2/MTZl2QRudtxmF0cTS\nErZPUXigLwh5eeISLpb0IWCRRF99B2PU367QvG52ndczSDe7qknuGOKGWBQ97yWKl7kTSz++GHFR\nNb7r6tL93YFnALeWallLEN4ilY2rRRqSYMTRmY7M+b3b3rZjzGcV49VBg1E3rkNdAfrJwC8UvVsQ\nBIgrFVIruLqH6xGiB+lc4ru1JXCZUvNiixt+Gb2+s89N9cw3SzqWjgk082/2nUTxf3VJvyfpvLW5\n2PkVo4mlBSTtQ7ByHgaeIKVUyF9FfhDYizA72gc4k/AHqcKXKl7LNXsaBFa2vbOkXQASk6xJg9jD\nkjazfRmApE0Z005ri3m6vztwWMfr/+pyrBu+R9DKr6VLGpL+dg/3EhTYHLRWN5Y0m/jOddpRvzn9\n+5maIT5a83oVTk2PAhe1GKspDieo9CsRv79+fnf32H6ZJlDnbX7BaGJph/8hOPBZ7oFd8BrgWNu5\nXdt4YmVYOlE1UTyacuRFWmBlSja5GXgbcGyqtUAo/faUXm+IWtn8MtXXIc9T+7cwiDSkpEMZW1UX\nYpg35sTaPiL926Yxt2+qcjp3rsNot9jv1L+rNXp5IH0V+Kqkw2y/vWdwtV7Z3ZJ+SsjxXND+Uudf\nzBr2BUxz/Bp4qEX8q4FfSjpO0jY5N7cyJK0laSdJbyweDeNfkNJAxfMlJJVZXT3ZaUTh/adE5/Px\nRJNkFmkBwHZB8VwHWMf2+i6JIUpqM8nUMVLukvRuSQulx36E3lgWJG2aVq1I2k3SwZKWzwy/hlgx\nX0so/H7A9m65507nPEjSnHTt50v6q6TcMVax/b/Av9KNfhvCbjj33A9K+kd6/FvSfyTVepqk2Lsl\n3dX5yD13aZxFEmGjGyprbVWTSkKVasVqwHlESuxuSV9T2CeM0AlPgS7N6fogFG5vIOxav1o8Go6x\nEDHBHE/k+L+VGfcxoiHxPqLe8SeiUa/Jua8nMQPT81k06Jwm8u3bEOmhpwz4s52wDm7CNfIEQrjy\nPiLFla2aQBSrRXi53ERYHV9cE7Ms4XvSeXxNYNmGP98N6d/tCeWAZQiae07s1enfS4gU3FMI+4B+\nP+vtgM80+L4Uj2cSvUyfaHi+bQkCwd3p+XrA6QP83mV1zxO9ZMcC/xnUueenx2jH0g5HEFvinzG2\nCm0kducQ0DuLuNFdS6THcvA6YkfxJ0dz2LoEy6YJ5kkJUZMelbRB8SDYUX8E/gAsX0csaHptLWIr\nu79t/9n2620/1fbTbL/Bqck1E4+nz+01wFdsf4X6usehxOTSieWArzQ4N8RiBEJM8/tu1rt0ZKLc\n/i/RDHsbmeSBbrD9IzLrerb/Vnr83vYhubElfJxg0t2fxrwBWKHhGJWXWfWipBelXp7riBrVTlXv\nn6kY1Vja4XHnS4LPA0mvIJrrtiAKmd8i/4v6sKM28LjC8OvPNC8e36Xw2TgsPX8H9SmhgjwwmxCw\nvJGYBNYBrmKsP6Atev6BSzqOWHFfavv2eQLtF1QNrPYd1A9KOoBornuhwtmwTlZkbXepT9g+W1IV\nIaMbfqzwpHkYeIdC8SHLJtctqcpKCtIJs4jvQFYzXMfCo4htSkR43PYDzXgig4Gid+wGQlV7f9v/\nqgmZsRhNLO1woaS9CYrw3MJ1gxXkm4idyj7O7Bwu4RpJSxE6R9cC/wSurg6ZB28j0ncfIW4O5xM9\nKT3hRB6QdAKwt+2b0/O1CDLDoFB15ziGmMAOVVj93gBcknYOOfgmqYMawPZNkr4H5E4sOwNvAPay\n/adUX/lCTUzVxNNE6wrbH5T0ecaaUx+iZqc7QKpymS79ONGbkrvLLk+gjxN03aYr/lskvQFYQKFU\nURiQDQpV37t1HXTzEWow6rxvgbSC6YTdoPtd0tOIXgCI/HeTlEwxxgrAHGda6w4C6tJx3O1YRfwC\nrnYi/Jrtd1XFE5/bFsQE+bAzHSQ1hA5qST8Bvm77zI7jWwPvtp3dtKloTn0fsLztvdMNdjXbPXuI\nJO1j+wj1sOj1gOx11ULEUiF/X8kcSz/7h4GtiEngbOCTTt38GedYmdB1e0QhQLkOwcy8P73esw9N\n0nJESnNTkk4asJ/te3POPZMwmliGCEk7Al9kTB15c2KLXauOrFAVvsBJAiXtXl6cct51se+3fVAH\n9XUunNGoJun7RP/Hd9MYuxES/LvUxab4uwk5lGOcKYdSij2f6Om4EriU0Dhr4iB5FvAuQqdqA0UH\n9V65N3dJLyBuMP8PWBhYAPin7Z6+Lin9dgaxui7qcBsCGxM2y79scP0npjHemFJ5ixBy/EOXFlGG\niOWgYtPiYrEmuwhFE+6GRF3mbKLOtJrtV2bEnksQPco6Y7va3jL3/DMFo1RYC/Si99o+NnOIjwAb\nuUMdmbjh1uFjLsnH2L4/rUZrJxbG+hauqXxXNfYE3k4woiBqHof1fvs8WIeoL31LoTd1NHBC5k3i\nJuC5BKvpAeB+hY1zboNltw7qJpTfr6VrP5m4Sb0RWLUqwCHvvjaRQisaIi8m0qBZq+0S+m5OlXQQ\nkfJ7mKCLr0vI09TZHeRiQh0kU8rybcB/iMl1SUkH265LRRZ4wvbjaWF2iO1DJV2fGbus7WNKz78t\n6T2ZsTMLg6SYzbQHsWotHt8kCt/ZlF9CvK/8fFbnsYrYeUy9cmMH+PMvTPRArEX4ZPQ7zguB3xM7\noO8QvRY5cYsD+xI07Uf6OG8hnNk07prO3wFwxYA+01ojMGLXUwg4AqxMohFnxPZNVc4cf6KNvorr\n3xU4mKhPZRvcEQSTXQiduhXTsVsyY88jFiALpMdu1BjWzdTHaMfSArb3LT9XdJEf1+Pt3fBTSWcz\nXh35zIr3l3GNpIOBrxOpqH1pSHWW9GPmTYU9QOxkjnDFSlp9WsSW4hcgemD2JNISXyJ6eTYnPoPn\nVMS+K73vucSkcjSREsuCQnp9h3TeBYvFvu1PZA7xkMJ3/Ya0A/gjY3IrbTG7/i3zNKduShBBcjAP\nVXnADKsJ3bEACyn8Z7YDvmb7MUlN8vl7EjueT9u+W9KK1JvTFXgzsVv9cnp+eTo2QgdGE8tg8RAV\nN8ROONSRC9OkpurI+xK9CCem2HOIFE8T3EX0VpQntvuIn+GbhOJwL3yJcJG8A+bWEL5P3Oxz8Cui\nwfMLtsusnh+oh7R8CYsQq9VrbT+eeb4yTiMm0GtpJkNTYHdid/kuwqb4WZRcGFui9iZp+1xJ1xEu\nmCIKyLmyQn1TlSG0xqoWHLRzUcxxQD2CWMzcCFyiEJbMrrE46nnvLj2/G/hcZuxviWbmEWowKt63\ngJKia8IsQiH3JNsf7BHSbYynA88nRCx/7mYWuaQelids/7NJXIq9xPYLux1TcoisiL3JHf4l3Y71\niF0A+HCDHUK3MdYldi0Q/SxZelsptpU5U8rPn+nmFPGcsbMK2JKeSTSozl0cNtgttvHRuZNYfFxK\n1NUud6aHjqRfE83ElxL08EakjYpxF8xdYCjETj/O2GdXePHUMjkTtf0rxIRugjzyXoe98wgljHYs\n7fB0xvw1Hgd+S6xis6AwbPoo0b0voi/jE7aPzohdm5CUWCY9/yuwhzusjGuwrKTl00qM1I/xlPRa\nnXf5NZKOYrxFbFYqLt3QtiBEEBtD0dS5N2NOhN+VdKTtQzOHuELS2k49OH3g1cAhCgfHEwhb4H52\nTt2QU8D+PLG7vJVYkEDc6GonFrX00bG9SvqebE5I+XxD0v3OY6StQSyiNge+KGl1or6zfc65Sz/D\nNnSoM5P/XTqK2GVeSxAAmuB7ROq5uN7XE7v0LNfUGYVhF3mm84MuxUaaFRLvAJ5cev5k4I7M2CuA\nLUrPX0zDAjKRZ/8tkZK6iKhXbEPUC95TE/skopfih4QU+nuBJzU496eJfPXmhFz9BsAGmbE3ETTT\n4vliDT/324iJ84401s1N4tMY/Wq8vQtYuuL1tTK/N9mfdUfsiYRY6C3p+SKkgnhm/HJE8ftwYsX+\nE+CAzNgFCXr1B4mJ7Eqiltfk+g8nFlS/I2pNNwNHNYi/qp/PrVcs8LN+x5ufH6NUWB9QWNO+g5DE\nKDvgLUGkBrKoq6kfY2vbj6bnCxMplpdlxBbqwJXHMsZ5ErA6sVK+3c2pr31B0oVdDtsZvvWSbiZo\n2oXF7WwijZil0pvy8t1Ofk96vUo6vTzOQsAriILw5ra7aYF1xnyKWOleR5AOznbDP8LUh7Oj+0t/\nXmN7Q41vDs3+3kh6Avg5ITx5WsNzP0RMBAcD59n+W8PLn5tuLf27OPBD21vVxBXpxZ0IRtcPGa+W\n0dMgT2OGbu8nNMpOIHaIOxMT/Ceb/hzzO0YTSx9I7K+lgc8Sq68CDzpDzkVjshrrEXTd04gv6msI\n2ujbMsY4lbg5lZu1NrS9XYOfYyGiF6Wos1xErCAfy4jtzFUD4AaqA/0ifX57MGYatR3wbYeo4SDG\nr/N979R4OxE4x/l5fhGd43sSfTAnEavuSptejTW0PpPoPzmf8TfHnMbWKwjx0ssdzaErE+yw52Ve\n+7oE2eSFRDrtV4Sy81EZsa9Jsc8jdoxXELWWKqn6zjGusv18ST8jbKz/Ruy+KvuIeixkClQuaBTN\nvKZ7mtKT8Z2fbhhNLEOAeshqJNgZRe1UgD2QMdHHS4ADc1bapTG+RaR0ChmN3QkZ8LdkxN5Ol1x1\n7io0Tc4fY2xSu5iQUM8tBG/AGJvuEtu5TW45Y89dzfd4/QRi1XqW+yzgpxv0nsSO50KiIHyu7Z6e\nNqr2qLEzGnMVFtgfIeod55CoyrYvanDtixOf/ebEgsa2V2gQvzqwNSGb/1TbizSI/V+ib+yljFHt\nv+XwmMmJX8kdxfZuxxpcz0I5C7GZhtHEMoWQUjrb2u5J2ZR0nO3dJe3nfNHFXmP1nU4rVo4tzn0K\n0aRWntTWtf3aiphler0GjcQ/666tb1mSjLHfTey2/kqoWf/I0YsxC/iV7ZUzxpjnd9/k+yDpyYxR\nlX/mBg6okq4h6mtXEFpZlxQpxIzYU4hd+p1FLFG36Cv9mtK4s3MXIylmnt+tpGtt59Lkix3nFoSK\nwra2n5YbO1MwYoUNGYl6uxVREN2K+IOr6gV4bqoRvFnSsXRszxveXP8jaeUiBZPolLlMmQslfYEG\nueoOrGy73PtxoELHqQqdXvPFqkj07znfGIreo88ThmEqzm97Tkb4k4HXdt6MHRYIr8q8hD2Y18Pl\nTV2O9cJswgp6QWANSTiTqkzUBP+S+d5OfI4gvDRlY81FYrX9NyHA+VZJy0va3BUCnCludYIRXwPR\nAAAgAElEQVRJtqTGS//PIa8pFYW76hsIVtgyBLtu/8qgGYrRxDIkKJoA30CwsK4mUhIr2a6zOj6c\n6LpeibjRlieWpjfX/YkJ4q40zrOJ9EwOit3Khh3nzzVueljSZrYvg7k1m0qtL7fwmm+IOsrvQcRK\nNdsrHiDtSnaw3UthuHI8hTbYG4AVNb6Hag5Ra8i5hr6pygmPKhQf+klh3gC8U2MNsBcDhzdMJR1D\nfO83Ts/vJRZidXTp1Qh69FKMl/5/EHhrVaCkTxNF/98S9OJPELI+lUrMMxmjVNgQIOle4kt6GJEK\neVDS3U1unJIOc4V/dwNm05OIP7qCFTaQpj/VSKCnGsOxQKEI/HeiD6en9L9qHCpzdkvp5n6TKxok\nVSGdnl6/3PamdefqEXs8Qc/9bR+xzwZWpAtphPiZaskDku4A1mlRG2qcwizF9l3TK43RltW2se0r\nc8+XYv5CULwPAc6w/W9Jd42K9r0x2rEMB6cQTKadiXRUwQrLRtWkknA+0RsyDzpSAWWsnNIiP+zx\nehPsx9gNpBv+YXtdhXIAtv+h0G2qQpXTYtZuKaWcblSpMbTLe+rSidcopOt/xPg0YM7n9gzgVklX\nE6KbRWytVEhKn90j6WWMOYg+h6CL5zZ73kXc3PtdQPSTwiywUccEcIGkbMWEhEcVNgEGSKy2Jj/L\nnZI+RNKJKw7artL8ejpj6epDEsNsETXo+J9pGE0sQ4Dt/RRy21sQX9YvAHMk7UT0sTTuT+iCqnTO\nthWvmbGO9ok6P8TkuoHHy+T/gAqtMSf3ygGg75t7whxCF67cO5H7uQ3CUOsSYPPEDDyfEA3dmVA/\n6IoSVfkhQjyzMVU5oXEKs4Q2Nb0CbQQ4Iaj9lxJKxVnnTjWhs4CzEsHmVcCiwO8lnW/7DQ3OPyMw\nSoVNAWis0W4XQtjxKTUhOWNOGLOpzflLRdSDGF/4nEOYnPXUJyuN0Xf/TYp/Ubfj7uJJPxFQS9fQ\n4rOVtC+wiMO0rY4i3ZqqnMZZj9iJLkksHv6PoCvX7jwkvZSokYyr6dmu6jHpNk4bVtvAnELTbnv7\nIuVbl/6dSRhNLFMMkhZxMqySdEpH2qHJOLUTi1r2ktSM3fVGp2iS246QQykXoB8kjL5q/csHlKtv\nfHPXYJw3dyJ2qBdBM9fQ0hjXE8oPXyacL2+VdLMzlAfaUpVLMXNTmA3jWtX00g7pBtv/krQbke79\nSgPK86cI6aNce4om1zbUxdxUwmhimcKoW4W2jW1TiM04f51nfeMiaim2lZxNvzd3Sdva/nGv1X/O\najXVFLZ0h2to7rWnmBcRlNvLbX8+pZTekzmxdevjyPmuvK/qddsHV8RWfp+a1PQk3USoDqxDkD+O\nJujbXXehXeIfJLTlHgWKHa6dRxWvG7vvv9f5DaMay9RG11k/h9lEdCbXoe9CrDrMsorjTqoBVZNK\nwvaSbqU/i9y2ufoP04cltO0fp3/bpDtmdeyO/kZYLmQjpewuVkje4+gar5xU1J6qvESTa+zAIGt6\nj9t22vl+1fZRNWm+8Sez2/wctcNP4NjTCqOJZRpiQMwmaFeIbWuWtZXt9yu8Te4FdiSkTXImljb9\nNzCAm3sLdHMNPavJAJI2JuTfFweWV1C397H9joqwKwiny6cwnl33IKHwXAnbfZMObDf53dThQUkH\nEFIyL1Q0GC9UEzMOkl5NqT7nmubKJkMPaJxpj9HEMrVR9UVty2yCsGg9NtVaIPWSZMYuZ/sVDc7V\nicYWuZJ2dMjd3AWsSv+5+tY3937hdq6hBQ4BXk6qUdm+UTWum22pypK+WjN+zx1TmzRaF+xM7Lz2\nsv0nhTfMF3KDJX2OqK0dnw7tlxZX2eZ8FchxwJwRGNVYpjAkbWX7nB6vtWY2SVrR4fs9rpfEYdda\nF3skcKj7NMtKf+DbETuk5xEd0We4Qn+sxIZqXSSVtANBVS1ELLNv7qppoKyJ/bztD9QdqxmjUPht\n3CQo6VqiprQ04eZ4DfCQ7Z5U5RRXueCoSg+qWnS11W6oKVKNZj3bT6TnCwDXO8P5NL1/HpMxt3BC\nnV8xmliGCIU21CeZ1yY1q5A4KNpqx7FKQT6FF4rT9a5K7B4eKV171h9oGqtskbsoMMcVFrmSzk3n\nXY/oRRiHhru1gtlUrg9lTRaSfkXIkxxDKBxn/xH1+MyzLJ1L7/8B4WnyNYJ2+27CMuH1uedXA6py\nj3GWIH7fg+i5yjnfZbY3S8X38ufd9G/mJuDFxe9aIWx6Uc7nL+lwon9lC0JA9HXE391ezX6a+R+j\nVNhwcQjhKXFzk5sTdGU2HSopi7aqdoJ8uUKJvc79EtsXlM/bkQKrKuRuQ9BLj6O6C7/uGvYh9J4e\nJvSymopYPgd4GfBm4nM/kfCD+WXFOeeaw6WbW4ElaJ5CeRshOPlMoj51DiGImAOlGs2uQHFDzL4P\nSFqL+PyXSWP9BXij7VszYpcjJO83JT7vy4D9bN9bF2t7s/Rv2+L7Z4HrFd3zImotB2TGbuIxk7ED\nJX2JwTQTz3cY7ViGiPTlfmmxLW8Y2zdtVQPoJUnjFJ4oJqivOVpdB9r+mKRj0qFxCsWultYoxljW\nFQq7kg61vW/F678CNnaDxrqKsbYgCAeLATcCH3QXGrVamsMNCmpBVU7xVwAfdmpqlPRiwk1yk4zY\ncwnf+LI53a62t2xw/WsTdSGA23ImtC5jPIPY6YuQ7e+5S+6I68tkbCZiNLEMEZI2IlJhFzNeXqO2\nmKmOhjgFBflGZ9rzppg2vSQfJZhcxYptO+Bk25/KjJ/NvHRlDyJfXVeDkfRTovehTkm6V/yTiZvi\n7sB9BEPrdCJFd7IrxEQV2lb32n4k3ZTXAY61fX+D8y9LKPKuQL7eVecYi9n+V/0754lr4+EzT9d7\nt2M9YpckmIjLExO4CPfV3wKvcYNGTUnrMO9nV7vzUEuTsZmEUSpsuPg08E8i/bRww9hBMJva9JLs\nAqzvMd/5zxFWyVkTCyHgeH+KKYyeJmuVcwBwhaSr6E8v60pi1b1dRxrnmpSHr8IpwIaSVmFsQvoe\nwY7LRWO9qwLqj6pcxl3pBlveddSSPRL+quiWL76zu5Ap908swK4BXlIqvM8iPF4+DfTcoZYh6Whi\nMu+0DaidWDzmbX+KpDNoaDI2kzDasQwRShLgLeL7Zjal+Btsr6foJdmOsBq+MHP1eRawS7HSlrQU\n8F3bWTUYSbe4usGzb2TsWK4m8vs3M3ZzyW58lCTbTsV/236w6bVJej9B+z20afE8d5XfI/Yqouh8\neolRlv27UAtLbAU1+GuEl4qJ3pr9nCHHIuk2Qu7/8Y7jCxI1yv+Xef232V4j571dYjtNxlYFVvPg\n+mDmG4x2LMPFeaqgFNfB9iklplQ/NNjGvSQlPEL00ZxL3CS2BC5T6nfIWP1fIWlt90lXrkHdD/G4\n7creiho8N9WIliDmmfuBN9u+NiP2MUUX/BsZ60hv1OAHnCHple5T78r27zp+z7W7HiVLbKJQn7uz\nK2ILOvXzmzL3Sni0c1IBsP24pCY9TFdKWsP2bX1cQ78mYzMOo4lluHgn8P70h/EYDaiTA2A2AfxY\n0u1pjHek3H2u//ip6VHgopwgjacr76nonu+LrpzGmwUs3pFjrxNUvFDS3sCPGZ8Ky52UjwbeYfvS\ndA2bETednGvfk2B1fdrRQ7QieWoDZewHfKif7w3wO0mbAJa0MEFVznHCbGOJ/UpJHyFSkFW221WY\nLWn9zvOm509qMM53iMnlTzT/3q1se+e0MMD2w2qwEptJGKXCpikGxWxSw16Stkg3p57ITIt8j7g5\n/4dYQS4JHGw7qwNbUreagJ3pCKguDpLdjk0kFP0XqzK+Ua+2OVbSU4iJ92XETfUcIh1VWeuQ9G7C\nqmAl4PeMv8FXfnaSvgDsTTDnHmJsEdRkIVUpre9Mrx5JdwLvY940aM737gqicH95SmeuTOz0n5dz\n7pmE0cQyRKTaxgVFATDVKV5s+0cZsX0zm9Sll6SMTIZMq+bONijVhnYljME+AFzbdLfTx3mLus3u\nRKPc94kb5M7A321/uCL2JNs7lXZs49Dk2iW9hdi1LEc0ar6AkILPER5tBbWwxJZ0mu3XTNzVgaQt\nbZ9b8foFtmudRnuNDXwEWIOYkDclvGgu6me8+RmjiWWI6EG/zCrkprTAMUBjZpMG00tyJ302d7ZF\nYrKtR7Cpvmb74lzKa4p/Y7fjrjG7qlk1u+qGJekZtv/Ya8eWs2IujXUz0YfxszTBrk4U0HfOiG1N\nVa4Zv2+5HUlX2t64/p39n1/SNwj5oM40aOViKqW8liN2XH2ZjM0kjGosw0U3Rd3c38kRwAV0bOlz\nYLvQbno7XXpJMof5HdEcNoyVyRHAb4h+hkvSzbqJ4dRGpf/PJtIb1xH+Hj2Rm27pEfvH9G/2BFKB\nf9v+tyQkPcn27ZJWy4ztm6qciTY1hzrVh0GcfxFiQmlkK51YgD9yyB39pN0lzv8YTSzDxTWSDmas\n2WpfomaQg7bMJmjXS/J+4ExJjZs728L2V4Gy2u49ig743PhxPQ+K5rvjerx9oEjpx88DTyVugv2k\nEO9NadMfAedK+jvwh8zYRd1A8LIPtFloDGKRUjmG20n4/0zSRrZ/3mKMGYHRxDJc7Av8L3Bien4O\nkcPNQVtmE7STvm/T3NkK6mEyRrDk+sFDhP7XZOAgYFvbOUysrrC9ffrvx1N6bkmiwTUHrajK8xMk\n/dJ2k9/7FsA+ku4hrCr6YjLOBIwmliHCIanR0wdC1ZpXb0j/lgX0mtKN2/SSLGN7q/q3TQhamYxp\nvIPiLKIYe9JgLq0W97WZVDqRwwTrQBuqcg7apMJqY1Pq75GKY7/pEVeoIpfPsWhxPPPn3zrjPSMw\nmlimOnrSV12hR1WHAfWStGrubIm2JmNPJ1woAR4n9KbqrJSLNFZPVBWAS7HXKNSQf0SD4vGgYHuJ\nblTlXKhe66wnM01hpdxpMnaW7cJ7fveMS7iSULjuesx2r9/Rt4md3f6270vXc3eTv6OiPibpqQym\nHjTfYsQKm8KoYrj0y2xKsYPoJXmQ6EuYqJVv1bnbmoz15YlSYtE9FdiEIE9ApEguqriplWO7IYuJ\nNwi0pSpLugHYkEhDnk1ona1mu1brTH2ajKXYpxM2Ad8lduvFzmMOcLjt1XvFlsZ4LmE18SNCWubO\nqv6bLvGvJuwa/gv4M0G1/4XtNXPHmCkY7VimL/piNsFgmElu74vRGG13WmrpiVIUfhUChGsUTC+F\nDPvXc2LrIOkA25/NeW+f2I8xqvIWBVW5QfwTDhmV7YFDnLTOMmNl+yFJexELg4MaxL4ceBMxIZYJ\nIg8CH8oZwPa1CmvmdxGK4k13HZ8kJuLzbK+fCCO7NBxjRmA0sUxt9Mw5D5PZlM73A0La5Kfuw0+m\nT7QyGSP6Xs6ivSfKCsWkknAfgyv+70hc30ShDVUZxrTO9qC51pnUp8mYQyD0O5J2sH1Kg+vtHOcJ\n4KuSTgYauWYCj9n+m6RZkmbZvlDS5/u9lvkZo4llaqNO86qMyWQ2ARxO6F4dmv5Iv2379ok8YSnH\nXQgizoWk46jJ0TsUDh6g/SrzIo1ZFhh4PVApOdIAE6091YaqDO20zvYjyCan2r5VYTLW9HM7Q9Ib\nmLfBs5YRqFCjXtb2r9PCoNhxrmP7pupoAO6XtDih6Hy8pD8TNboROjCqsQwRqYC5P2OyKABUdXCX\nYrsym2z3ZJlNBNJOaRfgw0TT5DcJ+fzHKgPbnXNcjUTSAoQCQF9y6H1ew/aErS30YVlQMW7fnet9\nnOtFJKqy7Ucn45xtoZAyKhiBcxs8bVdaVSusvA8haiMLEVIsP0+vZX3mBfmA+HvblfjsjneNztpM\nxGjHMlycTKz8v0nzLui+mE2DhMY7KV4PHE/4dOwBvHgCzncAkU9fRFLRaS/gUeDIQZ+vBtcRKbTz\nJC0qaQk38GWpwKSp5fZBVUbSpsDHmVcjrrYInhZS/8O8u40m2l39MgI/BDzXIavzPOA4SR9KbLys\nz9xjjptPECrJ4zAISZr5BaOJZbh43PZhfcYu2HljkLQ1Icg44ZD0Q4IuehzR8FfUHE6UdM1EnDMV\ntT8r6bO2D6gNmCBIeiuh1rsMsDLBVjqcCqptA/QrKz9ZOIowhBu3Y8hEsZD6Vh+xBfrtvVrAY7I6\nV6fC+xmSlmNwzqUjCnLCKBU2REj6OLE1P5XM7vkyswn4demlJQg5790m5GLnvY6X2L6g/p0Tdv5n\nMm8K8ZJJOvcNwPOAqzzmwniz7bUzYr/a5fADwDW2TxvslQ4ekq6y/fw+Y691aG21Of9twCqEHXIT\nRuAVwO62f106tgRRa9rMdhNPl17nmLQ05lTHaGIZItSHL0iqaSxNe2ZTX2jTJDjAa/gcUTC/jbGV\nr92/O2HT819l+/lKStQKe9zrchpLUw/O6oztTHYg/NefBdxl+z0TduEtoDHLgJ2ABQjRxvJi6LqK\n2GXSf99Nw4VUl7H6UoeWtC7wL9t3dhxfCNjJ9vG511BxjtHEkjCaWEZohKnQ6CfpDsL/vLGcy4DO\nfxAh3vlGQu/tHcBtrvBjKcVeAGzlZLObJqVzCGvnSSUgNIHaWQbczbxyKuXYJjJEKBw7V7V9jMIG\nYHHb3RZpjdGmTqJMy4uZgFGNZQjQAIy2hoUGjX57pN6DicBdBLNnKBMLsVPci7As2Ac4k6gb5OCZ\nhGLBA+n5YsB/ORw8h/Xz1MLJMkDSSrbvKr+WaMNVsSum9822Pc76WlKjuoSkjxGd/6sRfkQLEXTn\nQbl3Vl5P2jGtmkgbixC1zoK0kSNJMyMwmliGgxcRciDbdnmt1htimmA/ujBnBoSHgBsknU9Dk7MB\n4TWEPtY3+4g9iLj2i4gV/AuBzyQq63mDu8QJww+YV6vrZMLJsw5XdIntdqwK2xONjdcB2P5DqpUM\nCj1TOF1IG8tRIm3YvmWA1zGtMZpYhgAno6261f8Er/onGhNJmz09PYaFVwOHSLoEOAE4u0ht1cH2\nUZLOJIr/Aj5ku2hQ3L935HCRpF/WBJbs2GnPoX6VX+h8LaJwPi3rfC3a8FIetW1JTmMv1jC+Dd5J\nIm0A2P6VQpByhA6MJpapjYlc9U80Jqx4Z/s7khZmTGngjolsyOxy/j1T0XdrQhDxG5LOtf2WzCFm\nAX8h/v5WkbTKZDHaWmA1QlJnKcbvtB8krI6r0Frnq4STJB0BLJV2EG8mPw2Zg6oF0SO2H5XiLak+\nNipSd8GoeD+FMZ2LgRN57Qq59u8Q3hsiGFV7TPbNOU0uryBkTja3vWxGzOeBnQkmWKGxNmmMtraQ\ntLHtK/uMbaXzVRpnS8JaWMRu8dwGsZ93h4Nm+ZiktXqltNqQNmYaRhPLFMZ0pi9K+prtCVECUMiv\nv8H2Hen5c4Dvt+2RaHD+VxB05y2AiwgH0HNy0mHDZrS1RWJhvZV5u+dr2YDq4fzpDJ2v0hiVE0NG\nfF+WCel9swjSxtxJDfiWRzfReTBKhU1tTJq8Ry4kva/qdSfP+4maVBIWKiaVdK5fpt3DZOFNRG1l\nnz4miGEz2triNOBSgmjQtHu+lfNnwpbMqy5RqzihlpYJCYsARxekDYVG3SIEmWSEEkYTy9RG7hd+\nMjHpPixdcI2koxizCdiVuFlNCmy/vkX4sBltbbFo7u6gC/p2/hzAxDAIy4TzgZcB/0zPFyF6kDbJ\njJ8xGKXChghJTwM+Q/QxbC1pDWBj20cN+dKmNFJK5Z2E4KUIGfNvTHR6SWO+6XMPlf5vZ7hnStqj\n2/Hpwv6T9CnCcfLMPmL7dv4ctOKEOuyFbf82I+YG2+vVHRthNLEMFZLOIpq8Pmx73cQyud4ZmlPD\nRmps24ugoJb/QCfFYneE4UBjltSPEpbUkD+p9qXz1THGysC9th9JJI51iJ6i+zPjtyWYaY3thSVd\nDuxbyNcorI6/1m+n/vyMUSpsuHiK7ZMUcvA4LF/7VX2dbBwH3E5QST9BpKN+MRknlvQqwia2U7q9\n9uY2wGtYl/Bvh/BjqTSKknSS7Z00Zq88Dk1ursOE21lSbz2ASzgF2FDSKoTS8ulEmuuVmfGfon97\n4fcAJ0sq+o6eQTD8RujAaGIZLv6l8DQpmr1ewJjUx1THKrZ3lPSa1FfyPYIlMxk4BHgtoa016Vtu\nSfsRzKhCIeF4SUfaPrQibL/0b1t75aFD0qsZMzm7yPYZOXG27+mYkC+1fWPD0z+RFmCvBQ6xfaik\n6xvE920vbPvnqVF0NWIxc/tk9k9NJ4wmluHiv4kV18ppm70s4Xk+HVD8Qd0vaS3gTwSNdDLwO+CW\nIdI89wKe72T8lG5MVwI9JxaP+dWsYfus8muS3kZIg0x5KJSlNyJM3QD2k7SZM5xLu0zI382YkDvx\nmKRdiF6SolGzCSOwrb3waoRb62xgfUnYPrZB/IzAqMYyZKS6SrECmtQO8jaQ9BYiLbEOUSdaHPio\n7Qm/QUraiEiFXcx4ZtXBPYMGe/6bgY0KQcVUb/p5Tm1M4QvyEScvG0kfAF5sexBpoglHYmStZ/uJ\n9HwBoi6Y0wdyE0FOKSbkxYArG9ZY1gDeluK+L2lFYGfbn8uM79teWCGA+WJiYjmTSO1dZvt1udc/\nUzDasQwRkn4NfKF8M5Z0hu0pny6xXchoXEyYjk0mPk1QPmcDC0/yuSEm0qskFT732xH5/hy8mnAu\n3J/o2l89HZtOWAoomFhLNogT43tf/kPDXi3btxG+LsXzu4GsSSW9v4298OuAdYmJdM/E6hyknMx8\ng9HEMlw8Bmwh6flEs92jhFjflMcguqhbYBnbW03CebrC9sEKdeKC7ryn7aw8v+2/phrFeUTvzeum\nWef2Z4HrFf4shTpzrk103xNyBfmhMbOsBlWCmg/bfkLS45LmEKyyyV5UTQuMJpbh4iHbO0t6P3Cp\npJ2YPqJ2g+ii7hfnSdrK9jmTfF4AJH0FONF2N5vhXjGdPTALEzel10maVEZbG6T000VEnUXAB2z/\nKTO27wmZySM/VP39XSNpKeCbxPf+n8DVE3w90xKjGssQoZJQo6SXAl8nVuNTXopb0i221xrSuYte\nikeIXd+k0o1Tk+POhLryqcQkc81knHsqQNI6zLtTzfIQkrQ0IRpaju1pa9wlfjHGdg7PIVKJZw2q\nNtlDS2xT25dLelLRhCtpBWBOHc18pmI0sQwRkra1/ePS82cTKr2TkU5qhTZd1PMLFF7uOxCClMvb\nXjUzri+67lSApKMJwkanOnOOCOUnCZ21XzO2M7ArbI27jHEtQVdeGvgZcA2x8981d4ya8edR5ZZ0\nre3ndpt0RuiOUSpsCJC0uu3bgd9L6vyiTpebzGbAmxR+5n11UfcLSQt1rlAlPcX2Xyf63B1YhVgx\nrwDclhPQhq47RfAC22v0GbsTsHKqJfYL2X5I0l7EwuagJn0sqldH7mYv/JikY4DlJM2T/vT00Xmb\nNIwmluHgfYTF6Ze6vGYgewU3REw6PTZ1SR8HPCndTPZJrCAIMcBJWU2mvpXXEivvk4BP5kqKEB3i\nZbrud4DrGa9/NZVxpaQ1EjurKW4hGGV/bnF+SdqYoArvlY41uY9VqiO7uxfLqwjxyZcwiWKn0xmj\niWUIsL13+neLYV9LvxhQF3VTHAS83Patkl4HnCNpd9s/Y3ItBu4m+jH63SH1S9edCvgOMbn8ieY7\n1YJRdgvj+4+a0K33I1hop6bvwUrAhXVBaqGOnJh8JxNisdNCLHTYGNVYhghJOwI/tf2gpI8QK+5P\nNmDKDA1duqi3B5p2UTc954221y09XzOd/4PA/05m/lvSMxnTKgPAGQ6WqWv8c8TNcC5d1/YJE3Sp\nA4WkO4kd982M1ViwfU9G7K3AEV1iL8489wLA52zv3/CyB6KOLOnC6bwYnEyMJpYhQsm5TtJmxBf+\ni8CHbD9/yJdWi0F0UfdxzmuAV5XprZKWI+pSK7udQGKT6/gcUbC/jbGGP+euvCU9gzG67lW5dN2p\nAEkXNCm2d8RebPtFwzp/aYwFgKcxflGQI5v/aWKHeSJQNFo2YrXNFIxSYcNFcVPaBjjM9mmSPj7E\n62mC1l3UfeCDxA1h7o3Y9r2SXgRMpGNlJ7YHVnP//i/Lpn8XADZJelNZdN0pgNsVgqM/Znw6K+f6\nr5X0WUIfrxzb5MZ8vaTTgZMZf3PPpTu/C/g4cB8lVhvBdKtDYehVZm1Ol5ropGI0sQwXv5d0BFEY\n/HzqZp815GvKRRtZk75g+7wexx8gZF4mC33bC/ei6zKWUpzqWIT4ucvKB7nXX9B4X9AR2+TGvAzw\nt46YJp/fe4hFQa02WCdGabB8jFJhQ4SkRQm9qJtt/yqlSNYuOsolLW3770O9yAokqvRcF8dh1oYk\nneVJEnKUdAqhGdXYXljSbS3ouiO0RJKi2dJ2E0XjIvaj3Y5Ph76zycZoxzJE2H6I0krLIa3+x9Jb\nzmeSKLS5kDTH9j9Sc+Bv0qN4bZncQmif5+71WQiYTHvY09OjH7Sh6w4Vkl4OLAecb/s3peNvtn10\nw7H6qpWkbvvDgKfZXiupALza9qcyh7gLuEjST2iujP2v0v9nEzTkSTG3m24Y7VimMLp1AQ8bSurL\nqTGymxjghInyKdw1L6Z7LecFtheZqHMPCpJeSNQn+qHrDg2SPkPsTq8jfFAOKRiAdR3pHfReiJ/5\nOcAd0Mw9U9LFwP7AER6TQ8qWF1JI388D2wfmXkNprCcBp9t+edPY+R2jHcvUxpSb9Z0k/W2vOITT\n/4JoivxV5wuSfjfRJ9dg7IWPJrq7x1FupwG2BdZ3uDd+HPiepJVsv5d60sZvgH8QtsAPp/dfyphR\nVxMsavtqadwps9NaxQQiaTGPSej3i0UZqRt3xWhiGaEv9EhLPQDc00/+OhMfpze5Yd8JOmcZg1DY\n/a3tftNow8SCxe/V9v2StgWOTI2DlZ44tl8taXvgSOCLtk+X9FhO70sX/FXSyozZeVjZ2vUAACAA\nSURBVL+O8enjSqSu/aMIY7rlU5PvPrbfkRFbXlAsQLD7RvWVLhilwqYwpmIqrICknxH1n5uIFeja\nwI3Ak4G3eUiS9una9piqHdKSvkF03vdD1x0aJJ1BmNJd3HH8U0TvVS2bMfU6fZLQWNvA9nJ9XMdK\nxAS1CfB3QgVh19xJStJVhGHX6U1TaQqR2AKPA/dN4CJqWmM0sQwJkmYBN1V9oSe6GN4Gkk4gVAJu\nTc/XIHLfnwR+aHsyi+md1zZlVWiTmGEn7Ax14GFC0iIAth/u8tozbf++wVjrEs21fdtYp0lqlu0H\nG8ZdZfv5Gm9ZMU7RoSJ2ZeBe249IejFBGz/W+TpxMwajVNiQ4PCTuFHS8r26fqfqpJKwejGpQFjG\nSlrf9l0d+e9hYOgX0Au29xz2NfSDbhNKCVmKB0qq1A5NuRvTsSxVaoXL6pHAykR96s22+2Fk/U7S\nJoAlLUzYHOeOcwqwoaRViHTa6cD3CGHREUqYLs148yueAdwq6XxJpxePYV9UJu6QdJikF6XHN4Bf\nJqbMQEyXWmDKbsMlHSRpjqSF0u/9r5J2G/Z1tURl2lPSFpLuBf4g6RyFSVZWbAlfB/6HSLUeDBzS\nx3UCvA14J2EBfi9BU39nZuwTKfX1WoIV917ib3iEDox2LMNFY4rjFMKbCLXY9xA7hMuIP/zHgGF3\nKE/YjiUVf3cjVJ2fQbCcbgF+Anw3qQBUYSvb70/F7HuBHQlByu9O1DUPAuriQ1K8RNSMqtCpSn2u\nmqtSz7J9bvr/yZIOyIwbh7Q76tcU7DGFiOgbGWO0LdTnWPM1RhPLEGH7YklPIwQJAa623carYtJg\n++G0SznD9h0dL/9zIs8taUWP+bB0O1Ypg97ivGcBfwBOIyRk/kw0yj2HmExPk3RwDeuruBG9Evi+\n7f+bAqnDHOwJ/DfdZWx2qYlduEib2v6BpF8AP5T0QfJ3l0tJem2v5w20wlYkGIQrMF6EMkdAdE9i\nx/Np23ensab0gmBYGBXvhwhJOwFfAC4iVm6bA/vb/sEwrysHCnvdLxA3jRUlrQd8IvMPtO25u/mS\nX2v7uRN83tp6QN17FMrI2xE7necRq/0zPMUVrSVdAHzE9hVdXru7qq9JA1Cl7kF6KJBNfpB0I1Ef\n6Uu6v2bsU2zv0Hac+QGjiWWISF/yLYtdiqRlgfNyGCrDhsJ7/CWEZ3vBrrlpIjvIJa0OrEmkVsqe\nHHOICXnNiTp3x3UsBjycCBjPIeyJz3KHXXJF/NLAP2z/J421RHHTlbRlKeUzZaCQ8Pm3Q4aoaezL\ngL+4wwhO4ZHyLtsDExCto5oXrLBBna9j7CnbHjDZGBXvh4tZHamvvzF9fiePZ9QTBo3ViObEpYgc\nd/HYgDAdmyxcAsxWmH2dT6RIvp0bbPvvtv+T/v8vj/dj+fwgL3RQsP1/OZOKQqCzM/a8zkklHX+g\nPKl0i+0D+9W8/hVJH5O0saQNiscAzgtTmDQy2RjVWIaLn0o6G/h+er4zcNYQr6cJbpH0BmABSasS\ntM150iSDhO3TiDrGxravnMhz1UC2H5K0F3Co7YMkDUrZeVoUXCrQRuJkEPIodZ/f2oSkzksYb1sw\n8lQZIEYTyxBhe39JOwCbEn8QR9o+tSZsqmBf4MNEMfd7wNmEFtRk4HpJ7yTSYrOLg5PYZKjEDtsV\n2CsdG9Tf0nRf9ba5/kH87HVjbA+sZPvRAZyrE9N9UTAwjCaWIcP2KZLOJf0upnK3fQGFteuBDu/x\nDw/hEo4DbgdeTmg17crkypfvBxwAnJootCsRlOERho+6m/uNRCq1MfuyXFtLz2cBs0spwg80HXN+\nxWhiGSIk7UPcGB8mtuUiVlxTWjE1FZ0nlIFVg1Vs7yjpNba/o7DKPXuyTm77EqLOUjy/i0gFDgK/\nGdA4w0KbVfsgVvx1VPOnEfbKP2e8VlsOm/F8wu21oNMvSjR4bpLGGJo+3lTDaGIZLv4HWDNH0mIK\nopX3eEsU7Kv7Ja1FeJusMNEnlXQkUVO5uctrixE1skdsH18xxkLA24EXpkMXA4cXjDLbr+0VOxUg\naT/bX6k41nPV3ia29P4nEyrXmxKLsMsImvvfAGy/q2aIrn4smZhte26Plu1/KlxgR+jAdGEgza/4\nNdCYvjlFUPYeL9hZbeTkm+DIRNn9CKHXdBuTw6b6BvC/kn4h6WRJ35B0tKRLCeLCEkBdD9JhwHPT\nWN8gGG2HTeRFDxh7dDn2puI/Nav2NrEFTiDSWDsQKsV/AU7MiCvwStsXlx/ka339q8wgS7v2Kg21\nGYtRH8sQIWl94BjgKhp6p091SDrA9meHdO7KXoYBjL84sCFjki6/6KI+0Ct2HiXdbsemGpKUyRsI\nF8lLSy8tAfzH9ssmIrbLWPM0wkq6xvaGmfHdmmuz+q8kbURMbH9Ih54B7Gz72ryrnzkYpcKGiyOA\nC5h+boI52BEYysRCFNcnbGJJ6ZCL+gz/j6SVbf8a5vqL/GdQ1zaBuIIw1HoK8KXS8QcJT56Jiu3E\nhZJeD5yUnr+O0GmrhKS3E9p2K2m8VfISZNLkbf88NemuRtSDbs9tip1pGO1YhghJV9jeZNjXMREY\nZhfyRJ9b0qZEnv/ZxOKs8K2vJV1IeimxS70rxT0b2NP2iFWWAUkPAosxthCbxViNz7bn9IhbElia\nWOx8sPTSg3UsTEkvsX1Bh1bZXExSXXFaYbRjGS4ulLQ387oJTmm6cSaGuWKZ6HMfBbwXuJaGuw3b\n56eG0vKqt5uw45SEpBcAhwL/j7AkXgD4V68b+qBiC+ToivWIe4Cwzt4lXctTiR6oxSUt7h6eSAkv\nIjIL23Z5zcBoYunAaMcyREi6u8vhrJXvVMd8vmPpW28qNXYe7+Q6mEgIu9j+xiCvcaKQBCVfT7AB\nNyQk5FexXdvP1Ca2NMYLux1PFPCc+G0JP5f/IkgAzyZqZLU6c6pX1R4hYbRjGSJcoQg7H+DkIZ57\nQmTzS7hQ0heIlWp5p3ldRuxbbX+9FPN3SW8lGGLTArbvlLRA0js7RlK2lE+b2ISy+OhsQiG6EETN\nwaeAFxBir+tL2oJ62f8CpxAsvjJ+QLD8RihhNLEMEZLe2O247WMn+1qaQt2Nnx4ArrF9mu3PTOC5\n9yPqFA8C3wLWBz5Y0FUzehnaotitlJlIuXpTsyTJKVWQVAwWHvD1TSQeUlj63iDpIKIov9gkxAJg\ne1w6StKzCLXrXDxm+2+SZkmaZftCSZVU9ZKq9pIddZY5lCSFRhjDaGIZLjYq/X828FLgOmDKTyzE\n9a7O2M5kB+BWYC9JW9h+zwSe+822vyLp5cCyhLrwMeTb3LaC7TYOmWcDJ0k6nJiM3gb8dCAXNjnY\nnSiYv4uoMz2L+N1PdGwv3Aus1eD99ye6+KXA8ZL+DDxeE9Opql3gQSZXVXvaYFRjmUJIzJXjMuUl\nhgqF8dNWDg9wJC1I3Ni3BG62vcYEnvsm2+tI+grhB3PqZNR0JO1m+7uS3tftddsHZ4wxC9ibkAYR\n8Zl9K6WGpj3UwuwqJ1bSoYyRM2YRnvW/sb1b5jkWI3qPZhEac0sSNa+/ZcQOW1V72mC0Y5laeIiw\nuZ0OeCaRxig8WRYD/ivpiE00y+laSecAKwIHSFqCyekDKtI2fTGTEhYBvmn7cJibCnsS01eBoRMT\nLZt/Ten/jxP2ztk1Ndv/kvRsYNWkM7cowU7Lwe8kncp4OZn9bN+be/6ZgtHEMkQkra0Cs4A1GGv8\nmuo4iMiVX0SsvF8IfCatCM+b4HPvRaxU73L4ojyZSIdNKGwfkf49sMUwnUKGi1ASMpwPMKGy+XWK\nCnW7nkSU2JuQJFqZWCAdTqSh63AMYRGxY3q+Wzq2ZUbsjMJoYhkuns4Yy+Vx4LdE/nnKw/ZRks4k\nWDkCPmS7kLrYv3fkQLBZ+ncdafItMOqICzXhIyHDiUXdruedxHf2KgDbv0o9LTl4qu1jSs+/LWki\na4nTFqOJZbhYMIngzYWkrZk+vg6zCBHABYFVJK2S20/QEm0pp23RhrjwL0kbFNTk+VDIcNiy+XW7\nnkdsP1osSFJtMHeX9RdJuzHm+LoLIcQ6QgdGE8sQUKNbNNE9GANBomjuTNxQyxavEz6xDIBy2har\nAC8pERcOo0RcqIl9D3CypHFChhN1oROJ1Nz5LNvl73DWoqhNbEtcLOlDwCKStiT+Dn+cGftm4GvA\nl4nv+hXp2AgdGLHChoA2ukVTBZLuANaZCnIkiuXnTbbXnqTz3QE8L8mEFL/Pq2yvnsNOU3iyTEsh\nw1RTezWxKL2B2LFebLsrU25QsQ2ur/LzT6y8vYCtiM//bIKVV3kjTCSLd9v+8qCudX7GaMcyBHTq\nFk1T3AUsRKnzfLLQg3J64yReQlviwmoEUWM2sL6kadEUm7Ck7X9IegtwjO2Pdey6JyoWCEFI4Gce\nswPuRJXR2ALAdxI1+ZtNzpvYjq8hdisj1GA0sYzQLx4ibq7nM/leMq0op22QdkfnAH0RFyR9DHgx\nMbGcCWxN0Fany8SyoKRnADsB2RpfA4gt8CbgcEl/I5ocLwUus/13qDYLS5PDspIWtv1oH+e+XNLX\nCGOxsmtqjpTPjMJoYhmhX5yeHsPAUq62uJ0w2LakHznMpuoYYN3wOmBd4Hrbe0p6GiFLM13wCSJ9\ndJnDn2Ql4FeTEAuA7TcCSPov4rP8OiEomXsv+w0xQZzO+MmhtrmVMUr4J8qXxOSRRqYNRjWWEaYd\n1N0FcNLUlCV9Hfi27Z/3EXu17edJuhbYgpAFuSVHXXeEUD8ANgfWBv5K7PYuze2ITzvGTtj2J7oc\nH6FPjHYsIzSCpJNs7yTpZrrQNJ1h8dri3IXF7YodzaVLMLm0zy2AfSTdQ6x6C6OvnJ/9GklLETn+\na4lGyasn7EoHDEnH0P33XsuOahNbwiHAr4mmxgtt/6ZBLMBttscpb0vasdebO973GeAgj7c8+G/b\nH2l4DfM9RjuWERpB0jNs/zHJYswD2/dM4LmfTci4zMOmI1hhdWKCg7yOedD0Z5e0AjCng3I7pSGp\n3NU+G9ge+ENOba1NbMc4axKEic2AVYE7bO+eGdtttzvPsR6x8+yKc2NnGkY7lhEawfYf078TNoFU\nnPse4B5g48k+d5frKLsQNoJCen0zxvSmps3EYvuU8nNJ3ydTwqdNbClmDrA8/7+9O4+XrCrPPf57\nQEbtBlRUgiJgEBRBEEwAGwcGgxpUUEANaBCjUQMoCTGoXIHEi0Oi1+AVRb2oKDEaCJMKImEUcGBs\nZLgkDF40ihqBDthAw3P/WLvoOqfrnJqrzq56vp/P+XTXrlq1X+BQq9b0vqVA16aUJJJt88RVB49f\nCWw8K3PCYtpnN25YXdJajS32ktah5HmLWdKxRE9Uao/PHu7eS9mx9Ze2bxvivfsucdvn/V8N/AOz\nqhBSana0a/sZygHLxuntd0jaw/a7hxTusG1B+aAfVdvLmn4+3UUCyJ9TfjdfTZmCbFhGSeHfia8C\nFzRN6b0VmDd32bTKVFj0RNKxlP9ZT6WsMbyBkvvsFuCdtl86xHv3XeK2z/tfR9kJNKMKoe23d9D2\nJ8DzGgfyqgN7S+uyeN/iC8UvgKNmj0YG3bbFey2irGv9d9sXz2y3xnwHUjtIYrkXTSUPbJ/Xzf2n\nRUYs0au9PLPu+0mSrrR9XJUyY6jcf4nbfnRdhbDJLZRv6Y2pxGdQr6mwnksG9NO2QdLzgFMo2Ykl\n6VfAW2zf0GEM7bIctEtieROwwvb3JK0raZHtZZ3ce5qsNu4AorYelbR/48NV0v5Nzw17GDyjxK2k\n99Jlids+NaoQXkKpQvgp2szTSzq72sn2JOAmSRdVJ/dvolTBrIXqQGzba4Nu2+Qk4Ajbz7S9CfCX\n1bVBmfN3VyXl/r8An6subQycMcB7T4yMWKJXfwJ8CvgM5X/GK4EDqwXNYaf+b1Xidt95WwzWa4Dl\n1b0bVQjbnYP4+2EHNUyS1gbWBZ5cbbNtZCJeTFlrGkrbFh5v+8LGA9sXVal0RqGflPtTJR1L9KRa\nnN97jqcvG/LtX1udsl8OHAvl5D2loxs62/c3Pexo8dZN5RGq0/YvrB7+0PbdAwxvWN5Bycz8e5TF\n70bncB/l9Puw2s52m6SjKdNhUIpt3d7le8xnvtT9/aTcnypZvI+eVN9CD6HshHpsy22Xh916vfdY\nTt63WHxW9bhxQLLtrrRqyvDjwEVVu12BI23/y8ADHgJJh9o+YdRtm95jA8qXiSWUf3+XAMc0coX1\nS9LL58o3JuljwD2UzSKHUlLu3ziqTSN1ko4leiLpm8DNlJPwx1GmhG6yffgQ79k4eb+EknywYTFl\nQXWPYd27uv8ZlJ1vpwNft/3THt7jOmDPxihF0oaU3WXPH2iwQ1QtoDeyMwN0nJ25n7b9mCtTBF1k\nTVCPKfenUTqW6EljhCDpetvbqtQYOc/20BLyLYST9yq1V/albHdem5Lp9uvusI6OpKVuqhtTfVhd\n5xHVkumX5sjObPv1Q257NvNMO9l+dZv2LbMlNLUf+YHfSZY1luhVY9vmPdW30F9QTkIPTePkvaQ9\ngN/ZflTSsyllgttVbhxUDPdStjd/mVL58QRKB9NJdlyAcyWdx8oDkgcA3xl4oMPTT3bmftr2tflh\nEB2HpBcBx1AOxD6OlaOddluUp046lujVSdV89wcp6fOfABw9ontfAuxa3f8CyonqAyjTcUMlaRdK\ngbZdKZsU9rF96fytVrJ9ZFNKFwEn2f7XoQQ7HI0OfUWVXuVu2p/96Ltt8+aHfvSZteGLlJ2AVwGP\nDCKeSZWOJXp1QbVgegnVh4OkzUZ0b9l+QNIhwAm2PybpmqHfVLqDsnj7deDtVGdXJL0AOiv4JOmj\ntt9HWaeZfa0O+snO3HPbQayRVD5Ni6wNHba913adRpdjkzWW6MkcO7OucimANex7X0PZkfNJ4BDb\nP5m9djGk+17Eyg+3xm6wBneyvjTHv7fru/hgXDDUR3bmbtsOao1E0o9t79j871zS5bZ36aDtRygj\nnNOZWTU1FSRnyYgluiJpK8oW4/WqKZ2GxfSQ6bdHhwNHAf9adSqbAxe2adO3TvOfSdrT9vmzrr2T\n0hlurpl13hcBIymrPAiSLrC9O4CrWijN14bVtrnj6PMc0IysDcB/0nnWhkYKox2bQyMVJFeREUt0\nRdJrgNdSssQ2F9taRtkdNcqcXS1JOsH2oWO8f6tRyXrABrTY0dbpjrJxajo9fyFlZ1fz6fnv2H7O\nMNq2eK++zgFVI5+7gTUo6yXrAZ+x/e+dxjDPe7/FdrIdk44leiRpZ3dYDnbUWn2wj/j+IyuTPCpV\nZoPG6fmfMfP0/Odtf3oYbVu814I9BzTu37uFJFNh0at9VFLA/w44l7KN9D22vzresBaEifu2VqXQ\n+VQvp+f7advCarOmvn5DB8l0NZqS2vOlg5kq6ViiVy+3/deS9gHuAvajTHWkY5lsv1CVKl7SB4EX\nAH/X4QJ2P20bWp0D+nYH7RoZIf64i3t1a+K+UPQqafOjV2tUf74S+KcFtk4w7m+Od4z5/sN0dNUx\nLAH+iJKE88Rht5W0FpRzQJS09dtSRskndbJV21VJbeBdtu9s/qFsqhiEcf/eLRjpWKJXZ0u6mbJD\n5oJqrnv5mGNqGGqWY0n7qVQwRNIHJZ3eOMsCYHuUKfxHrXEw8FXAibbPpBw0HHbbKwAknWL7dNtH\n2H5vD4dL92xx7RWdNGx1TmvWtdrs7hu2LN5Hz6qT7/fZfkSlJsYi27+onltly+0A7tdXvqgBxtHI\nj7aEssvr74H3e2ZFzYkk6RzKAvwewA6UNbYfdrJ43mfbGyi7wf4HcOTs522fvkqjme0f2+4N/EfT\nU4uA79s+sIMYxnZ2q27SscRQDGOHjKSXzPf8oNJ+dBBHIwHn8ZR69adO4k6wViStC+xF+ee+VdJG\nwDauUs1L2sBzpLDvs+0SSsqe/Zm5zR3K4dR5yzX0s9276ezWx5jZqS2mbHXeer720ygdSwzFJH/Q\n9vPNe9L184Wik7aSDrH9xXmebzlSlrTY9n2Sntiq3XydSx3Obi006VhiKIa5p1/SFpRvnrPreowk\ny2y7b97TrJ8vFIP4MjLX752kc2z/saTbaZ2Op+3vzkI+u7XQZLtx1NHJwIcoucJeBhzMaHfkPJmS\nURlJm1TXbh7h/Reyfr6pDuJbbsvfA9t/XP3ZT6LUf5f0fkp5iMc+O9tNw02jdCwxLHcM8b3XsX2B\nJFXbRY+RdCmlsxmFb7HyW+/alOJjt1Dm4WO82nZOkjZmZU2V0si+pIP3PpNSufR7JG3+vNKxRE8k\nvRv4mu17qscbAG+0/RkY+pbb5SqVF2+V9BeU9Y6nDPF+M3hWFuVqq/E7RnX/Ba6fkePQR52SPko5\nVHkjKzsHU8o/tLNuJ2dmImss0SNJ19rebta1kSzYS3ohcBOwPvC3lN05H7P9g2Hfe56YJj5PVNWZ\nX2/7efO85omtFsL7adtljKfP96VG0i3AtrYfnOs187T9O+By252c9J9qGbFEr1arpqIMIGl1Oj/s\n1q9Nbf+IUijq4Or++wEj6VgkHdH0cDVKapJfjeLe4+RS/fE6SZvY/ukcr2nZMfTTtln13/ncudLC\ndDBSvo2SNaLrjoWSFub9kh4CHmJlkbFOqk9OlXQs0avzgG9I+ixlKuHPKckoR+EoSgXAdteGZVHT\n31dQ1lxOG9G9x20j4CeSfgjc37jY4eHUfto2HG37m01pYf6ekham08OpD1BqsVzAzGJdh7VraHtR\nu9dEkY4levU+yrrCOynf3L4LfGGYN5T0Ckpuso0l/WPTU4upygSPyI22Z3Ri1TfpUXVs43TsmNo2\nrJIWRtIxXbQ/i1UPWHZEkiiHNDez/beSngFsZLvT0sxTI2ssURuSng9sBxxHSe3RsAy4cK5T20OI\no1Vqj4lfY2lQHxUc+2lbtR/b4VRJJwKPArvZfk61YeW7tl/YpunUSccSXRlRXYt2Maxh++Fh36fF\nfRsjpv2Bf256ajHwXNt/MOqYRk19VHDsp23Te/R0OHUQv7eNLw/Nm1QkXZeMC6vKVFh0axR1LVpq\nfDgAV0saR6f2c8rByFcDVzVdX0YpczsNPgC80LMqOAKddA79tAXA9gOSzgSe2uXh1EH83j5cbVJp\nbFjZkDKCiVnSsURXXNW1qA4mjlrjw+Fk4IfA/xvlzW1fB1wn6dRxjJgWiJ4qOA6gLQCSDqUchP0l\nKz/UTanPMqdOf28lXWF75zme/kfgX4GnSPow8Hrgg51HPz3SsURPJC1j1SmFeynf6P/S9m2DvqdX\nFmtaRCn29F/A14F/sf3LQd9vHptWmY3HkqtszFpVcPzOCNo2HA5safs3Xbbr1NpzPWH7a5KuAnan\nTOW91vZNQ4qj1rLGEj2RdCxlauhUyv9kbwCeRklt8k7bLx1BDNtSPpxeB9xle49h37O672WszFW2\nN1WuMtujSikzVpJeB7yI8t/9EndRbKuftlX7C4E9bQ9lF+B8mzAk7QT8xPay6vEiytra2A7mLlTp\nWKInkn7gWYWtJF1pe6dRLWhKehqwH6VTWzSKjQPVfa+yvYOkpY30LpIutb3rKO6/EEhazMxcWx2f\nmO+lbdOh1K2BLSlnh5rPoXyi0/u3uc98Hcs1wAuaDgWvBvx4WnYDdiNTYdGrR6tdPo2F19c3PTfU\nbysq1QAPADas7v9ntm8c5j1nGWuusnGS9A7Kdu/fUdY4RPnv3Una+Z7bsvJQ6k+rnzVZmelhkL9v\n8+UreyzTBDyWTSCfoS1kxBI9kbQ5pbZ8Y6HzCsrOqJ8BO9i+bIj3/gilwNK1w7pHm/svuFxloyLp\nVmBn278eZdum99iv1eHU2dfmaLs6cN58U6aSnmf7hjmeO52yVfrE6tK7gJfZfm2n8U+LdCwRXern\nw63uJJ0L7Gv7gVG2bXqPvg6nSjoLOMj2vT3c+ymUnWG7UUZJFwDv6faQ5zRIxxI9kfR04ATKQqyB\ny4DDbd811sBGYJpP3kvanrLd+wd0mWurz7YDOZwq6RvATsD5zMxXNm8M1WjnMNuf7OQ+0y7zg9Gr\nkyk7wvarHh9YXdtzbBEN2QLKVTZOnwP+DVhK94cD+2k7qMOp36p+umL7EUmvoewEjDYyYomeqHU9\nllWuTZKFkqtsnCRdbnuXUbdteo++0/lIWgfYxPYtXbb7MLAeZcTUPNq5up94JlE6luiJpO8BX2Ll\nYbc3Agfb3n1sQY1I84dblYjwGbavH3NYI1F9uN4JnM3M6axOtgz33LbpPV4EHMPK0sKNmigdHU6V\ntDcl1f6atjeTtB1wnDtI3V+doZnNtnfrNP5pkY4lelLlafo0ZVeYgcspayzjSPUyUpIuokzJPA64\nllLk62LbR8zXbhJIur3F5Y4+2Ptp2/QeN1Omvq6iqe58pyfxq5PzuwEXNSWSfOw8UgxG1liiJy5V\nALsp0DRJ1rN9n6S3ASfb/pCkqRix2N5sHG2b3Gu72zQwzVbYvreUVnlMR9+uq5T//xP4PduvkPRc\nyvbpL/YRz0RKxxJdkXQC8/yP2MkOnwnwuCpd+/6UjL1TQ9KbW123/ZVhtm1yoaSPA6czczqt03WO\nGyS9CVhd0hbAYZTRdie+RNmg0vhv/n8p6y3pWGZJxxLd+vG4A1gAjqOUZr7M9o+qw6K3jjmmUWku\narU2JSHj1UAnnUM/bRsaaYR2bLpmyvRWJw6ldAwPUnY1nkc55NqJJ9v+hqSjAGyvkPRIu0bTKGss\n0ZcqEZ9t//e4Y1koJB1l+/hxxzEKktYDTulk8XuQbXvV58n9iygJT893Kfi1E/BR2y8ZTrT11VUt\nhIgGSc+rkvLdANwo6SpJW487rgViv/YvmRgPAFuMqq2k9SR9QtKPq59/qDqoTh3V4bVWjgDOAjaX\n9H3KSOvQLu49NTIVFr06CTjC9oUAkl4KfB7o65zChJgvkWGtSTqblWtsq1FqYT8W7gAAEm5JREFU\n0nSUyqaftk3+D+XLzP7V44Mo6x77trn3IA633kgp9PUA5ezSGZR1lpglU2HRk1ap8UeVLn+hm+T0\nLpKap31WAHd2msann7ZN79HTwdyqds/29HG4tUoHcx/wterSG4ENbE/TCLUjGbFEr26TdDRwSvX4\nQKDVOYVpNLEjFuCVtt/XfEHSR2dfG0Lbht9JWtLInl0dmPxdB+0+aXt3Sc+3/eUu7tdsy1lfnC6U\ndF2P7zXRssYSvXorpR7K6ZTpgQ0plRSj++mdOmmVC+4VI2jb8E7gf0u6Q9KdlEO6f95Bu42qEdMr\nJG0v6QXNPx3e+5pqwR4ASX8IfL/L+KdCpsIiuiRpQ+DPgE2ZWQnxreOKadiq4mrvohTl+o+mpxYB\n37d94DDazvOeiwFs39fh618PHAIsYdUt8x2lZZF0E6V65U+rS5tQ6vI8Wr3HSCqY1kE6luiJpGcD\nf8WqH64TnzdJ0uXApayaVuS0sQU1ZNXOqw2A44G/aXpqWbtcX/20bfFe6wNvZtXfu44O5ko62nan\n51Zmt33mfM9PQzqjTqVjiZ5Uc8ufZdUP16vmbDQhJj2L80JWdepXMiv1fjfrJlXi0C0ohzQb7S8Z\nYJhTL4v30asVtk9s/7KJdI6kV9r+9rgDmUJr95Pss8rvdjjwdEoC0Z0oZbUnfqQ9ShmxRFckPbH6\n62HA3ZSF+55SoNeVpGXA4yn/3A+zMnX74rEGNgUkvRf4b+Acevi9k7SUklrmStvbSdoKONb2AcOI\nd1plxBLduopyyK2xpfbIpudMWaCdaLYXjTuGKfYQ8HFKvq/Gt+Jufu+W214uCUlr2b5Z0pbDCHSa\npWOJrjRSn0ta2/by5uckrd261WSQtFX1QdRye2oqCY7EEcDv2/51j+3vqjYAnAGcL+m3lLLHMUCZ\nCouetDpdPsknzgEknWT77akkOD6SzgLeYPuBAbzXSyilhs+1/VB1bYNpKDE9bBmxRFckPQ3YGFhH\n0vasnBJbDKw7tsBGwPbbqz9fNu5YptgjwLVV5968xtJ1HSDbF7e4fAEwsV+ORiUdS3Trj4A/peyq\n+UTT9WXA+8cR0KhJapXw8F5gqe27Rx3PlDmj+hmWSU7HMzKZCoueSHrdJB8InI+kbwE7A40psZdS\nzlY8GzjO9ilzNI0FbtKnc0clI5boie3TJL0K2JqZB82OG19UI/Mo8Bzbv4THaqGfSKlueAkrE3PG\ngFQpXI6ijJS/Y/vUpuc+Y/tdYwsuVpEklNETSZ8FDqAUOhKluNW8KS8myKaNTqVyN/Ds6izFw2OK\nadKdTPk9Ow14g6TTJK1VPbfT3M26lqmwAUjHEr3axfabgd/aPpYyNfSMMcc0KpdKOkfSWyS9BTgT\nuETS44F7xhzbpHqW7b+xfUZVyvhq4N8kPambN5G0ymhy1rXd+4wzyFRY9K5RA+MBSb8H/AbYbIzx\njNK7KRULl1C+4X4FOM1lwTI7xoZjLUmr2X4UwPaHJd1FmXp8QhfvM6N8tqTVgR0aj6chc8QopGOJ\nXp1THTT7GOU0PsAXxhjPSFQfROfZ3oMyLROjcTYln9f3Ghdsf1nSL4ET2jWWdBRl1+I6khqp9kU5\nyX/S4MOdbtkVFj2RtA6l6NKulJQalwInzj6NP4mqQ3oH2b533LFEdyQdb/uocccx6dKxRE+q+t/L\ngK9Wl94IrG97//FFNRrVP/tOwPnA/Y3rvRzSi/5JOtj2yV28fmPKRpPmei5Jmz9A6ViiJ5Kum1X/\nu+W1SVQt2K+ij1rq0QdJP7W9SYev/QjwBuBGVtYRcrUhIAYkayzRq2sk7WT7Spiu+t/pQEZP0vVz\nPQU8tYu32gfY0vaDbV8ZPUvHEr36Q+DNkmbU/67qXUx0/W9JW1DK7D6XmYdDJ75kwBg9lZJOaHaC\nSAGXd/E+twFr0JRnLAYvHUv0aq9xBzBGJwMfAj5J2V58MDlYN2znAE+wfe3sJyRd1MX7PEBJYnkB\nfSaxjLlljSWiS5Kusr2DpKW2t6muXWp713HHNu3apb3P+thoZMQS0b3lklYDbpX0F8DPgKeMOaYo\n5k17X519WQfYxPYtowtruiSlS0T33kOpPXMY5dT2QUDLb8IxcvNOSUraG7gWOLd6vF11LikGKFNh\nETEx2qW9l3QV5QT/Rba3r649NqUZg5GpsIguSdoR+ACrHrKb2J1wE2SF7XulGQObfLsesHQsEd37\nGnAksJRSmyUWjna7826Q9CZg9Wrb+GF0t105OpA1loju/cr2WbZvt31n42fcQU2DAaS9P5SS4fhB\n4FRKSen3DCzAALLGEtE1SbtTcqPNPgtx+tiCmhKz11CqbNNLbT+3w/bb275maAEGkKmwiF4cDGxF\nOcHdmAozkI5lSAaY9v4TkjYCvgl83fZPBhtpQEYsEV3LLqLxGUTae0lPA/anlNZeDPyz7b8bRHxR\npGOJ6JKkzwOftH3juGOZRpI2ALZgZp62rtPeS9oG+GvgANtrDi7CSMcS0SVJNwHPAm6nrLGICU+8\nuVBIehtwOPB0ykHHnYArbO/WYfvnUEYq+wG/Br5OKSt993Aink7pWCK6JOmZra5nZ9jwVdmzXwhc\naXs7SVsBx9o+oMP2VwL/BHzT9s+HGOpUy+J9RJfSgYzVctvLJSFpLds3S9qy08a2d2rkChtijFMv\n51giok7ukrQ+cAZwvqQzgY5HHskVNhqZCouIWpL0EmA94FzbD1XX2qXNb5Ur7Pqsjw1WpsIiopZs\nX9zi8rxp82mdKywGLB1LREyS5ApbALLGEhGTpN3cfnKFjUDWWCJiYrSrx9JB+xNsHzrImKZRRiwR\nMUn6XTx50UCimHLpWCKiNgaQNj9GIB1LRNTJ1s0PqrT5OzQe2/6vkUcUq0jHEhELnqSjJC0DtpV0\nX/WzDLgbOHOQtxrge02tdCwRseDZPt72IuDjthdXP4tsP6nTNPqSVpf08TYv+1T/0UZ2hUVErUja\nGHgmTefwOk2bL+nfgN2dD76hygHJiKgNSR8B3gDcCDxSXTbQaT2Wa4AzJX0TuL9xMWWlBysjloio\nDUm3ANvafrDH9ie3uGzbb+0vsmiWEUtE1MltwBqUk/Nds33wYMOJVtKxRESdPABcK+kCmjoX24d1\n0ljS04ETKAchDVwGHG77riHEOrXSsUREnZxV/fTqZEqOsP2qxwdW1/bsM65okjWWiKiVRgVI27f0\n0PZa29u1uxb9yTmWiKiNAVSA/LWkA6szLatLOhD4zTBinWbpWCKiTo4B/gC4B8D2tcBmXbR/K7A/\n8AvgP4HXV9digLLGEhF10qoCZMfz+bZ/Crx64FHFDOlYIqJO+qoAKWkzSrGvTZl5cj+dzQBl8T4i\nakPSusAHgJdTEkaeB/yt7eUdtr8O+CKwFHi0cd32xYOPdnqlY4mIqSHpB7b/cNxxTLp0LBFRG5J2\nBN7PqlNZ23bY/k3AFsB3mXnA8uqBBjrlssYSEXXyNeBIZk1ldWEb4CBgt6b2rh7HgKRjiYg6+ZXt\nfk7e7wNsbvuhQQUUq0rHEhF18iFJXwBm5wrrNO39dcD6lMqTMSTpWCKiTg4GtqJkOG6eyuq0Y3kq\ncLOkHzGzY8p24wFKxxIRdfJ829v00f5DA4sk5pSOJSLq5EpJz7V9Yy+Nc15lNLLdOCJqQ9JNwLOA\n2ylTWaJUgOx0u/EyVqaAWZMypXa/7cVDCHdqZcQSEXWyVz+NbS9qfizptZSkljFAGbFERG1IOsX2\nQe2udfmeV9reqf/ooiEjloiok62bH0haHdih08aS9m16uBqwI11kR47OpGOJiAVP0lGUVC7rSLqv\ncRl4CDipi7fau+nvK4A7gNcMIsZYKVNhEVEbko63fVQf7V9k+/vtrkV/0rFERK1I2oCSSHLtxjXb\nl3TY9mrbL2h3LfqTqbCIqA1JbwMOB54OXAvsBFxBmySSknYGdgE2lHRE01OLgdWHE+30Ss37iKiT\nw4EXAnfafhmwPfCrDtqtCTyB8mV6UdPPfZS69zFAGbFERJ0st71cEpLWsn2zpC3bNapO3F8s6Uu2\n75zrdZJOsH3oQCOeQulYIqJO7pK0PnAGcL6k3wI/77TxfJ1K5UX9BBdFFu8jopYkvQRYDzh3UPVV\nspA/GBmxREStSFoCbGH7ZEkbAhtTcofFApHF+4ioDUkfAt4HNM6yrAF8dZC3GOB7Ta10LBFRJ/sA\nrwbuB7D9c8ruro5I2rzNSz7Ve2jRkKmwiKiTh2xbkgEkPb7L9l+StDHwI+AS4FLbSxtP2v7SwCKd\nYhmxRESdfEPS54D1Jf0Z8D3g8502tv1i4DnACcAGwLck/ddQIp1i2RUWEbUiaU/g5ZT1kPNsn99F\n2yXArtXP+pTT+5fa/qdhxDqt0rFERC1UKfLPs71HH+/xCPBj4Hjg24PaphwzZY0lImrB9iOSHpC0\nnu17e3ybJ1EOQb4YOEzSo8AVto8eWKCRjiUiamU5sFTS+VQ7wwBsH9ZJY9v3SLoNeAYlkeUulC3L\nMUCZCouI2pD0lhaXbfsrHbb/D+AW4DLgUuAHmQ4bvIxYIqJO1rc946yJpMO7aL+F7UcHHFPMku3G\nEVEnrUYsf9pF+9+XdIGkGwAkbSvpgwOJLB6TqbCIWPAkvRF4E7CEMoXVsAh4pNOdYpIuBo4EPmd7\n++raDbafN+CQp1qmwiKiDi4H/hN4MvAPTdeXAdd38T7r2v6hNCMl2Ir+w4tm6VgiYsGr6qjcCew8\n3+skXWF7vtf8WtKzgEZKmNdTOqwYoHQsETFJ1m7z/LuBk4CtJP2Mkm7/T4Ye1ZTJGktETIx2hbok\nrUWpcb8p8ERKzXvbPm40EU6HjFgiYpqcCdwDXE0XJY2jO+lYImLBk7SW7Qc7eWmb559ue69BxBRz\nyzmWiKiDKwAkndLmdQe1ef5ySdsMJqSYS0YsEVEHa1bpXHaRtO/sJ22fXv15Q5v3WQL8qaTbgQcp\nIxzb3nbQAU+zdCwRUQd/Ttm9tT6w96znDJze4fu8YpBBRWvZFRYRtSHpENtfHHccMb90LBFRG5LW\npIxeXlxduhj4rO2HxxdVzJaOJSJqQ9IXKPVTvlxdOoiSK+xt44sqZkvHEhG1Iek6289vdy3GK9uN\nI6JOHqlyfQEgaXPgkTHGEy1kV1hE1MmRwIVVeWEBzwQOHm9IMVumwiKiVqp8X1tSOpabm0/kS9rT\n9vljCy6AdCwRMUHaJaGM0cgaS0RMkna5wmIE0rFExCTJFMwCkI4lIiIGKh1LREySO8YdQKRjiYga\nkbSfpEXV3z8o6XRJjy3W214l83GMXjqWiKiTo20vk7QE+CNKapcTxxxTzJKOJSLqpHHK/lXAibbP\nBNYcYzzRQjqWiKiTn0n6HLA/8O3qsGQ+xxaYHJCMiNqQtC6wF7DU9q2SNgK2sf3dMYcWTdKxRERt\nVAko77L9oKSXAtsCX7F9z3gji2YZQkZEnZxGyXD8+8AXgc2AU8cbUsyWjiUi6uRR2yuAfYH/Zfu9\nwEZjjilmSccSEXXysKQ3Am8GzqmurTHGeKKFdCwRUScHAzsDH7Z9u6TNgK+OOaaYJYv3EVErktYB\nNrF9y7hjidYyYomI2pC0N3AtcG71eDtJZ403qpgtHUtE1MkxwB8A9wDYvpayMywWkHQsEVEnK2zf\nO+ta5vMXmMeNO4CIiC7cIOlNwOqStgAOAy4fc0wxS0YsEVEnhwJbAw9SDkbeC7xnrBHFKrIrLCIi\nBiojloioDUnnS1q/6fEGks4bZ0yxqnQsEVEnT25OOGn7t8BTxhhPtJCOJSLq5FFJmzQeSHom2RW2\n4GRXWETUyQeAyyRdXD1+MfD2McYTLWTxPiJqRdKTgZ0AAVfY/vWYQ4pZMhUWEbUhaR/gYdvn2D4b\nWCHpteOOK2bKiCUiakPStba3m3XtGtvbjyumWFVGLBFRJ60+s7JWvMCkY4mIOvmxpE9IepakzSV9\nErhq3EHFTOlYIqJODgUeAv4Z+CawHHj3WCOKVWSNJSIiBipzkxFRG5IupMWBSNu7jSGcmEM6loio\nk79q+vvawOuAFWOKJeaQqbCIqDVJF9t+ybjjiJUyYomI2pD0xKaHqwE7Ak8bUzgxh3QsEVEnV1HW\nWAQ8DNwBHDLOgGJV2W4cEXXyPmA725sBpwD3Aw+MN6SYLR1LRNTJB23fJ2kJsCfwJeDE8YYUs6Vj\niYg6eaT681XAZ22fCaw5xniihXQsEVEnP5P0OWB/4NuS1iKfYwtOthtHRG1IWhfYC1hq+1ZJGwHb\n2P7umEOLJulYIiJioDKEjIiIgUrHEhERA5WOJSIiBiodS0REDNT/B/Lq1aOOqr/BAAAAAElFTkSu\nQmCC\n",
      "text/plain": [
       "<Figure size 432x288 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAY0AAAK1CAYAAAA0ZrKMAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nImLG/h8Y41g4qySGUgAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<Figure size 432x288 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "ax1 = plt.axes()\n",
    "sns.heatmap(results_up, ax = ax1)\n",
    "ax1.set_title('Up-Regulated Protein Enrichments for Renal Cancer Tumors')\n",
    "plt.show()\n",
    "\n",
    "ax2 = plt.axes()\n",
    "sns.heatmap(results_down, ax = ax2)\n",
    "ax2.set_title('Down-Regulated Protein Enrichments for Renal Cancer Tumors')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 6: Perform Gene-set Enrichment Analysis and link with cancer drug database."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "tumor_site_Other_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:48:07,689 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "          Gene_set                       Term Overlap   P-value  \\\n",
      "0  KEGG_2019_Human  Selenocompound metabolism    1/17  0.006781   \n",
      "1  KEGG_2019_Human   Hepatocellular carcinoma   1/168  0.065268   \n",
      "2  KEGG_2019_Human         Pathways in cancer   1/530  0.193376   \n",
      "\n",
      "   Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0               1.0            0                     0  147.058824   \n",
      "1               1.0            0                     0   14.880952   \n",
      "2               1.0            0                     0    4.716981   \n",
      "\n",
      "   Combined Score   Genes  \n",
      "0      734.359493  TXNRD1  \n",
      "1       40.613893  TXNRD1  \n",
      "2        7.750568  TXNRD1  \n",
      "tumor_size_in_cm_Above_Mean(6.51)_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:48:10,595 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "          Gene_set                       Term Overlap   P-value  \\\n",
      "0  KEGG_2019_Human  Selenocompound metabolism    1/17  0.004243   \n",
      "1  KEGG_2019_Human   Hepatocellular carcinoma   1/168  0.041304   \n",
      "2  KEGG_2019_Human         Pathways in cancer   1/530  0.125673   \n",
      "\n",
      "   Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0               1.0            0                     0  235.294118   \n",
      "1               1.0            0                     0   23.809524   \n",
      "2               1.0            0                     0    7.547170   \n",
      "\n",
      "   Combined Score   Genes  \n",
      "0     1285.282536  TXNRD1  \n",
      "1       75.876009  TXNRD1  \n",
      "2       15.653391  TXNRD1  \n",
      "tumor_focality_Multifocal_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:48:13,518 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "           Gene_set                                     Term Overlap  \\\n",
      "0   KEGG_2019_Human            Starch and sucrose metabolism    1/36   \n",
      "1   KEGG_2019_Human                              Ferroptosis    1/40   \n",
      "2   KEGG_2019_Human                    Pyrimidine metabolism    1/57   \n",
      "3   KEGG_2019_Human                                Mitophagy    1/65   \n",
      "4   KEGG_2019_Human                              Shigellosis    1/65   \n",
      "5   KEGG_2019_Human    RIG-I-like receptor signaling pathway    1/70   \n",
      "6   KEGG_2019_Human                mRNA surveillance pathway    1/91   \n",
      "7   KEGG_2019_Human             Longevity regulating pathway   1/102   \n",
      "8   KEGG_2019_Human                      Platelet activation   1/124   \n",
      "9   KEGG_2019_Human                                Autophagy   1/128   \n",
      "10  KEGG_2019_Human                 Apelin signaling pathway   1/137   \n",
      "11  KEGG_2019_Human                              Necroptosis   1/162   \n",
      "12  KEGG_2019_Human                            RNA transport   1/165   \n",
      "13  KEGG_2019_Human      NOD-like receptor signaling pathway   1/178   \n",
      "14  KEGG_2019_Human                               Alcoholism   1/180   \n",
      "15  KEGG_2019_Human                           Focal adhesion   1/199   \n",
      "16  KEGG_2019_Human                     Viral carcinogenesis   1/201   \n",
      "17  KEGG_2019_Human                   Rap1 signaling pathway   1/206   \n",
      "18  KEGG_2019_Human  Human T-cell leukemia virus 1 infection   1/219   \n",
      "19  KEGG_2019_Human                      MicroRNAs in cancer   1/299   \n",
      "\n",
      "     P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0   0.028425               1.0            0                     0   34.722222   \n",
      "1   0.031536               1.0            0                     0   31.250000   \n",
      "2   0.044654               1.0            0                     0   21.929825   \n",
      "3   0.050770               1.0            0                     0   19.230769   \n",
      "4   0.050770               1.0            0                     0   19.230769   \n",
      "5   0.054573               1.0            0                     0   17.857143   \n",
      "6   0.070393               1.0            0                     0   13.736264   \n",
      "7   0.078580               1.0            0                     0   12.254902   \n",
      "8   0.094752               1.0            0                     0   10.080645   \n",
      "9   0.097663               1.0            0                     0    9.765625   \n",
      "10  0.104182               1.0            0                     0    9.124088   \n",
      "11  0.122059               1.0            0                     0    7.716049   \n",
      "12  0.124182               1.0            0                     0    7.575758   \n",
      "13  0.133325               1.0            0                     0    7.022472   \n",
      "14  0.134723               1.0            0                     0    6.944444   \n",
      "15  0.147905               1.0            0                     0    6.281407   \n",
      "16  0.149281               1.0            0                     0    6.218905   \n",
      "17  0.152714               1.0            0                     0    6.067961   \n",
      "18  0.161577               1.0            0                     0    5.707763   \n",
      "19  0.214234               1.0            0                     0    4.180602   \n",
      "\n",
      "    Combined Score  Genes  \n",
      "0       123.628260    AGL  \n",
      "1       108.019637   ATG5  \n",
      "2        68.175536  CTPS2  \n",
      "3        57.316392   ATG5  \n",
      "4        57.316392   ATG5  \n",
      "5        51.932290   ATG5  \n",
      "6        36.451411  UPF3A  \n",
      "7        31.172046   ATG5  \n",
      "8        23.755005   TLN2  \n",
      "9        22.717098   ATG5  \n",
      "10       20.635171  HDAC4  \n",
      "11       16.228760   PPIA  \n",
      "12       15.803079  UPF3A  \n",
      "13       14.150051   ATG5  \n",
      "14       13.920359  HDAC4  \n",
      "15       12.004933   TLN2  \n",
      "16       11.827871  HDAC4  \n",
      "17       11.402854   TLN2  \n",
      "18       10.403966   TLN2  \n",
      "19        6.440991  HDAC4  \n",
      "histologic_grade_G3or4_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:48:16,458 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "           Gene_set                                       Term Overlap  \\\n",
      "0   KEGG_2019_Human                  Selenocompound metabolism    1/17   \n",
      "1   KEGG_2019_Human                  Type II diabetes mellitus    1/46   \n",
      "2   KEGG_2019_Human            Arginine and proline metabolism    1/49   \n",
      "3   KEGG_2019_Human      Regulation of lipolysis in adipocytes    1/55   \n",
      "4   KEGG_2019_Human            Adipocytokine signaling pathway    1/69   \n",
      "5   KEGG_2019_Human               Longevity regulating pathway   1/102   \n",
      "6   KEGG_2019_Human                         Insulin resistance   1/108   \n",
      "7   KEGG_2019_Human                     AMPK signaling pathway   1/120   \n",
      "8   KEGG_2019_Human                                  Autophagy   1/128   \n",
      "9   KEGG_2019_Human                     FoxO signaling pathway   1/132   \n",
      "10  KEGG_2019_Human                  Insulin signaling pathway   1/137   \n",
      "11  KEGG_2019_Human  Non-alcoholic fatty liver disease (NAFLD)   1/149   \n",
      "12  KEGG_2019_Human                 cGMP-PKG signaling pathway   1/166   \n",
      "13  KEGG_2019_Human                   Hepatocellular carcinoma   1/168   \n",
      "14  KEGG_2019_Human                        MicroRNAs in cancer   1/299   \n",
      "15  KEGG_2019_Human                         Pathways in cancer   1/530   \n",
      "\n",
      "     P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0   0.005936               1.0            0                     0  168.067227   \n",
      "1   0.015992               1.0            0                     0   62.111801   \n",
      "2   0.017027               1.0            0                     0   58.309038   \n",
      "3   0.019095               1.0            0                     0   51.948052   \n",
      "4   0.023905               1.0            0                     0   41.407867   \n",
      "5   0.035163               1.0            0                     0   28.011204   \n",
      "6   0.037198               1.0            0                     0   26.455026   \n",
      "7   0.041257               1.0            0                     0   23.809524   \n",
      "8   0.043955               1.0            0                     0   22.321429   \n",
      "9   0.045302               1.0            0                     0   21.645022   \n",
      "10  0.046982               1.0            0                     0   20.855057   \n",
      "11  0.051006               1.0            0                     0   19.175455   \n",
      "12  0.056681               1.0            0                     0   17.211704   \n",
      "13  0.057347               1.0            0                     0   17.006803   \n",
      "14  0.100086               1.0            0                     0    9.555662   \n",
      "15  0.171410               1.0            0                     0    5.390836   \n",
      "\n",
      "    Combined Score   Genes  \n",
      "0       861.643146  TXNRD1  \n",
      "1       256.875327    IRS2  \n",
      "2       237.490573   PYCR2  \n",
      "3       205.628539    IRS2  \n",
      "4       154.603453    IRS2  \n",
      "5        93.774494    IRS2  \n",
      "6        87.076439    IRS2  \n",
      "7        75.902985    IRS2  \n",
      "8        69.745186    IRS2  \n",
      "9        66.978601    IRS2  \n",
      "10       63.774362    IRS2  \n",
      "11       57.062530    IRS2  \n",
      "12       49.402973    IRS2  \n",
      "13       48.616253  TXNRD1  \n",
      "14       21.994540    IRS2  \n",
      "15        9.507788  TXNRD1  \n",
      "pathologic_staging_regional_lymph_nodes_pN_pN0or1_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:48:19,460 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "           Gene_set                                 Term Overlap   P-value  \\\n",
      "0   KEGG_2019_Human            Selenocompound metabolism    1/17  0.006781   \n",
      "1   KEGG_2019_Human      Staphylococcus aureus infection    1/68  0.026883   \n",
      "2   KEGG_2019_Human                 Salmonella infection    1/86  0.033892   \n",
      "3   KEGG_2019_Human                   Salivary secretion    1/90  0.035444   \n",
      "4   KEGG_2019_Human             Hepatocellular carcinoma   1/168  0.065268   \n",
      "5   KEGG_2019_Human  NOD-like receptor signaling pathway   1/178  0.069033   \n",
      "6   KEGG_2019_Human                         Tuberculosis   1/179  0.069408   \n",
      "7   KEGG_2019_Human                       Focal adhesion   1/199  0.076895   \n",
      "8   KEGG_2019_Human              Proteoglycans in cancer   1/201  0.077641   \n",
      "9   KEGG_2019_Human               MAPK signaling pathway   1/295  0.112103   \n",
      "10  KEGG_2019_Human                   Pathways in cancer   1/530  0.193376   \n",
      "\n",
      "    Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0                1.0            0                     0  147.058824   \n",
      "1                1.0            0                     0   36.764706   \n",
      "2                1.0            0                     0   29.069767   \n",
      "3                1.0            0                     0   27.777778   \n",
      "4                1.0            0                     0   14.880952   \n",
      "5                1.0            0                     0   14.044944   \n",
      "6                1.0            0                     0   13.966480   \n",
      "7                1.0            0                     0   12.562814   \n",
      "8                1.0            0                     0   12.437811   \n",
      "9                1.0            0                     0    8.474576   \n",
      "10               1.0            0                     0    4.716981   \n",
      "\n",
      "    Combined Score   Genes  \n",
      "0       734.359493  TXNRD1  \n",
      "1       132.950800    CAMP  \n",
      "2        98.388543    FLNC  \n",
      "3        92.772276    CAMP  \n",
      "4        40.613893  TXNRD1  \n",
      "5        37.544613    CAMP  \n",
      "6        37.259056    CAMP  \n",
      "7        32.227549    FLNC  \n",
      "8        31.786829    FLNC  \n",
      "9        18.545233    FLNC  \n",
      "10        7.750568  TXNRD1  \n",
      "history_of_cancer_Yes_P_values\n",
      "           Gene_set                                               Term  \\\n",
      "0   KEGG_2019_Human                Complement and coagulation cascades   \n",
      "1   KEGG_2019_Human                                            Malaria   \n",
      "2   KEGG_2019_Human                                Platelet activation   \n",
      "3   KEGG_2019_Human                            African trypanosomiasis   \n",
      "4   KEGG_2019_Human                                         Proteasome   \n",
      "5   KEGG_2019_Human                    Arginine and proline metabolism   \n",
      "6   KEGG_2019_Human                                      RNA transport   \n",
      "7   KEGG_2019_Human                    Staphylococcus aureus infection   \n",
      "8   KEGG_2019_Human                                         Amoebiasis   \n",
      "9   KEGG_2019_Human                                Nitrogen metabolism   \n",
      "10  KEGG_2019_Human                              Arginine biosynthesis   \n",
      "11  KEGG_2019_Human                 Mannose type O-glycan biosynthesis   \n",
      "12  KEGG_2019_Human                               Histidine metabolism   \n",
      "13  KEGG_2019_Human                     Collecting duct acid secretion   \n",
      "14  KEGG_2019_Human                            beta-Alanine metabolism   \n",
      "15  KEGG_2019_Human                  Phospholipase D signaling pathway   \n",
      "16  KEGG_2019_Human        Protein processing in endoplasmic reticulum   \n",
      "17  KEGG_2019_Human           Glycine, serine and threonine metabolism   \n",
      "18  KEGG_2019_Human               Porphyrin and chlorophyll metabolism   \n",
      "19  KEGG_2019_Human           Vasopressin-regulated water reabsorption   \n",
      "20  KEGG_2019_Human                         Nucleotide excision repair   \n",
      "21  KEGG_2019_Human  Endocrine and other factor-regulated calcium r...   \n",
      "22  KEGG_2019_Human                                  Cocaine addiction   \n",
      "23  KEGG_2019_Human                            Ovarian steroidogenesis   \n",
      "24  KEGG_2019_Human                              N-Glycan biosynthesis   \n",
      "25  KEGG_2019_Human                          Vibrio cholerae infection   \n",
      "26  KEGG_2019_Human                                 Mineral absorption   \n",
      "27  KEGG_2019_Human              Regulation of lipolysis in adipocytes   \n",
      "28  KEGG_2019_Human                               Long-term depression   \n",
      "29  KEGG_2019_Human                   Cortisol synthesis and secretion   \n",
      "..              ...                                                ...   \n",
      "55  KEGG_2019_Human                               Serotonergic synapse   \n",
      "56  KEGG_2019_Human                              Glutamatergic synapse   \n",
      "57  KEGG_2019_Human                                           Lysosome   \n",
      "58  KEGG_2019_Human                          Relaxin signaling pathway   \n",
      "59  KEGG_2019_Human                               Dopaminergic synapse   \n",
      "60  KEGG_2019_Human                 Vascular smooth muscle contraction   \n",
      "61  KEGG_2019_Human                       Systemic lupus erythematosus   \n",
      "62  KEGG_2019_Human                         Estrogen signaling pathway   \n",
      "63  KEGG_2019_Human  Signaling pathways regulating pluripotency of ...   \n",
      "64  KEGG_2019_Human                                          Apoptosis   \n",
      "65  KEGG_2019_Human             Adrenergic signaling in cardiomyocytes   \n",
      "66  KEGG_2019_Human                         Oxytocin signaling pathway   \n",
      "67  KEGG_2019_Human                                           Ribosome   \n",
      "68  KEGG_2019_Human                                   Cushing syndrome   \n",
      "69  KEGG_2019_Human                            Hippo signaling pathway   \n",
      "70  KEGG_2019_Human                         JAK-STAT signaling pathway   \n",
      "71  KEGG_2019_Human                                         Alcoholism   \n",
      "72  KEGG_2019_Human    Kaposi sarcoma-associated herpesvirus infection   \n",
      "73  KEGG_2019_Human                          Calcium signaling pathway   \n",
      "74  KEGG_2019_Human                               Viral carcinogenesis   \n",
      "75  KEGG_2019_Human                       Epstein-Barr virus infection   \n",
      "76  KEGG_2019_Human                             Rap1 signaling pathway   \n",
      "77  KEGG_2019_Human                             cAMP signaling pathway   \n",
      "78  KEGG_2019_Human                    Human cytomegalovirus infection   \n",
      "79  KEGG_2019_Human                                      Thermogenesis   \n",
      "80  KEGG_2019_Human                                        Endocytosis   \n",
      "81  KEGG_2019_Human                                 Pathways in cancer   \n",
      "82  KEGG_2019_Human             Cytokine-cytokine receptor interaction   \n",
      "83  KEGG_2019_Human                     Human papillomavirus infection   \n",
      "84  KEGG_2019_Human                   Herpes simplex virus 1 infection   \n",
      "\n",
      "   Overlap   P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  \\\n",
      "0     5/79  0.000023          0.007065            0                     0   \n",
      "1     3/49  0.001226          0.188808            0                     0   \n",
      "2    4/124  0.002020          0.207366            0                     0   \n",
      "3     2/37  0.011040          0.850049            0                     0   \n",
      "4     2/45  0.016051          0.988718            0                     0   \n",
      "5     2/49  0.018857          0.967969            0                     0   \n",
      "6    3/165  0.034302          1.000000            0                     0   \n",
      "7     2/68  0.034665          1.000000            0                     0   \n",
      "8     2/96  0.064280          1.000000            0                     0   \n",
      "9     1/17  0.070666          1.000000            0                     0   \n",
      "10    1/21  0.086562          1.000000            0                     0   \n",
      "11    1/23  0.094409          1.000000            0                     0   \n",
      "12    1/23  0.094409          1.000000            0                     0   \n",
      "13    1/27  0.109904          1.000000            0                     0   \n",
      "14    1/31  0.125137          1.000000            0                     0   \n",
      "15   2/148  0.133298          1.000000            0                     0   \n",
      "16   2/165  0.158464          1.000000            0                     0   \n",
      "17    1/40  0.158475          1.000000            0                     0   \n",
      "18    1/42  0.165711          1.000000            0                     0   \n",
      "19    1/44  0.172885          1.000000            0                     0   \n",
      "20    1/47  0.183533          1.000000            0                     0   \n",
      "21    1/48  0.187052          1.000000            0                     0   \n",
      "22    1/49  0.190556          1.000000            0                     0   \n",
      "23    1/49  0.190556          1.000000            0                     0   \n",
      "24    1/50  0.194046          1.000000            0                     0   \n",
      "25    1/50  0.194046          1.000000            0                     0   \n",
      "26    1/51  0.197520          1.000000            0                     0   \n",
      "27    1/55  0.211270          1.000000            0                     0   \n",
      "28    1/60  0.228130          1.000000            0                     0   \n",
      "29    1/65  0.244633          1.000000            0                     0   \n",
      "..     ...       ...               ...          ...                   ...   \n",
      "55   1/113  0.386342          1.000000            0                     0   \n",
      "56   1/114  0.388996          1.000000            0                     0   \n",
      "57   1/123  0.412375          1.000000            0                     0   \n",
      "58   1/130  0.429945          1.000000            0                     0   \n",
      "59   1/131  0.432412          1.000000            0                     0   \n",
      "60   1/132  0.434869          1.000000            0                     0   \n",
      "61   1/133  0.437315          1.000000            0                     0   \n",
      "62   1/137  0.446996          1.000000            0                     0   \n",
      "63   1/139  0.451774          1.000000            0                     0   \n",
      "64   1/143  0.461209          1.000000            0                     0   \n",
      "65   1/145  0.465866          1.000000            0                     0   \n",
      "66   1/153  0.484099          1.000000            0                     0   \n",
      "67   1/153  0.484099          1.000000            0                     0   \n",
      "68   1/155  0.488561          1.000000            0                     0   \n",
      "69   1/160  0.499548          1.000000            0                     0   \n",
      "70   1/162  0.503877          1.000000            0                     0   \n",
      "71   1/180  0.541212          1.000000            0                     0   \n",
      "72   1/186  0.553029          1.000000            0                     0   \n",
      "73   1/188  0.556900          1.000000            0                     0   \n",
      "74   1/201  0.581271          1.000000            0                     0   \n",
      "75   1/201  0.581271          1.000000            0                     0   \n",
      "76   1/206  0.590287          1.000000            0                     0   \n",
      "77   1/212  0.600854          1.000000            0                     0   \n",
      "78   1/225  0.622833          1.000000            0                     0   \n",
      "79   1/231  0.632569          1.000000            0                     0   \n",
      "80   1/244  0.652821          1.000000            0                     0   \n",
      "81   2/530  0.668914          1.000000            0                     0   \n",
      "82   1/294  0.720936          1.000000            0                     0   \n",
      "83   1/330  0.761624          1.000000            0                     0   \n",
      "84   1/492  0.883127          1.000000            0                     0   \n",
      "\n",
      "    Odds Ratio  Combined Score                 Genes  \n",
      "0    14.718870      157.236539  C4B;FGB;FGA;FGG;F13B  \n",
      "1    14.238253       95.452942         GYPC;HBB;HBA2  \n",
      "2     7.501875       46.547318      FGB;FGA;FGG;GNAS  \n",
      "3    12.570710       56.646969              HBB;HBA2  \n",
      "4    10.335917       42.708093           PSMC6;PSME4  \n",
      "5     9.492169       37.692411            ARG1;CNDP1  \n",
      "6     4.228330       14.260204   CLNS1A;GEMIN2;RNPS1  \n",
      "7     6.839945       22.996146               C4B;FGG  \n",
      "8     4.844961       13.297023             ARG1;GNAS  \n",
      "9    13.679891       36.248915                   CA3  \n",
      "10   11.074197       27.097394                  ARG1  \n",
      "11   10.111223       23.863683               POMGNT1  \n",
      "12   10.111223       23.863683                 CNDP1  \n",
      "13    8.613264       19.019373                SLC4A1  \n",
      "14    7.501875       15.591518                 CNDP1  \n",
      "15    3.142678        6.333029            CYTH2;GNAS  \n",
      "16    2.818887        5.193037           RAD23A;YOD1  \n",
      "17    5.813953       10.710239                  BPGM  \n",
      "18    5.537099        9.952998                  HMBS  \n",
      "19    5.285412        9.276566                  GNAS  \n",
      "20    4.948046        8.388717                RAD23A  \n",
      "21    4.844961        8.121934                  GNAS  \n",
      "22    4.746084        7.868093                  GNAS  \n",
      "23    4.746084        7.868093                  GNAS  \n",
      "24    4.651163        7.626337                  DOLK  \n",
      "25    4.651163        7.626337                  GNAS  \n",
      "26    4.559964        7.395880                 ATP7A  \n",
      "27    4.228330        6.573449                  GNAS  \n",
      "28    3.875969        5.728067                  GNAS  \n",
      "29    3.577818        5.037547                  GNAS  \n",
      "..         ...             ...                   ...  \n",
      "55    2.058037        1.957257                  GNAS  \n",
      "56    2.039984        1.926123                  GNAS  \n",
      "57    1.890717        1.674839                 AP4E1  \n",
      "58    1.788909        1.510014                  GNAS  \n",
      "59    1.775253        1.488329                  GNAS  \n",
      "60    1.761804        1.467072                  GNAS  \n",
      "61    1.748557        1.446233                   C4B  \n",
      "62    1.697505        1.366841                  GNAS  \n",
      "63    1.673080        1.329384                 IL6ST  \n",
      "64    1.626281        1.258585                 SPTA1  \n",
      "65    1.603849        1.225112                  GNAS  \n",
      "66    1.519988        1.102698                  GNAS  \n",
      "67    1.519988        1.102698                 RPL22  \n",
      "68    1.500375        1.074706                  GNAS  \n",
      "69    1.453488        1.008796                  SAV1  \n",
      "70    1.435544        0.983954                 IL6ST  \n",
      "71    1.291990        0.793210                  GNAS  \n",
      "72    1.250313        0.740617                 IL6ST  \n",
      "73    1.237011        0.724108                  GNAS  \n",
      "74    1.157006        0.627720                 IL6ST  \n",
      "75    1.157006        0.627720                 PSMC6  \n",
      "76    1.128923        0.595107                  GNAS  \n",
      "77    1.096972        0.558802                  GNAS  \n",
      "78    1.033592        0.489382                  GNAS  \n",
      "79    1.006745        0.461055                  GNAS  \n",
      "80    0.953107        0.406455                 CYTH2  \n",
      "81    0.877578        0.352874            GNAS;IL6ST  \n",
      "82    0.791014        0.258823                 IL6ST  \n",
      "83    0.704722        0.191897                  GNAS  \n",
      "84    0.472679        0.058748                 SRPK1  \n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[85 rows x 10 columns]\n",
      "vital_status_at_12months_follow_up_Deceased_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:48:28,600 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "           Gene_set                                         Term Overlap  \\\n",
      "0   KEGG_2019_Human    Aldosterone-regulated sodium reabsorption    1/37   \n",
      "1   KEGG_2019_Human  Amino sugar and nucleotide sugar metabolism    1/48   \n",
      "2   KEGG_2019_Human                       Cholesterol metabolism    1/50   \n",
      "3   KEGG_2019_Human                        p53 signaling pathway    1/72   \n",
      "4   KEGG_2019_Human                         Salmonella infection    1/86   \n",
      "5   KEGG_2019_Human                                     Lysosome   1/123   \n",
      "6   KEGG_2019_Human                                   Cell cycle   1/124   \n",
      "7   KEGG_2019_Human                                  Necroptosis   1/162   \n",
      "8   KEGG_2019_Human                                RNA transport   1/165   \n",
      "9   KEGG_2019_Human          NOD-like receptor signaling pathway   1/178   \n",
      "10  KEGG_2019_Human                               Focal adhesion   1/199   \n",
      "11  KEGG_2019_Human                      Proteoglycans in cancer   1/201   \n",
      "12  KEGG_2019_Human                       MAPK signaling pathway   1/295   \n",
      "\n",
      "     P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0   0.023792               1.0            0                     0   41.580042   \n",
      "1   0.030764               1.0            0                     0   32.051282   \n",
      "2   0.032026               1.0            0                     0   30.769231   \n",
      "3   0.045816               1.0            0                     0   21.367521   \n",
      "4   0.054496               1.0            0                     0   17.889088   \n",
      "5   0.077087               1.0            0                     0   12.507817   \n",
      "6   0.077691               1.0            0                     0   12.406948   \n",
      "7   0.100360               1.0            0                     0    9.496676   \n",
      "8   0.102127               1.0            0                     0    9.324009   \n",
      "9   0.109750               1.0            0                     0    8.643042   \n",
      "10  0.121937               1.0            0                     0    7.730963   \n",
      "11  0.123089               1.0            0                     0    7.654038   \n",
      "12  0.175713               1.0            0                     0    5.215124   \n",
      "\n",
      "    Combined Score  Genes  \n",
      "0       155.443526    SFN  \n",
      "1       111.584117   CMAS  \n",
      "2       105.883094   NPC1  \n",
      "3        65.878875    SFN  \n",
      "4        52.050603   FLNC  \n",
      "5        32.055235   NPC1  \n",
      "6        31.699955    SFN  \n",
      "7        21.832805  RBCK1  \n",
      "8        21.273058  EIF3D  \n",
      "9        19.097261  RBCK1  \n",
      "10       16.267900   FLNC  \n",
      "11       16.034021   FLNC  \n",
      "12        9.068605   FLNC  \n",
      "tumor_necrosis_Present_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:48:31,494 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "           Gene_set                                         Term Overlap  \\\n",
      "0   KEGG_2019_Human                    Selenocompound metabolism    1/17   \n",
      "1   KEGG_2019_Human                           Pathways in cancer   2/530   \n",
      "2   KEGG_2019_Human          Antigen processing and presentation    1/77   \n",
      "3   KEGG_2019_Human                      IL-17 signaling pathway    1/93   \n",
      "4   KEGG_2019_Human                              Prostate cancer    1/97   \n",
      "5   KEGG_2019_Human      Progesterone-mediated oocyte maturation    1/99   \n",
      "6   KEGG_2019_Human                    Th17 cell differentiation   1/107   \n",
      "7   KEGG_2019_Human                   Estrogen signaling pathway   1/137   \n",
      "8   KEGG_2019_Human       Fluid shear stress and atherosclerosis   1/139   \n",
      "9   KEGG_2019_Human                                  Necroptosis   1/162   \n",
      "10  KEGG_2019_Human  Protein processing in endoplasmic reticulum   1/165   \n",
      "11  KEGG_2019_Human                     Hepatocellular carcinoma   1/168   \n",
      "12  KEGG_2019_Human          NOD-like receptor signaling pathway   1/178   \n",
      "13  KEGG_2019_Human                   PI3K-Akt signaling pathway   1/354   \n",
      "\n",
      "     P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0   0.004243               1.0            0                     0  235.294118   \n",
      "1   0.006647               1.0            0                     0   15.094340   \n",
      "2   0.019104               1.0            0                     0   51.948052   \n",
      "3   0.023037               1.0            0                     0   43.010753   \n",
      "4   0.024018               1.0            0                     0   41.237113   \n",
      "5   0.024508               1.0            0                     0   40.404040   \n",
      "6   0.026468               1.0            0                     0   37.383178   \n",
      "7   0.033787               1.0            0                     0   29.197080   \n",
      "8   0.034274               1.0            0                     0   28.776978   \n",
      "9   0.039853               1.0            0                     0   24.691358   \n",
      "10  0.040579               1.0            0                     0   24.242424   \n",
      "11  0.041304               1.0            0                     0   23.809524   \n",
      "12  0.043719               1.0            0                     0   22.471910   \n",
      "13  0.085430               1.0            0                     0   11.299435   \n",
      "\n",
      "    Combined Score            Genes  \n",
      "0      1285.282536           TXNRD1  \n",
      "1        75.677650  HSP90AB1;TXNRD1  \n",
      "2       205.602737         HSP90AB1  \n",
      "3       162.178843         HSP90AB1  \n",
      "4       153.770990         HSP90AB1  \n",
      "5       149.847983         HSP90AB1  \n",
      "6       135.769287         HSP90AB1  \n",
      "7        98.910242         HSP90AB1  \n",
      "8        97.075763         HSP90AB1  \n",
      "9        79.569385         HSP90AB1  \n",
      "10       77.685113         HSP90AB1  \n",
      "11       75.876009           TXNRD1  \n",
      "12       70.336465         HSP90AB1  \n",
      "13       27.797264         HSP90AB1  \n",
      "margin_status_Margin(s)_involved_by_invasive_carcinoma_P_values\n",
      "           Gene_set                                               Term  \\\n",
      "0   KEGG_2019_Human        Protein processing in endoplasmic reticulum   \n",
      "1   KEGG_2019_Human                                     Protein export   \n",
      "2   KEGG_2019_Human  Glycosylphosphatidylinositol (GPI)-anchor bios...   \n",
      "3   KEGG_2019_Human                               Pancreatic secretion   \n",
      "4   KEGG_2019_Human          Chagas disease (American trypanosomiasis)   \n",
      "5   KEGG_2019_Human                                 Insulin resistance   \n",
      "6   KEGG_2019_Human                                          Autophagy   \n",
      "7   KEGG_2019_Human                             FoxO signaling pathway   \n",
      "8   KEGG_2019_Human                               Steroid biosynthesis   \n",
      "9   KEGG_2019_Human                          One carbon pool by folate   \n",
      "10  KEGG_2019_Human               Other types of O-glycan biosynthesis   \n",
      "11  KEGG_2019_Human                                      RNA transport   \n",
      "12  KEGG_2019_Human                         cGMP-PKG signaling pathway   \n",
      "13  KEGG_2019_Human             Nicotinate and nicotinamide metabolism   \n",
      "14  KEGG_2019_Human                          Pentose phosphate pathway   \n",
      "15  KEGG_2019_Human                          Calcium signaling pathway   \n",
      "16  KEGG_2019_Human                             cAMP signaling pathway   \n",
      "17  KEGG_2019_Human            Human T-cell leukemia virus 1 infection   \n",
      "18  KEGG_2019_Human           Vasopressin-regulated water reabsorption   \n",
      "19  KEGG_2019_Human                          Type II diabetes mellitus   \n",
      "20  KEGG_2019_Human                             Cholesterol metabolism   \n",
      "21  KEGG_2019_Human                                        Endocytosis   \n",
      "22  KEGG_2019_Human                     Glycosaminoglycan biosynthesis   \n",
      "23  KEGG_2019_Human                   Herpes simplex virus 1 infection   \n",
      "24  KEGG_2019_Human              Regulation of lipolysis in adipocytes   \n",
      "25  KEGG_2019_Human                             Glutathione metabolism   \n",
      "26  KEGG_2019_Human                   Inflammatory bowel disease (IBD)   \n",
      "27  KEGG_2019_Human                Central carbon metabolism in cancer   \n",
      "28  KEGG_2019_Human                        Aminoacyl-tRNA biosynthesis   \n",
      "29  KEGG_2019_Human                             Long-term potentiation   \n",
      "..              ...                                                ...   \n",
      "52  KEGG_2019_Human                             AMPK signaling pathway   \n",
      "53  KEGG_2019_Human                                           Lysosome   \n",
      "54  KEGG_2019_Human                                         Cell cycle   \n",
      "55  KEGG_2019_Human                                     Oocyte meiosis   \n",
      "56  KEGG_2019_Human                          Relaxin signaling pathway   \n",
      "57  KEGG_2019_Human                                        Spliceosome   \n",
      "58  KEGG_2019_Human                          Insulin signaling pathway   \n",
      "59  KEGG_2019_Human                           Apelin signaling pathway   \n",
      "60  KEGG_2019_Human  Signaling pathways regulating pluripotency of ...   \n",
      "61  KEGG_2019_Human             Adrenergic signaling in cardiomyocytes   \n",
      "62  KEGG_2019_Human          Non-alcoholic fatty liver disease (NAFLD)   \n",
      "63  KEGG_2019_Human                                     Gastric cancer   \n",
      "64  KEGG_2019_Human                             mTOR signaling pathway   \n",
      "65  KEGG_2019_Human                                          Phagosome   \n",
      "66  KEGG_2019_Human                         Oxytocin signaling pathway   \n",
      "67  KEGG_2019_Human                                        Hepatitis C   \n",
      "68  KEGG_2019_Human                              Wnt signaling pathway   \n",
      "69  KEGG_2019_Human                                Cellular senescence   \n",
      "70  KEGG_2019_Human                            Hippo signaling pathway   \n",
      "71  KEGG_2019_Human                                        Hepatitis B   \n",
      "72  KEGG_2019_Human                           Hepatocellular carcinoma   \n",
      "73  KEGG_2019_Human                                  Alzheimer disease   \n",
      "74  KEGG_2019_Human                                 Huntington disease   \n",
      "75  KEGG_2019_Human                       Epstein-Barr virus infection   \n",
      "76  KEGG_2019_Human           Human immunodeficiency virus 1 infection   \n",
      "77  KEGG_2019_Human                    Human cytomegalovirus infection   \n",
      "78  KEGG_2019_Human                                      Thermogenesis   \n",
      "79  KEGG_2019_Human                             MAPK signaling pathway   \n",
      "80  KEGG_2019_Human                                MicroRNAs in cancer   \n",
      "81  KEGG_2019_Human                                 Pathways in cancer   \n",
      "\n",
      "   Overlap       P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  \\\n",
      "0    7/165  1.696952e-07          0.000052            0                     0   \n",
      "1     4/23  2.954349e-07          0.000045            0                     0   \n",
      "2     2/25  1.771221e-03          0.181845            0                     0   \n",
      "3     2/98  2.499488e-02          1.000000            0                     0   \n",
      "4    2/103  2.740756e-02          1.000000            0                     0   \n",
      "5    2/108  2.991048e-02          1.000000            0                     0   \n",
      "6    2/128  4.077469e-02          1.000000            0                     0   \n",
      "7    2/132  4.310229e-02          1.000000            0                     0   \n",
      "8     1/19  4.646646e-02          1.000000            0                     0   \n",
      "9     1/20  4.885255e-02          1.000000            0                     0   \n",
      "10    1/22  5.360720e-02          1.000000            0                     0   \n",
      "11   2/165  6.406216e-02          1.000000            0                     0   \n",
      "12   2/166  6.474253e-02          1.000000            0                     0   \n",
      "13    1/30  7.239397e-02          1.000000            0                     0   \n",
      "14    1/30  7.239397e-02          1.000000            0                     0   \n",
      "15   2/188  8.030707e-02          1.000000            0                     0   \n",
      "16   2/212  9.845761e-02          1.000000            0                     0   \n",
      "17   2/219  1.039544e-01          1.000000            0                     0   \n",
      "18    1/44  1.043952e-01          1.000000            0                     0   \n",
      "19    1/46  1.088776e-01          1.000000            0                     0   \n",
      "20    1/50  1.177765e-01          1.000000            0                     0   \n",
      "21   2/244  1.242348e-01          1.000000            0                     0   \n",
      "22    1/53  1.243935e-01          1.000000            0                     0   \n",
      "23   3/492  1.247140e-01          1.000000            0                     0   \n",
      "24    1/55  1.287778e-01          1.000000            0                     0   \n",
      "25    1/56  1.309618e-01          1.000000            0                     0   \n",
      "26    1/65  1.503784e-01          1.000000            0                     0   \n",
      "27    1/65  1.503784e-01          1.000000            0                     0   \n",
      "28    1/66  1.525094e-01          1.000000            0                     0   \n",
      "29    1/67  1.546351e-01          1.000000            0                     0   \n",
      "..     ...           ...               ...          ...                   ...   \n",
      "52   1/120  2.601245e-01          1.000000            0                     0   \n",
      "53   1/123  2.656933e-01          1.000000            0                     0   \n",
      "54   1/124  2.675404e-01          1.000000            0                     0   \n",
      "55   1/125  2.693830e-01          1.000000            0                     0   \n",
      "56   1/130  2.785279e-01          1.000000            0                     0   \n",
      "57   1/134  2.857630e-01          1.000000            0                     0   \n",
      "58   1/137  2.911426e-01          1.000000            0                     0   \n",
      "59   1/137  2.911426e-01          1.000000            0                     0   \n",
      "60   1/139  2.947069e-01          1.000000            0                     0   \n",
      "61   1/145  3.052948e-01          1.000000            0                     0   \n",
      "62   1/149  3.122667e-01          1.000000            0                     0   \n",
      "63   1/149  3.122667e-01          1.000000            0                     0   \n",
      "64   1/152  3.174506e-01          1.000000            0                     0   \n",
      "65   1/152  3.174506e-01          1.000000            0                     0   \n",
      "66   1/153  3.191701e-01          1.000000            0                     0   \n",
      "67   1/155  3.225962e-01          1.000000            0                     0   \n",
      "68   1/158  3.277038e-01          1.000000            0                     0   \n",
      "69   1/160  3.310879e-01          1.000000            0                     0   \n",
      "70   1/160  3.310879e-01          1.000000            0                     0   \n",
      "71   1/163  3.361327e-01          1.000000            0                     0   \n",
      "72   1/168  3.444579e-01          1.000000            0                     0   \n",
      "73   1/171  3.494039e-01          1.000000            0                     0   \n",
      "74   1/193  3.845737e-01          1.000000            0                     0   \n",
      "75   1/201  3.968950e-01          1.000000            0                     0   \n",
      "76   1/212  4.134429e-01          1.000000            0                     0   \n",
      "77   1/225  4.324265e-01          1.000000            0                     0   \n",
      "78   1/231  4.409837e-01          1.000000            0                     0   \n",
      "79   1/295  5.247480e-01          1.000000            0                     0   \n",
      "80   1/299  5.295537e-01          1.000000            0                     0   \n",
      "81   1/530  7.393402e-01          1.000000            0                     0   \n",
      "\n",
      "    Odds Ratio  Combined Score                                     Genes  \n",
      "0    16.969697      264.545051  ERLEC1;RRBP1;HYOU1;CALR;PDIA6;SIL1;UGGT1  \n",
      "1    69.565217     1045.900339                  SPCS3;SRPRA;SRP68;SEC11C  \n",
      "2    32.000000      202.754753                                 PIGS;PIGT  \n",
      "3     8.163265       30.114974                               CD38;ATP2A2  \n",
      "4     7.766990       27.937369                                SMAD3;CALR  \n",
      "5     7.407407       25.996640                              RPS6KA3;IRS2  \n",
      "6     6.250000       19.998085                                IGBP1;IRS2  \n",
      "7     6.060606       19.055632                                SMAD3;IRS2  \n",
      "8    21.052632       64.611045                                    DHCR24  \n",
      "9    20.000000       60.378974                                   ALDH1L2  \n",
      "10   18.181818       53.201308                                    POFUT1  \n",
      "11    4.848485       13.323159                              EIF2B5;EIF3E  \n",
      "12    4.819277       13.191985                               ATP2A2;IRS2  \n",
      "13   13.333333       35.008431                                      CD38  \n",
      "14   13.333333       35.008431                                      G6PD  \n",
      "15    4.255319       10.731479                               CD38;ATP2A2  \n",
      "16    3.773585        8.747657                              FXYD1;ATP2A2  \n",
      "17    3.652968        8.269602                                SMAD3;CALR  \n",
      "18    9.090909       20.541556                                       NSF  \n",
      "19    8.695652       19.282876                                      IRS2  \n",
      "20    8.000000       17.111730                                      NPC1  \n",
      "21    3.278689        6.837974                                SMAD3;GBF1  \n",
      "22    7.547170       15.730607                                    B3GAT3  \n",
      "23    2.439024        5.077395                         EIF2B5;CALR;SRSF9  \n",
      "24    7.272727       14.906670                                      IRS2  \n",
      "25    7.142857       14.520353                                      G6PD  \n",
      "26    6.153846       11.659079                                     SMAD3  \n",
      "27    6.153846       11.659079                                      G6PD  \n",
      "28    6.060606       11.397146                                      TARS  \n",
      "29    5.970149       11.144399                                   RPS6KA3  \n",
      "..         ...             ...                                       ...  \n",
      "52    3.333333        4.488650                                      IRS2  \n",
      "53    3.252033        4.310285                                      NPC1  \n",
      "54    3.225806        4.253177                                     SMAD3  \n",
      "55    3.200000        4.197188                                   RPS6KA3  \n",
      "56    3.076923        3.933037                                     SMAD3  \n",
      "57    2.985075        3.739082                                     SRSF9  \n",
      "58    2.919708        3.602751                                      IRS2  \n",
      "59    2.919708        3.602751                                     SMAD3  \n",
      "60    2.877698        3.515896                                     SMAD3  \n",
      "61    2.758621        3.273041                                    ATP2A2  \n",
      "62    2.684564        3.124557                                      IRS2  \n",
      "63    2.684564        3.124557                                     SMAD3  \n",
      "64    2.631579        3.019560                                   RPS6KA3  \n",
      "65    2.631579        3.019560                                      CALR  \n",
      "66    2.614379        2.985702                                      CD38  \n",
      "67    2.580645        2.919623                                     EIF3E  \n",
      "68    2.531646        2.824418                                     SMAD3  \n",
      "69    2.500000        2.763429                                     SMAD3  \n",
      "70    2.500000        2.763429                                     SMAD3  \n",
      "71    2.453988        2.675459                                     SMAD3  \n",
      "72    2.380952        2.537579                                     SMAD3  \n",
      "73    2.339181        2.459712                                    ATP2A2  \n",
      "74    2.072539        1.980559                                    DNALI1  \n",
      "75    1.990050        1.838972                                      CALR  \n",
      "76    1.886792        1.666483                                      CALR  \n",
      "77    1.777778        1.490388                                      CALR  \n",
      "78    1.731602        1.417744                                   RPS6KA3  \n",
      "79    1.355932        0.874355                                   RPS6KA3  \n",
      "80    1.337793        0.850462                                      IRS2  \n",
      "81    0.754717        0.227922                                     SMAD3  \n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[82 rows x 10 columns]\n",
      "tobacco_smoking_history_Current_Smoker_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:48:39,226 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "          Gene_set                      Term Overlap   P-value  \\\n",
      "0  KEGG_2019_Human  Homologous recombination    1/41  0.014264   \n",
      "\n",
      "   Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0               1.0            0                     0   69.686411   \n",
      "\n",
      "   Combined Score  Genes  \n",
      "0      296.168151  BARD1  \n",
      "anesthesia_insulin_Yes_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:48:42,494 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "           Gene_set                                               Term  \\\n",
      "0   KEGG_2019_Human        Protein processing in endoplasmic reticulum   \n",
      "1   KEGG_2019_Human                       Epstein-Barr virus infection   \n",
      "2   KEGG_2019_Human                                        Shigellosis   \n",
      "3   KEGG_2019_Human                                          Autophagy   \n",
      "4   KEGG_2019_Human                    Terpenoid backbone biosynthesis   \n",
      "5   KEGG_2019_Human                           Renin-angiotensin system   \n",
      "6   KEGG_2019_Human                          Calcium signaling pathway   \n",
      "7   KEGG_2019_Human                   Mucin type O-glycan biosynthesis   \n",
      "8   KEGG_2019_Human                                        Ferroptosis   \n",
      "9   KEGG_2019_Human                                         Proteasome   \n",
      "10  KEGG_2019_Human                          Type II diabetes mellitus   \n",
      "11  KEGG_2019_Human                         Hedgehog signaling pathway   \n",
      "12  KEGG_2019_Human                            Glycerolipid metabolism   \n",
      "13  KEGG_2019_Human                                          Mitophagy   \n",
      "14  KEGG_2019_Human  Epithelial cell signaling in Helicobacter pylo...   \n",
      "15  KEGG_2019_Human                    Fc epsilon RI signaling pathway   \n",
      "16  KEGG_2019_Human                    Adipocytokine signaling pathway   \n",
      "17  KEGG_2019_Human                        Prolactin signaling pathway   \n",
      "18  KEGG_2019_Human              RIG-I-like receptor signaling pathway   \n",
      "19  KEGG_2019_Human                                  Pancreatic cancer   \n",
      "20  KEGG_2019_Human                                             Glioma   \n",
      "21  KEGG_2019_Human                                          Pertussis   \n",
      "22  KEGG_2019_Human                           ECM-receptor interaction   \n",
      "23  KEGG_2019_Human                                         Peroxisome   \n",
      "24  KEGG_2019_Human                             ErbB signaling pathway   \n",
      "25  KEGG_2019_Human                                  Colorectal cancer   \n",
      "26  KEGG_2019_Human                               Salmonella infection   \n",
      "27  KEGG_2019_Human                   Th1 and Th2 cell differentiation   \n",
      "28  KEGG_2019_Human                            IL-17 signaling pathway   \n",
      "29  KEGG_2019_Human                             GnRH signaling pathway   \n",
      "..              ...                                                ...   \n",
      "51  KEGG_2019_Human                               Dopaminergic synapse   \n",
      "52  KEGG_2019_Human                             FoxO signaling pathway   \n",
      "53  KEGG_2019_Human                          Insulin signaling pathway   \n",
      "54  KEGG_2019_Human                     Ubiquitin mediated proteolysis   \n",
      "55  KEGG_2019_Human                                            Measles   \n",
      "56  KEGG_2019_Human             Fluid shear stress and atherosclerosis   \n",
      "57  KEGG_2019_Human                                          Apoptosis   \n",
      "58  KEGG_2019_Human               Retrograde endocannabinoid signaling   \n",
      "59  KEGG_2019_Human          Non-alcoholic fatty liver disease (NAFLD)   \n",
      "60  KEGG_2019_Human                         Oxytocin signaling pathway   \n",
      "61  KEGG_2019_Human                              Wnt signaling pathway   \n",
      "62  KEGG_2019_Human                            Hippo signaling pathway   \n",
      "63  KEGG_2019_Human                                        Necroptosis   \n",
      "64  KEGG_2019_Human                                        Hepatitis B   \n",
      "65  KEGG_2019_Human                                     Tight junction   \n",
      "66  KEGG_2019_Human                                        Influenza A   \n",
      "67  KEGG_2019_Human                NOD-like receptor signaling pathway   \n",
      "68  KEGG_2019_Human                                       Tuberculosis   \n",
      "69  KEGG_2019_Human    Kaposi sarcoma-associated herpesvirus infection   \n",
      "70  KEGG_2019_Human                                     Focal adhesion   \n",
      "71  KEGG_2019_Human                            Proteoglycans in cancer   \n",
      "72  KEGG_2019_Human           Human immunodeficiency virus 1 infection   \n",
      "73  KEGG_2019_Human                             cAMP signaling pathway   \n",
      "74  KEGG_2019_Human            Human T-cell leukemia virus 1 infection   \n",
      "75  KEGG_2019_Human                              Ras signaling pathway   \n",
      "76  KEGG_2019_Human                                        Endocytosis   \n",
      "77  KEGG_2019_Human                             MAPK signaling pathway   \n",
      "78  KEGG_2019_Human                                MicroRNAs in cancer   \n",
      "79  KEGG_2019_Human            Neuroactive ligand-receptor interaction   \n",
      "80  KEGG_2019_Human                                 Pathways in cancer   \n",
      "\n",
      "   Overlap   P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  \\\n",
      "0    3/165  0.003763          1.000000            0                     0   \n",
      "1    3/201  0.006513          1.000000            0                     0   \n",
      "2     2/65  0.006781          0.696137            0                     0   \n",
      "3    2/128  0.024586          1.000000            0                     0   \n",
      "4     1/22  0.040997          1.000000            0                     0   \n",
      "5     1/23  0.042822          1.000000            0                     0   \n",
      "6    2/188  0.049540          1.000000            0                     0   \n",
      "7     1/31  0.057293          1.000000            0                     0   \n",
      "8     1/40  0.073319          1.000000            0                     0   \n",
      "9     1/45  0.082108          1.000000            0                     0   \n",
      "10    1/46  0.083856          1.000000            0                     0   \n",
      "11    1/47  0.085600          1.000000            0                     0   \n",
      "12    1/61  0.109689          1.000000            0                     0   \n",
      "13    1/65  0.116457          1.000000            0                     0   \n",
      "14    1/68  0.121500          1.000000            0                     0   \n",
      "15    1/68  0.121500          1.000000            0                     0   \n",
      "16    1/69  0.123175          1.000000            0                     0   \n",
      "17    1/70  0.124847          1.000000            0                     0   \n",
      "18    1/70  0.124847          1.000000            0                     0   \n",
      "19    1/75  0.133159          1.000000            0                     0   \n",
      "20    1/75  0.133159          1.000000            0                     0   \n",
      "21    1/76  0.134812          1.000000            0                     0   \n",
      "22    1/82  0.144667          1.000000            0                     0   \n",
      "23    1/83  0.146299          1.000000            0                     0   \n",
      "24    1/85  0.149554          1.000000            0                     0   \n",
      "25    1/86  0.151176          1.000000            0                     0   \n",
      "26    1/86  0.151176          1.000000            0                     0   \n",
      "27    1/92  0.160850          1.000000            0                     0   \n",
      "28    1/93  0.162451          1.000000            0                     0   \n",
      "29    1/93  0.162451          1.000000            0                     0   \n",
      "..     ...       ...               ...          ...                   ...   \n",
      "51   1/131  0.221160          1.000000            0                     0   \n",
      "52   1/132  0.222650          1.000000            0                     0   \n",
      "53   1/137  0.230056          1.000000            0                     0   \n",
      "54   1/137  0.230056          1.000000            0                     0   \n",
      "55   1/138  0.231529          1.000000            0                     0   \n",
      "56   1/139  0.232999          1.000000            0                     0   \n",
      "57   1/143  0.238853          1.000000            0                     0   \n",
      "58   1/148  0.246109          1.000000            0                     0   \n",
      "59   1/149  0.247552          1.000000            0                     0   \n",
      "60   1/153  0.253297          1.000000            0                     0   \n",
      "61   1/158  0.260419          1.000000            0                     0   \n",
      "62   1/160  0.263249          1.000000            0                     0   \n",
      "63   1/162  0.266069          1.000000            0                     0   \n",
      "64   1/163  0.267475          1.000000            0                     0   \n",
      "65   1/170  0.277243          1.000000            0                     0   \n",
      "66   1/171  0.278628          1.000000            0                     0   \n",
      "67   1/178  0.288251          1.000000            0                     0   \n",
      "68   1/179  0.289615          1.000000            0                     0   \n",
      "69   1/186  0.299095          1.000000            0                     0   \n",
      "70   1/199  0.316376          1.000000            0                     0   \n",
      "71   1/201  0.318997          1.000000            0                     0   \n",
      "72   1/212  0.333241          1.000000            0                     0   \n",
      "73   1/212  0.333241          1.000000            0                     0   \n",
      "74   1/219  0.342154          1.000000            0                     0   \n",
      "75   1/232  0.358399          1.000000            0                     0   \n",
      "76   1/244  0.373048          1.000000            0                     0   \n",
      "77   1/295  0.431754          1.000000            0                     0   \n",
      "78   1/299  0.436125          1.000000            0                     0   \n",
      "79   1/338  0.477062          1.000000            0                     0   \n",
      "80   1/530  0.639960          1.000000            0                     0   \n",
      "\n",
      "    Odds Ratio  Combined Score             Genes  \n",
      "0     9.569378       53.420544  MAPK9;RRBP1;SIL1  \n",
      "1     7.855460       39.543848  PSMD8;MAPK9;CD44  \n",
      "2    16.194332       80.869577        MAPK9;CD44  \n",
      "3     8.223684       30.473476        MAPK9;ATG7  \n",
      "4    23.923445       76.417359              PMVK  \n",
      "5    22.883295       72.098715             LNPEP  \n",
      "6     5.599104       16.825161       P2RX4;CAMK1  \n",
      "7    16.977929       48.549606            GALNT2  \n",
      "8    13.157895       34.380658              ATG7  \n",
      "9    11.695906       29.236511             PSMD8  \n",
      "10   11.441648       28.359920             MAPK9  \n",
      "11   11.198208       27.525920             KIF3A  \n",
      "12    8.628128       19.069081             LPIN3  \n",
      "13    8.097166       17.410784             MAPK9  \n",
      "14    7.739938       16.314534             MAPK9  \n",
      "15    7.739938       16.314534             MAPK9  \n",
      "16    7.627765       15.973664             MAPK9  \n",
      "17    7.518797       15.644110             MAPK9  \n",
      "18    7.518797       15.644110             MAPK9  \n",
      "19    7.017544       14.148842             MAPK9  \n",
      "20    7.017544       14.148842             CAMK1  \n",
      "21    6.925208       13.877225             MAPK9  \n",
      "22    6.418485       12.408979              CD44  \n",
      "23    6.341154       12.188347              PMVK  \n",
      "24    6.191950       11.765326             MAPK9  \n",
      "25    6.119951       11.562473             MAPK9  \n",
      "26    6.119951       11.562473             MAPK9  \n",
      "27    5.720824       10.453575             MAPK9  \n",
      "28    5.659310       10.285094             MAPK9  \n",
      "29    5.659310       10.285094             MAPK9  \n",
      "..         ...             ...               ...  \n",
      "51    4.017678        6.062141             MAPK9  \n",
      "52    3.987241        5.989451             MAPK9  \n",
      "53    3.841721        5.645146             MAPK9  \n",
      "54    3.841721        5.645146             UBE2F  \n",
      "55    3.813883        5.579898             MAPK9  \n",
      "56    3.786445        5.515787             MAPK9  \n",
      "57    3.680530        5.270176             MAPK9  \n",
      "58    3.556188        4.985708             MAPK9  \n",
      "59    3.532321        4.931596             MAPK9  \n",
      "60    3.439972        4.723739             CAMK1  \n",
      "61    3.331113        4.481888             MAPK9  \n",
      "62    3.289474        4.390309              WWC1  \n",
      "63    3.248863        4.301495             MAPK9  \n",
      "64    3.228931        4.258089             MAPK9  \n",
      "65    3.095975        3.971710             MAPK9  \n",
      "66    3.077870        3.933146             MAPK9  \n",
      "67    2.956830        3.678076             MAPK9  \n",
      "68    2.940312        3.643642             MAPK9  \n",
      "69    2.829655        3.415374             MAPK9  \n",
      "70    2.644803        3.043706             MAPK9  \n",
      "71    2.618487        2.991814              CD44  \n",
      "72    2.482622        2.728128             MAPK9  \n",
      "73    2.482622        2.728128             MAPK9  \n",
      "74    2.403268        2.577495             MAPK9  \n",
      "75    2.268603        2.327832             MAPK9  \n",
      "76    2.157032        2.126939              GBF1  \n",
      "77    1.784121        1.498483             MAPK9  \n",
      "78    1.760253        1.460705              CD44  \n",
      "79    1.557147        1.152459             P2RX4  \n",
      "80    0.993049        0.443248             MAPK9  \n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[81 rows x 10 columns]\n",
      "anesthesia_steroids_Yes_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:48:45,398 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "           Gene_set                                             Term Overlap  \\\n",
      "0   KEGG_2019_Human           Nicotinate and nicotinamide metabolism    1/30   \n",
      "1   KEGG_2019_Human                  Fructose and mannose metabolism    1/33   \n",
      "2   KEGG_2019_Human      Amino sugar and nucleotide sugar metabolism    1/48   \n",
      "3   KEGG_2019_Human                            p53 signaling pathway    1/72   \n",
      "4   KEGG_2019_Human                                GABAergic synapse    1/89   \n",
      "5   KEGG_2019_Human                               Salivary secretion    1/90   \n",
      "6   KEGG_2019_Human                               Morphine addiction    1/91   \n",
      "7   KEGG_2019_Human                       Hematopoietic cell lineage    1/97   \n",
      "8   KEGG_2019_Human                            Circadian entrainment    1/97   \n",
      "9   KEGG_2019_Human                             Pancreatic secretion    1/98   \n",
      "10  KEGG_2019_Human                              Cholinergic synapse   1/112   \n",
      "11  KEGG_2019_Human                             Serotonergic synapse   1/113   \n",
      "12  KEGG_2019_Human                            Glutamatergic synapse   1/114   \n",
      "13  KEGG_2019_Human                        Relaxin signaling pathway   1/130   \n",
      "14  KEGG_2019_Human                             Dopaminergic synapse   1/131   \n",
      "15  KEGG_2019_Human                         Apelin signaling pathway   1/137   \n",
      "16  KEGG_2019_Human             Retrograde endocannabinoid signaling   1/148   \n",
      "17  KEGG_2019_Human                       Oxytocin signaling pathway   1/153   \n",
      "18  KEGG_2019_Human                                       Alcoholism   1/180   \n",
      "19  KEGG_2019_Human  Kaposi sarcoma-associated herpesvirus infection   1/186   \n",
      "20  KEGG_2019_Human                        Calcium signaling pathway   1/188   \n",
      "21  KEGG_2019_Human                      Chemokine signaling pathway   1/190   \n",
      "22  KEGG_2019_Human         Human immunodeficiency virus 1 infection   1/212   \n",
      "23  KEGG_2019_Human                  Human cytomegalovirus infection   1/225   \n",
      "24  KEGG_2019_Human                            Ras signaling pathway   1/232   \n",
      "25  KEGG_2019_Human                       PI3K-Akt signaling pathway   1/354   \n",
      "26  KEGG_2019_Human                               Pathways in cancer   1/530   \n",
      "\n",
      "     P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0   0.008967          1.000000            0                     0  111.111111   \n",
      "1   0.009860          1.000000            0                     0  101.010101   \n",
      "2   0.014316          1.000000            0                     0   69.444444   \n",
      "3   0.021409          1.000000            0                     0   46.296296   \n",
      "4   0.026408          1.000000            0                     0   37.453184   \n",
      "5   0.026701          1.000000            0                     0   37.037037   \n",
      "6   0.026994          1.000000            0                     0   36.630037   \n",
      "7   0.028753          1.000000            0                     0   34.364261   \n",
      "8   0.028753          0.983985            0                     0   34.364261   \n",
      "9   0.029046          0.894604            0                     0   34.013605   \n",
      "10  0.033137          0.927836            0                     0   29.761905   \n",
      "11  0.033429          0.858003            0                     0   29.498525   \n",
      "12  0.033720          0.798912            0                     0   29.239766   \n",
      "13  0.038376          0.844277            0                     0   25.641026   \n",
      "14  0.038667          0.793954            0                     0   25.445293   \n",
      "15  0.040407          0.777841            0                     0   24.330900   \n",
      "16  0.043592          0.789781            0                     0   22.522523   \n",
      "17  0.045036          0.770622            0                     0   21.786492   \n",
      "18  0.052806          0.856008            0                     0   18.518519   \n",
      "19  0.054525          0.839686            0                     0   17.921147   \n",
      "20  0.055098          0.808098            0                     0   17.730496   \n",
      "21  0.055670          0.779378            0                     0   17.543860   \n",
      "22  0.061946          0.829531            0                     0   15.723270   \n",
      "23  0.065638          0.842348            0                     0   14.814815   \n",
      "24  0.067620          0.833084            0                     0   14.367816   \n",
      "25  0.101622          1.000000            0                     0    9.416196   \n",
      "26  0.148848          1.000000            0                     0    6.289308   \n",
      "\n",
      "    Combined Score  Genes  \n",
      "0       523.796272   CD38  \n",
      "1       466.588970    MPI  \n",
      "2       294.889612    MPI  \n",
      "3       177.960309  AIFM2  \n",
      "4       136.108447  GNG11  \n",
      "5       134.186930   CD38  \n",
      "6       132.312167  GNG11  \n",
      "7       121.959449   CD38  \n",
      "8       121.959449  GNG11  \n",
      "9       120.370352   CD38  \n",
      "10      101.401941  GNG11  \n",
      "11      100.246051  GNG11  \n",
      "12       99.112730  GNG11  \n",
      "13       83.597875  GNG11  \n",
      "14       82.767916  GNG11  \n",
      "15       78.071645  GNG11  \n",
      "16       70.560508  GNG11  \n",
      "17       67.544337   CD38  \n",
      "18       54.465487  GNG11  \n",
      "19       52.134324  GNG11  \n",
      "20       51.394496   CD38  \n",
      "21       50.672229  GNG11  \n",
      "22       43.734279  GNG11  \n",
      "23       40.349748  GNG11  \n",
      "24       38.704659  GNG11  \n",
      "25       21.530094  GNG11  \n",
      "26       11.980055  GNG11  \n",
      "tumor_status_at_12months_follow_up_With_Tumor_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:48:49,760 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "           Gene_set                                         Term Overlap  \\\n",
      "0   KEGG_2019_Human  Protein processing in endoplasmic reticulum   3/165   \n",
      "1   KEGG_2019_Human             Mucin type O-glycan biosynthesis    1/31   \n",
      "2   KEGG_2019_Human                    Type II diabetes mellitus    1/46   \n",
      "3   KEGG_2019_Human              Arginine and proline metabolism    1/49   \n",
      "4   KEGG_2019_Human        Regulation of lipolysis in adipocytes    1/55   \n",
      "5   KEGG_2019_Human                  Aminoacyl-tRNA biosynthesis    1/66   \n",
      "6   KEGG_2019_Human              Adipocytokine signaling pathway    1/69   \n",
      "7   KEGG_2019_Human          Antigen processing and presentation    1/77   \n",
      "8   KEGG_2019_Human            Ribosome biogenesis in eukaryotes   1/101   \n",
      "9   KEGG_2019_Human                 Longevity regulating pathway   1/102   \n",
      "10  KEGG_2019_Human    Chagas disease (American trypanosomiasis)   1/103   \n",
      "11  KEGG_2019_Human                           Insulin resistance   1/108   \n",
      "12  KEGG_2019_Human               Neurotrophin signaling pathway   1/119   \n",
      "13  KEGG_2019_Human                       AMPK signaling pathway   1/120   \n",
      "14  KEGG_2019_Human                                   Cell cycle   1/124   \n",
      "15  KEGG_2019_Human                                    Autophagy   1/128   \n",
      "16  KEGG_2019_Human                       FoxO signaling pathway   1/132   \n",
      "17  KEGG_2019_Human                    Insulin signaling pathway   1/137   \n",
      "18  KEGG_2019_Human    Non-alcoholic fatty liver disease (NAFLD)   1/149   \n",
      "19  KEGG_2019_Human                                    Phagosome   1/152   \n",
      "20  KEGG_2019_Human                                RNA transport   1/165   \n",
      "21  KEGG_2019_Human                   cGMP-PKG signaling pathway   1/166   \n",
      "22  KEGG_2019_Human                 Epstein-Barr virus infection   1/201   \n",
      "23  KEGG_2019_Human     Human immunodeficiency virus 1 infection   1/212   \n",
      "24  KEGG_2019_Human      Human T-cell leukemia virus 1 infection   1/219   \n",
      "25  KEGG_2019_Human              Human cytomegalovirus infection   1/225   \n",
      "26  KEGG_2019_Human                          MicroRNAs in cancer   1/299   \n",
      "27  KEGG_2019_Human             Herpes simplex virus 1 infection   1/492   \n",
      "\n",
      "     P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0   0.000485          0.149321            0                     0   19.138756   \n",
      "1   0.029055          1.000000            0                     0   33.955857   \n",
      "2   0.042826          1.000000            0                     0   22.883295   \n",
      "3   0.045558          1.000000            0                     0   21.482277   \n",
      "4   0.050999          1.000000            0                     0   19.138756   \n",
      "5   0.060899          1.000000            0                     0   15.948963   \n",
      "6   0.063581          1.000000            0                     0   15.255530   \n",
      "7   0.070700          1.000000            0                     0   13.670540   \n",
      "8   0.091751          1.000000            0                     0   10.422095   \n",
      "9   0.092618          1.000000            0                     0   10.319917   \n",
      "10  0.093484          1.000000            0                     0   10.219724   \n",
      "11  0.097805          1.000000            0                     0    9.746589   \n",
      "12  0.107241          1.000000            0                     0    8.845644   \n",
      "13  0.108094          1.000000            0                     0    8.771930   \n",
      "14  0.111499          1.000000            0                     0    8.488964   \n",
      "15  0.114892          1.000000            0                     0    8.223684   \n",
      "16  0.118272          1.000000            0                     0    7.974482   \n",
      "17  0.122481          1.000000            0                     0    7.683442   \n",
      "18  0.132503          1.000000            0                     0    7.064641   \n",
      "19  0.134992          1.000000            0                     0    6.925208   \n",
      "20  0.145698          1.000000            0                     0    6.379585   \n",
      "21  0.146517          1.000000            0                     0    6.341154   \n",
      "22  0.174695          1.000000            0                     0    5.236973   \n",
      "23  0.183368          1.000000            0                     0    4.965243   \n",
      "24  0.188841          1.000000            0                     0    4.806537   \n",
      "25  0.193506          1.000000            0                     0    4.678363   \n",
      "26  0.248981          1.000000            0                     0    3.520507   \n",
      "27  0.377156          1.000000            0                     0    2.139495   \n",
      "\n",
      "    Combined Score             Genes  \n",
      "0       146.062283  RRBP1;CALR;PDIA6  \n",
      "1       120.154449            GALNT2  \n",
      "2        72.096471              IRS2  \n",
      "3        66.354023             PYCR2  \n",
      "4        56.956007              IRS2  \n",
      "5        44.633914              TARS  \n",
      "6        42.035614              IRS2  \n",
      "7        36.217444              CALR  \n",
      "8        24.895072              POP1  \n",
      "9        24.553918              IRS2  \n",
      "10       24.220371              CALR  \n",
      "11       22.658713              IRS2  \n",
      "12       19.749470            MAGED1  \n",
      "13       19.515378              IRS2  \n",
      "14       18.622565              ORC5  \n",
      "15       17.794107              IRS2  \n",
      "16       17.023644              IRS2  \n",
      "17       16.133701              IRS2  \n",
      "18       14.278678              IRS2  \n",
      "19       13.868000              CALR  \n",
      "20       12.288466              POP1  \n",
      "21       12.178923              IRS2  \n",
      "22        9.137016              CALR  \n",
      "23        8.422356              CALR  \n",
      "24        8.011766              CALR  \n",
      "25        7.683972              CALR  \n",
      "26        4.894842              IRS2  \n",
      "27        2.086211              CALR  \n",
      "tumor_status_at_24months_follow_up_With_Tumor_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:48:52,649 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Empty DataFrame\n",
      "Columns: [Gene_set, Term, Overlap, P-value, Adjusted P-value, Old P-value, Old Adjusted P-value, Odds Ratio, Combined Score, Genes]\n",
      "Index: []\n",
      "success_of_treatment_at_12months_follow_up_Persistent_Disease_or_Deceased_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:48:55,527 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "           Gene_set                                         Term Overlap  \\\n",
      "0   KEGG_2019_Human          Antigen processing and presentation    2/77   \n",
      "1   KEGG_2019_Human  Protein processing in endoplasmic reticulum   2/165   \n",
      "2   KEGG_2019_Human                 Epstein-Barr virus infection   2/201   \n",
      "3   KEGG_2019_Human             Mucin type O-glycan biosynthesis    1/31   \n",
      "4   KEGG_2019_Human                          MicroRNAs in cancer   2/299   \n",
      "5   KEGG_2019_Human                    Type II diabetes mellitus    1/46   \n",
      "6   KEGG_2019_Human              Arginine and proline metabolism    1/49   \n",
      "7   KEGG_2019_Human                       Cholesterol metabolism    1/50   \n",
      "8   KEGG_2019_Human        Regulation of lipolysis in adipocytes    1/55   \n",
      "9   KEGG_2019_Human                                  Shigellosis    1/65   \n",
      "10  KEGG_2019_Human              Adipocytokine signaling pathway    1/69   \n",
      "11  KEGG_2019_Human                     ECM-receptor interaction    1/82   \n",
      "12  KEGG_2019_Human                      IL-17 signaling pathway    1/93   \n",
      "13  KEGG_2019_Human                              Prostate cancer    1/97   \n",
      "14  KEGG_2019_Human                   Hematopoietic cell lineage    1/97   \n",
      "15  KEGG_2019_Human      Progesterone-mediated oocyte maturation    1/99   \n",
      "16  KEGG_2019_Human            Ribosome biogenesis in eukaryotes   1/101   \n",
      "17  KEGG_2019_Human                 Longevity regulating pathway   1/102   \n",
      "18  KEGG_2019_Human    Chagas disease (American trypanosomiasis)   1/103   \n",
      "19  KEGG_2019_Human                    Th17 cell differentiation   1/107   \n",
      "20  KEGG_2019_Human                           Insulin resistance   1/108   \n",
      "21  KEGG_2019_Human               Neurotrophin signaling pathway   1/119   \n",
      "22  KEGG_2019_Human                       AMPK signaling pathway   1/120   \n",
      "23  KEGG_2019_Human                                     Lysosome   1/123   \n",
      "24  KEGG_2019_Human                                   Cell cycle   1/124   \n",
      "25  KEGG_2019_Human                                    Autophagy   1/128   \n",
      "26  KEGG_2019_Human                       FoxO signaling pathway   1/132   \n",
      "27  KEGG_2019_Human                    Insulin signaling pathway   1/137   \n",
      "28  KEGG_2019_Human                   Estrogen signaling pathway   1/137   \n",
      "29  KEGG_2019_Human       Fluid shear stress and atherosclerosis   1/139   \n",
      "30  KEGG_2019_Human    Non-alcoholic fatty liver disease (NAFLD)   1/149   \n",
      "31  KEGG_2019_Human                                    Phagosome   1/152   \n",
      "32  KEGG_2019_Human                                  Necroptosis   1/162   \n",
      "33  KEGG_2019_Human                                RNA transport   1/165   \n",
      "34  KEGG_2019_Human                   cGMP-PKG signaling pathway   1/166   \n",
      "35  KEGG_2019_Human          NOD-like receptor signaling pathway   1/178   \n",
      "36  KEGG_2019_Human                      Proteoglycans in cancer   1/201   \n",
      "37  KEGG_2019_Human     Human immunodeficiency virus 1 infection   1/212   \n",
      "38  KEGG_2019_Human      Human T-cell leukemia virus 1 infection   1/219   \n",
      "39  KEGG_2019_Human              Human cytomegalovirus infection   1/225   \n",
      "40  KEGG_2019_Human                   PI3K-Akt signaling pathway   1/354   \n",
      "41  KEGG_2019_Human             Herpes simplex virus 1 infection   1/492   \n",
      "42  KEGG_2019_Human                           Pathways in cancer   1/530   \n",
      "\n",
      "     P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0   0.002658          0.818539            0                     0   25.974026   \n",
      "1   0.011660          1.000000            0                     0   12.121212   \n",
      "2   0.016954          1.000000            0                     0    9.950249   \n",
      "3   0.030562          1.000000            0                     0   32.258065   \n",
      "4   0.035451          1.000000            0                     0    6.688963   \n",
      "5   0.045029          1.000000            0                     0   21.739130   \n",
      "6   0.047898          1.000000            0                     0   20.408163   \n",
      "7   0.048853          1.000000            0                     0   20.000000   \n",
      "8   0.053611          1.000000            0                     0   18.181818   \n",
      "9   0.063061          1.000000            0                     0   15.384615   \n",
      "10  0.066815          1.000000            0                     0   14.492754   \n",
      "11  0.078919          1.000000            0                     0   12.195122   \n",
      "12  0.089044          1.000000            0                     0   10.752688   \n",
      "13  0.092700          1.000000            0                     0   10.309278   \n",
      "14  0.092700          1.000000            0                     0   10.309278   \n",
      "15  0.094522          1.000000            0                     0   10.101010   \n",
      "16  0.096342          1.000000            0                     0    9.900990   \n",
      "17  0.097250          1.000000            0                     0    9.803922   \n",
      "18  0.098157          1.000000            0                     0    9.708738   \n",
      "19  0.101778          1.000000            0                     0    9.345794   \n",
      "20  0.102681          1.000000            0                     0    9.259259   \n",
      "21  0.112558          1.000000            0                     0    8.403361   \n",
      "22  0.113451          1.000000            0                     0    8.333333   \n",
      "23  0.116124          1.000000            0                     0    8.130081   \n",
      "24  0.117013          1.000000            0                     0    8.064516   \n",
      "25  0.120562          1.000000            0                     0    7.812500   \n",
      "26  0.124097          1.000000            0                     0    7.575758   \n",
      "27  0.128497          1.000000            0                     0    7.299270   \n",
      "28  0.128497          1.000000            0                     0    7.299270   \n",
      "29  0.130252          1.000000            0                     0    7.194245   \n",
      "30  0.138972          1.000000            0                     0    6.711409   \n",
      "31  0.141572          1.000000            0                     0    6.578947   \n",
      "32  0.150185          1.000000            0                     0    6.172840   \n",
      "33  0.152753          1.000000            0                     0    6.060606   \n",
      "34  0.153607          1.000000            0                     0    6.024096   \n",
      "35  0.163795          1.000000            0                     0    5.617978   \n",
      "36  0.182997          1.000000            0                     0    4.975124   \n",
      "37  0.192032          1.000000            0                     0    4.716981   \n",
      "38  0.197732          1.000000            0                     0    4.566210   \n",
      "39  0.202587          1.000000            0                     0    4.444444   \n",
      "40  0.300466          1.000000            0                     0    2.824859   \n",
      "41  0.392493          1.000000            0                     0    2.032520   \n",
      "42  0.415739          1.000000            0                     0    1.886792   \n",
      "\n",
      "    Combined Score          Genes  \n",
      "0       154.034661  HSP90AB1;CALR  \n",
      "1        53.959185  HSP90AB1;CALR  \n",
      "2        40.569912      CALR;CD44  \n",
      "3       112.516208         GALNT2  \n",
      "4        22.338459      IRS2;CD44  \n",
      "5        67.400893           IRS2  \n",
      "6        62.013861          PYCR2  \n",
      "7        60.378974           NPC1  \n",
      "8        53.199977           IRS2  \n",
      "9        42.517857           CD44  \n",
      "10       39.214872           IRS2  \n",
      "11       30.967467           CD44  \n",
      "12       26.006685       HSP90AB1  \n",
      "13       24.519467       HSP90AB1  \n",
      "14       24.519467           CD44  \n",
      "15       23.827455       HSP90AB1  \n",
      "16       23.166889           POP1  \n",
      "17       22.847771           IRS2  \n",
      "18       22.535782           CALR  \n",
      "19       21.354779       HSP90AB1  \n",
      "20       21.075257           IRS2  \n",
      "21       18.355360         MAGED1  \n",
      "22       18.136564           IRS2  \n",
      "23       17.504868           NPC1  \n",
      "24       17.302172           ORC5  \n",
      "25       16.528057           IRS2  \n",
      "26       15.808252           IRS2  \n",
      "27       14.976977           IRS2  \n",
      "28       14.976977       HSP90AB1  \n",
      "29       14.663933       HSP90AB1  \n",
      "30       13.244832           IRS2  \n",
      "31       12.861475           CALR  \n",
      "32       11.703000       HSP90AB1  \n",
      "33       11.387473           POP1  \n",
      "34       11.285277           IRS2  \n",
      "35       10.163699       HSP90AB1  \n",
      "36        8.449174           CD44  \n",
      "37        7.783457           CALR  \n",
      "38        7.401108           CALR  \n",
      "39        7.095932           CALR  \n",
      "40        3.396668       HSP90AB1  \n",
      "41        1.900888           CALR  \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "42        1.656035       HSP90AB1  \n",
      "new_tumor_event_after_initial_treatment_at_24months_follow_up_Yes_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:48:58,428 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "          Gene_set                                     Term Overlap   P-value  \\\n",
      "0  KEGG_2019_Human                Selenocompound metabolism    1/17  0.009313   \n",
      "1  KEGG_2019_Human                 Renin-angiotensin system    1/23  0.012581   \n",
      "2  KEGG_2019_Human                 Hepatocellular carcinoma   1/168  0.088636   \n",
      "3  KEGG_2019_Human                Calcium signaling pathway   1/188  0.098698   \n",
      "4  KEGG_2019_Human  Neuroactive ligand-receptor interaction   1/338  0.171000   \n",
      "5  KEGG_2019_Human                       Pathways in cancer   1/530  0.255845   \n",
      "\n",
      "   Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0               1.0            0                     0  106.951872   \n",
      "1               1.0            0                     0   79.051383   \n",
      "2               1.0            0                     0   10.822511   \n",
      "3               1.0            0                     0    9.671180   \n",
      "4               1.0            0                     0    5.379236   \n",
      "5               1.0            0                     0    3.430532   \n",
      "\n",
      "   Combined Score   Genes  \n",
      "0      500.148528  TXNRD1  \n",
      "1      345.897666   LNPEP  \n",
      "2       26.225257  TXNRD1  \n",
      "3       22.395469   P2RX4  \n",
      "4        9.500212   P2RX4  \n",
      "5        4.676441  TXNRD1  \n",
      "percent_necrotic_surface_area_Above_Mean(5.21)_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:49:01,360 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "          Gene_set                                 Term Overlap   P-value  \\\n",
      "0  KEGG_2019_Human                       Protein export    1/23  0.008023   \n",
      "1  KEGG_2019_Human  Complement and coagulation cascades    1/79  0.027328   \n",
      "2  KEGG_2019_Human                             Lysosome   1/123  0.042270   \n",
      "\n",
      "   Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0               1.0            0                     0  124.223602   \n",
      "1               1.0            0                     0   36.166365   \n",
      "2               1.0            0                     0   23.228804   \n",
      "\n",
      "   Combined Score  Genes  \n",
      "0      599.427861  SRP72  \n",
      "1      130.192765     F5  \n",
      "2       73.488545  GNPTG  \n"
     ]
    }
   ],
   "source": [
    "for col in sig_cols_up:\n",
    "    col_name = col.columns[0]\n",
    "    col_name = \"_\".join((col_name.split(\" \")))\n",
    "    print(col_name)\n",
    "    gene_name_list = list(col.index)\n",
    "    enrichment = gp.enrichr(gene_list = gene_name_list, \n",
    "                            description=col_name, \n",
    "                            gene_sets='KEGG_2019_Human', \n",
    "                            outdir='test/renal')\n",
    "    #print(enrichment.res2d)\n",
    "    barplot(enrichment.res2d, title=col_name, ofname=col_name)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "tumor_focality_Multifocal_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:49:04,253 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "hemoglobin_Normal_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:49:16,118 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "history_of_cancer_Yes_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:49:19,047 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "margin_status_Margin(s)_involved_by_invasive_carcinoma_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:49:21,911 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "residual_tumor_R1:Microscopic_residual_tumor_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:49:24,732 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "anesthesia_insulin_Yes_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:49:27,655 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "new_tumor_event_after_initial_treatment_at_24months_follow_up_Yes_P_values\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-19 16:49:30,491 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    }
   ],
   "source": [
    "for col in sig_cols_down:\n",
    "    col_name = col.columns[0]\n",
    "    col_name = \"_\".join((col_name.split(\" \")))\n",
    "    print(col_name)\n",
    "    gene_name_list = list(col.index)\n",
    "    enrichment = gp.enrichr(gene_list = gene_name_list, \n",
    "                            description=col_name, \n",
    "                            gene_sets='KEGG_2019_Human', \n",
    "                            outdir='test/renal')\n",
    "    #print(enrichment.res2d)\n",
    "    barplot(enrichment.res2d, title=col_name, ofname=col_name)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [],
   "source": [
    "#All requests for up-regulation\n",
    "dgidb_requests_up = list(map(bf.dgidb_get_request, sig_genes_up.values()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\n",
      "    \"APEX1\": {\n",
      "        \"LUCANTHONE\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"ATP1B2\": {\n",
      "        \"ACETYLDIGITOXIN\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"DIGOXIN\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"DIGITOXIN\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"DESLANOSIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"CDK6\": {\n",
      "        \"(7S)-HYDROXYL-STAUROSPORINE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"PHA-793887\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ALVOCIDIB\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"Roniciclib\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"APREMILAST\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"RIBOCICLIB SUCCINATE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"G1T28-1\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"AZD-5438\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"Ribociclib\": [\n",
      "            \"inhibitor\",\n",
      "            \"antagonist\"\n",
      "        ],\n",
      "        \"PALBOCICLIB\": [\n",
      "            \"Inhibitor\",\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"RGB-286638\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"PENTOBARBITAL\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ABEMACICLIB\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"AT-7519\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"DDB1\": {\n",
      "        \"POMALIDOMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"LENALIDOMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"THALIDOMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"KAT5\": {\n",
      "        \"CHEMBL1215739\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"KDM5A\": {\n",
      "        \"CHEMBL1336959\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"MMP28\": {\n",
      "        \"MARIMASTAT\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"NOTCH3\": {\n",
      "        \"NIROGACESTAT\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"NOTCH4\": {\n",
      "        \"NIROGACESTAT\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"PGF\": {\n",
      "        \"AFLIBERCEPT\": [\n",
      "            \"inhibitor\",\n",
      "            \"binder\"\n",
      "        ],\n",
      "        \"CONBERCEPT\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"REN\": {\n",
      "        \"ALISKIREN FUMARATE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ALISKIREN\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ENALKIREN\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"REMIKIREN\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"SELP\": {\n",
      "        \"RG-1512\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"RO-4905417\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"BIMOSIAMOSE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"NADROPARIN CALCIUM\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"DALTEPARIN SODIUM\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    }\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "#S125 example\n",
    "s125_example = bf.dgidb_get_request(outlier_up_dict['S125'], genes = True, \n",
    "                                    interaction_types = ['inhibitor'])\n",
    "s125_dict = bf.dgidb_json_parse(s125_example, genes = True)\n",
    "print(json.dumps(s125_dict, indent=4))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [],
   "source": [
    "dgidb_requests_down = []\n",
    "\n",
    "for col in sig_cols_down:\n",
    "    sig_genes = list(col.index)\n",
    "    json_obj = bf.dgidb_get_request(sig_genes)\n",
    "    dgidb_requests_down.append(json_obj)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [],
   "source": [
    "#All requests for down-regulation\n",
    "dgidb_requests_down = list(map(bf.dgidb_get_request, sig_genes_down.values()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "UP-REGULATED:\n",
      "\n",
      "Genes and drugs for:  tumor_site_Other_P_values\n",
      "{\n",
      "    \"TXNRD1\": {\n",
      "        \"ARSENIC TRIOXIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"MOTEXAFIN GADOLINIUM\": [],\n",
      "        \"CHEMBL449269\": [],\n",
      "        \"FLAVIN ADENINE DINUCLEOTIDE\": [],\n",
      "        \"SPERMIDINE\": [],\n",
      "        \"FOTEMUSTINE\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for:  tumor_size_in_cm_Above_Mean(6.51)_P_values\n",
      "{\n",
      "    \"TXNRD1\": {\n",
      "        \"ARSENIC TRIOXIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"MOTEXAFIN GADOLINIUM\": [],\n",
      "        \"CHEMBL449269\": [],\n",
      "        \"FLAVIN ADENINE DINUCLEOTIDE\": [],\n",
      "        \"SPERMIDINE\": [],\n",
      "        \"FOTEMUSTINE\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for:  tumor_focality_Multifocal_P_values\n",
      "{\n",
      "    \"HDAC4\": {\n",
      "        \"TASQUINIMOD\": [\n",
      "            \"allosteric modulator\"\n",
      "        ],\n",
      "        \"BELINOSTAT\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CUDC-101\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"DACINOSTAT\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CHEMBL1213492\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"PANOBINOSTAT\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"QUISINOSTAT\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ROMIDEPSIN\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"SCRIPTAID\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CHEMBL3110004\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TRICHOSTATIN\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CHEMBL1851943\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"PANOBINOSTAT LACTATE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ENTINOSTAT\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CHEMBL100014\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"VALPROIC ACID\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"SODIUM PHENYLBUTYRATE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ABEXINOSTAT\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"VORINOSTAT\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CUDC-907\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TACEDINALINE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"MOCETINOSTAT\": [],\n",
      "        \"CHEMBL191482\": []\n",
      "    },\n",
      "    \"KRT8\": {\n",
      "        \"TENECTEPLASE\": []\n",
      "    },\n",
      "    \"PPIA\": {\n",
      "        \"L-PROLINE\": [\n",
      "            \"binder\"\n",
      "        ],\n",
      "        \"CYCLOSPORINE\": [\n",
      "            \"inhibitor\",\n",
      "            \"modulator\"\n",
      "        ],\n",
      "        \"VOCLOSPORIN\": [],\n",
      "        \"CHEMBL1269597\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for:  histologic_grade_G3or4_P_values\n",
      "{\n",
      "    \"IRS2\": {\n",
      "        \"ASPIRIN\": [],\n",
      "        \"DEXAMETHASONE\": []\n",
      "    },\n",
      "    \"NPEPPS\": {\n",
      "        \"ANTAQ\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TOSEDOSTAT\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"PYCR2\": {\n",
      "        \"CHEMBL1161866\": [],\n",
      "        \"L-PROLINE\": []\n",
      "    },\n",
      "    \"TXNRD1\": {\n",
      "        \"ARSENIC TRIOXIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"MOTEXAFIN GADOLINIUM\": [],\n",
      "        \"CHEMBL449269\": [],\n",
      "        \"FLAVIN ADENINE DINUCLEOTIDE\": [],\n",
      "        \"SPERMIDINE\": [],\n",
      "        \"FOTEMUSTINE\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for:  pathologic_staging_regional_lymph_nodes_pN_pN0or1_P_values\n",
      "{\n",
      "    \"CAMP\": {\n",
      "        \"SELENOCYSTEINE\": []\n",
      "    },\n",
      "    \"SHBG\": {\n",
      "        \"SPIRONOLACTONE\": [\n",
      "            \"binder\"\n",
      "        ],\n",
      "        \"BUSULFAN\": [],\n",
      "        \"LISINOPRIL\": [],\n",
      "        \"NORGESTREL\": [],\n",
      "        \"DROLOXIFENE\": []\n",
      "    },\n",
      "    \"TXNRD1\": {\n",
      "        \"ARSENIC TRIOXIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"MOTEXAFIN GADOLINIUM\": [],\n",
      "        \"CHEMBL449269\": [],\n",
      "        \"FLAVIN ADENINE DINUCLEOTIDE\": [],\n",
      "        \"SPERMIDINE\": [],\n",
      "        \"FOTEMUSTINE\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for:  history_of_cancer_Yes_P_values\n",
      "{\n",
      "    \"ARG1\": {\n",
      "        \"CHLORAL BETAINE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"SODIUM BENZOATE\": [],\n",
      "        \"UREA\": [],\n",
      "        \"NEDOCROMIL\": [],\n",
      "        \"FLUTICASONE PROPIONATE\": [],\n",
      "        \"CHEMBL1234777\": [],\n",
      "        \"CHEMBL1522056\": [],\n",
      "        \"CHEMBL260629\": [],\n",
      "        \"ORNITHINE\": [],\n",
      "        \"BUDESONIDE\": []\n",
      "    },\n",
      "    \"ATP7A\": {\n",
      "        \"OXALIPLATIN\": [],\n",
      "        \"CARBOPLATIN\": [],\n",
      "        \"DOCETAXEL\": [],\n",
      "        \"THALIDOMIDE\": [],\n",
      "        \"PROGESTERONE\": []\n",
      "    },\n",
      "    \"C4B\": {\n",
      "        \"GLOBULIN, IMMUNE\": [\n",
      "            \"binder\"\n",
      "        ]\n",
      "    },\n",
      "    \"CA1\": {\n",
      "        \"METHYCLOTHIAZIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ETHOXZOLAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"METHOCARBAMOL\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"BENDROFLUMETHIAZIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"BENZTHIAZIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CYCLOTHIAZIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"METHAZOLAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"HYDROFLUMETHIAZIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ZONISAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"HYDROCHLOROTHIAZIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TRICHLORMETHIAZIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ETHINAMATE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"DIAZOXIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"DICHLORPHENAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ACETAZOLAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"BENZOLAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"BRINZOLAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CHLORTHALIDONE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"DORZOLAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"GALLIC ACID\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"INDISULAM\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"SULPIRIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TOPIRAMATE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"QUINETHAZONE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ELLAGIC ACID\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"SODIUM CARBONATE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"POLMACOXIB\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ACETAZOLAMIDE SODIUM\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"LEVETIRACETAM\": [],\n",
      "        \"CHLOROTHIAZIDE\": [],\n",
      "        \"CHEMBL451332\": []\n",
      "    },\n",
      "    \"CA3\": {\n",
      "        \"ZONISAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ELLAGIC ACID\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ETHOXZOLAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ACETAZOLAMIDE\": [],\n",
      "        \"ISOTRETINOIN\": []\n",
      "    },\n",
      "    \"CYTH2\": {\n",
      "        \"CHEMBL23552\": [],\n",
      "        \"FORMIC ACID\": []\n",
      "    },\n",
      "    \"EPB41\": {\n",
      "        \"BUPROPION\": []\n",
      "    },\n",
      "    \"FGA\": {\n",
      "        \"Sucralfate\": [\n",
      "            \"antagonist\"\n",
      "        ],\n",
      "        \"FIBRINOLYSIN, HUMAN\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"EPTIFIBATIDE\": [],\n",
      "        \"ANISTREPLASE\": [],\n",
      "        \"ANCROD\": [],\n",
      "        \"ABCIXIMAB\": [],\n",
      "        \"RETEPLASE\": [],\n",
      "        \"ALTEPLASE\": [],\n",
      "        \"ALFIMEPRASE\": [],\n",
      "        \"TENECTEPLASE\": [],\n",
      "        \"TIROFIBAN\": []\n",
      "    },\n",
      "    \"FGB\": {\n",
      "        \"Sucralfate\": [\n",
      "            \"antagonist\"\n",
      "        ],\n",
      "        \"FIBRINOLYSIN, HUMAN\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ALFIMEPRASE\": [],\n",
      "        \"EPTIFIBATIDE\": [],\n",
      "        \"TIROFIBAN\": [],\n",
      "        \"ABCIXIMAB\": []\n",
      "    },\n",
      "    \"FGG\": {\n",
      "        \"Sucralfate\": [\n",
      "            \"antagonist\"\n",
      "        ],\n",
      "        \"FIBRINOLYSIN, HUMAN\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"EPTIFIBATIDE\": [],\n",
      "        \"ABCIXIMAB\": [],\n",
      "        \"ALFIMEPRASE\": [],\n",
      "        \"TIROFIBAN\": []\n",
      "    },\n",
      "    \"GNAS\": {\n",
      "        \"COLFORSIN\": [],\n",
      "        \"FLUOROURACIL\": []\n",
      "    },\n",
      "    \"HBA2\": {\n",
      "        \"EFAPROXIRAL\": [\n",
      "            \"negative modulator\"\n",
      "        ]\n",
      "    },\n",
      "    \"HBB\": {\n",
      "        \"IRON DEXTRAN\": [\n",
      "            \"activator\"\n",
      "        ],\n",
      "        \"EFAPROXIRAL\": [\n",
      "            \"negative modulator\"\n",
      "        ],\n",
      "        \"CHEMBL1205452\": [],\n",
      "        \"CHEMBL77562\": [],\n",
      "        \"SEBACIC ACID\": [],\n",
      "        \"CHEMBL76029\": []\n",
      "    },\n",
      "    \"IL6ST\": {\n",
      "        \"SA237\": [\n",
      "            \"antagonist\"\n",
      "        ]\n",
      "    },\n",
      "    \"MAPK14\": {\n",
      "        \"PF-03715455\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CHEMBL1236539\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"Acumapimod\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"AZD-6703\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"BMS-582949\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"PROPOXYPHENE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"DILMAPIMOD\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"DORAMAPIMOD\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"LOSMAPIMOD\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CHEMBL1951415\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"PH-797804\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CHEMBL306380\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"RALIMETINIB\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"SB-202190\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"SB-203580\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"SB-220025\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CHEMBL313417\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TAK-715\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TALMAPIMOD\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"VX-702\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"VX-745\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"GSK-610677\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"LEO-15520\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"R-1487 (CHEMBL1766582)\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"Ro-3201195\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"RWJ-67657\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"SC-80036\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"SCIO-323\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"SD-0006\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TA-5493\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ARRY-797\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"SEMAPIMOD\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"PG-760564\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"PS-516895\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"FX-005\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"AMG-548\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"AVE-9940\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"SB-85635\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"KC-706\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"PAMAPIMOD\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"Pexmetinib\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"LY-3007113\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"AZD-7624\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CHEMBL305178\": [],\n",
      "        \"DOXORUBICIN\": [],\n",
      "        \"VASOPRESSIN\": [],\n",
      "        \"EPOETIN BETA\": [],\n",
      "        \"HYDROGEN PEROXIDE\": [],\n",
      "        \"CHEMBL194009\": [],\n",
      "        \"CHEMBL494072\": [],\n",
      "        \"CHEMBL194322\": [],\n",
      "        \"CHEMBL237127\": [],\n",
      "        \"RALIMETINIB MESYLATE\": [],\n",
      "        \"SULINDAC SULFIDE\": [],\n",
      "        \"CHEMBL87277\": [],\n",
      "        \"CHEMBL193156\": [],\n",
      "        \"2-CHLOROPHENOL\": [],\n",
      "        \"CHEMBL564912\": [],\n",
      "        \"CHEMBL252128\": [],\n",
      "        \"MORPHINE\": [],\n",
      "        \"CHEMBL492265\": [],\n",
      "        \"CHEMBL29641\": [],\n",
      "        \"RESVERATROL\": [],\n",
      "        \"CHEMBL193264\": [],\n",
      "        \"CHEMBL199237\": [],\n",
      "        \"CHEMBL559401\": [],\n",
      "        \"CHEMBL425616\": [],\n",
      "        \"CHEMBL197277\": [],\n",
      "        \"CHEMBL379760\": [],\n",
      "        \"PHORBOL MYRISTATE ACETATE\": [],\n",
      "        \"METHOXSALEN\": [],\n",
      "        \"LITHIUM\": [],\n",
      "        \"HALOPERIDOL\": [],\n",
      "        \"DOXYCYCLINE\": [],\n",
      "        \"CHEMBL191598\": [],\n",
      "        \"2-METHOXYESTRADIOL\": [],\n",
      "        \"CHEMBL522387\": [],\n",
      "        \"CHEMBL258202\": [],\n",
      "        \"CHEMBL478649\": [],\n",
      "        \"CHEMBL273158\": [],\n",
      "        \"CHEMBL410668\": [],\n",
      "        \"CHEMBL96741\": [],\n",
      "        \"RAVIDASVIR\": [],\n",
      "        \"CHEMBL195393\": [],\n",
      "        \"GW607117X\": [],\n",
      "        \"CHEMBL590753\": [],\n",
      "        \"CHEMBL365776\": [],\n",
      "        \"CHEMBL85860\": [],\n",
      "        \"CHEMBL94417\": [],\n",
      "        \"PIRFENIDONE\": [],\n",
      "        \"CHEMBL380373\": [],\n",
      "        \"CHEMBL371491\": [],\n",
      "        \"CHEMBL522579\": [],\n",
      "        \"CHEMBL257341\": [],\n",
      "        \"CHEMBL195450\": []\n",
      "    },\n",
      "    \"MTRR\": {\n",
      "        \"CYANOCOBALAMIN\": [\n",
      "            \"cofactor\"\n",
      "        ],\n",
      "        \"METHIONINE\": [\n",
      "            \"product of\"\n",
      "        ],\n",
      "        \"HYDROXOCOBALAMIN\": [\n",
      "            \"other\"\n",
      "        ],\n",
      "        \"VITAMIN B12\": [],\n",
      "        \"TEGAFUR\": []\n",
      "    },\n",
      "    \"PRDX2\": {\n",
      "        \"CHEMBL1160508\": []\n",
      "    },\n",
      "    \"PSMC6\": {\n",
      "        \"OPROZOMIB\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CARFILZOMIB\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"IXAZOMIB CITRATE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"BORTEZOMIB\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"PSME4\": {\n",
      "        \"BORTEZOMIB\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CARFILZOMIB\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"WRAP53\": {\n",
      "        \"CARBOQUONE\": [],\n",
      "        \"FLUOROURACIL\": [],\n",
      "        \"CYCLOPHOSPHAMIDE\": []\n",
      "    }\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "} \n",
      "\n",
      "Genes and drugs for:  vital_status_at_12months_follow_up_Deceased_P_values\n",
      "{\n",
      "    \"TFPI2\": {\n",
      "        \"HEPARIN\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for:  tumor_necrosis_Present_P_values\n",
      "{\n",
      "    \"HSP90AB1\": {\n",
      "        \"RETASPIMYCIN\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"NVP-AUY922\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"GANETESPIB\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TANESPIMYCIN\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"RETASPIMYCIN HYDROCHLORIDE (CHEMBL377559)\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ONALESPIB\": [],\n",
      "        \"CHEMBL399530\": [],\n",
      "        \"ALVESPIMYCIN\": [],\n",
      "        \"RADICICOL\": [],\n",
      "        \"GELDANAMYCIN\": [],\n",
      "        \"CHEMBL383189\": [],\n",
      "        \"CHEMBL2204502\": [],\n",
      "        \"CHEMBL553939\": [],\n",
      "        \"CHEMBL113690\": [],\n",
      "        \"CHEMBL2170470\": []\n",
      "    },\n",
      "    \"TXNRD1\": {\n",
      "        \"ARSENIC TRIOXIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"MOTEXAFIN GADOLINIUM\": [],\n",
      "        \"CHEMBL449269\": [],\n",
      "        \"FLAVIN ADENINE DINUCLEOTIDE\": [],\n",
      "        \"SPERMIDINE\": [],\n",
      "        \"FOTEMUSTINE\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for:  margin_status_Margin(s) involved by invasive carcinoma_P_values\n",
      "{\n",
      "    \"ATP2A2\": {\n",
      "        \"ENOXACIN\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ISTAROXIME\": [],\n",
      "        \"CELECOXIB\": []\n",
      "    },\n",
      "    \"B3GAT3\": {\n",
      "        \"CHEMBL1162071\": [],\n",
      "        \"URIDINE_DIPHOSPHATE\": []\n",
      "    },\n",
      "    \"CALR\": {\n",
      "        \"TRETINOIN\": [],\n",
      "        \"GENTAMICIN\": [],\n",
      "        \"TENECTEPLASE\": [],\n",
      "        \"ETRETINATE\": [],\n",
      "        \"MELATONIN\": [],\n",
      "        \"OLTIPRAZ\": []\n",
      "    },\n",
      "    \"CD38\": {\n",
      "        \"DARATUMUMAB\": [\n",
      "            \"antibody\",\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ISATUXIMAB\": [\n",
      "            \"antibody\"\n",
      "        ],\n",
      "        \"SAR-650984\": [],\n",
      "        \"HuMax-CD38\": [],\n",
      "        \"THROMBIN\": []\n",
      "    },\n",
      "    \"ECE1\": {\n",
      "        \"CHEMBL571153\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"DAGLUTRIL\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"INDOLE-3-BUTYRIC ACID\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ARDENERMIN\": []\n",
      "    },\n",
      "    \"G6PD\": {\n",
      "        \"GLYCOLIC ACID\": [],\n",
      "        \"SODIUM SULFATE\": [],\n",
      "        \"SULFAMETHOXAZOLE\": [],\n",
      "        \"NITROFURANTOIN\": [],\n",
      "        \"TRAMETINIB\": [],\n",
      "        \"TRIAMCINOLONE\": [],\n",
      "        \"QUININE SULFATE\": [],\n",
      "        \"CO-TRIMOXAZOLE\": [],\n",
      "        \"SULFISOXAZOLE\": [],\n",
      "        \"DIAZEPAM\": [],\n",
      "        \"PREDNISOLONE\": [],\n",
      "        \"SULFASALAZINE\": [],\n",
      "        \"PRIMAQUINE\": [],\n",
      "        \"SODIUM ASCORBATE\": [],\n",
      "        \"ASCORBATE\": [],\n",
      "        \"LIDOCAINE\": [],\n",
      "        \"METOCLOPRAMIDE\": [],\n",
      "        \"PYRIMETHAMINE\": [],\n",
      "        \"PEGLOTICASE\": [],\n",
      "        \"SULFADOXINE\": [],\n",
      "        \"CARMUSTINE\": [],\n",
      "        \"BUSULFAN\": [],\n",
      "        \"DABRAFENIB\": [],\n",
      "        \"SODIUM CHLORIDE\": [],\n",
      "        \"SUCCIMER\": [],\n",
      "        \"NALIDIXIC ACID\": [],\n",
      "        \"ETHYL NITROSOUREA\": [],\n",
      "        \"PENICILLIN G POTASSIUM\": [],\n",
      "        \"OMEPRAZOLE\": [],\n",
      "        \"SODIUM NITRITE\": [],\n",
      "        \"GLIPIZIDE\": [],\n",
      "        \"GLIMEPIRIDE\": [],\n",
      "        \"CHLORPROPAMIDE\": [],\n",
      "        \"NIMESULIDE\": [],\n",
      "        \"RASBURICASE\": [],\n",
      "        \"POTASSIUM CHLORIDE\": [],\n",
      "        \"TRIMETHOPRIM\": [],\n",
      "        \"CHEMBL445472\": [],\n",
      "        \"CHEMBL1161862\": [],\n",
      "        \"MAFENIDE\": [],\n",
      "        \"CHLOROQUINE\": [],\n",
      "        \"ARTESUNATE\": [],\n",
      "        \"METHYLENE BLUE\": [],\n",
      "        \"PRILOCAINE\": [],\n",
      "        \"ERYTHROMYCIN\": [],\n",
      "        \"PROPRANOLOL\": [],\n",
      "        \"CHLORPROGUANIL\": [],\n",
      "        \"ZINC CHLORIDE\": [],\n",
      "        \"TRIAPINE\": [],\n",
      "        \"GLYBURIDE\": []\n",
      "    },\n",
      "    \"GSPT1\": {\n",
      "        \"CHEMBL384759\": []\n",
      "    },\n",
      "    \"IRS2\": {\n",
      "        \"ASPIRIN\": [],\n",
      "        \"DEXAMETHASONE\": []\n",
      "    },\n",
      "    \"NMT1\": {\n",
      "        \"CHEMBL355497\": []\n",
      "    },\n",
      "    \"NSF\": {\n",
      "        \"BITOSCANATE\": []\n",
      "    },\n",
      "    \"RPS6KA3\": {\n",
      "        \"CHEMBL573107\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"AT-9283\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"UREA\": [],\n",
      "        \"ASPIRIN\": [],\n",
      "        \"REGRAMOSTIM\": []\n",
      "    },\n",
      "    \"SMAD3\": {\n",
      "        \"GENISTEIN\": [],\n",
      "        \"LEUPROLIDE ACETATE\": [],\n",
      "        \"DEXAMETHASONE\": [],\n",
      "        \"HALOFUGINONE\": []\n",
      "    },\n",
      "    \"TARS\": {\n",
      "        \"THREONINE\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for:  tobacco_smoking_history_Current Smoker_P_values\n",
      "{\n",
      "    \"CPN1\": {\n",
      "        \"PYRAZINAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"SHBG\": {\n",
      "        \"SPIRONOLACTONE\": [\n",
      "            \"binder\"\n",
      "        ],\n",
      "        \"BUSULFAN\": [],\n",
      "        \"LISINOPRIL\": [],\n",
      "        \"NORGESTREL\": [],\n",
      "        \"DROLOXIFENE\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for:  anesthesia_insulin_Yes_P_values\n",
      "{\n",
      "    \"CD44\": {\n",
      "        \"HYALURONIC ACID\": [],\n",
      "        \"STAUROSPORINE\": [],\n",
      "        \"INTERFERON GAMA-1B\": [],\n",
      "        \"MYCOPHENOLIC ACID\": [],\n",
      "        \"GENTAMICIN\": [],\n",
      "        \"MOMETASONE FUROATE\": []\n",
      "    },\n",
      "    \"HINT1\": {\n",
      "        \"ADENOSINE PHOSPHATE\": [\n",
      "            \"product of\"\n",
      "        ],\n",
      "        \"MESALAMINE\": [],\n",
      "        \"CHEMBL283807\": [],\n",
      "        \"CHEMBL1230617\": []\n",
      "    },\n",
      "    \"LNPEP\": {\n",
      "        \"TOSEDOSTAT\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"MAPK9\": {\n",
      "        \"HEXANE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"GW620972X\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CHEMBL210618\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"RGB-286638\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"SP-600125\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CC-401\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TANZISERTIB\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"Bentamapimod\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"CAMPTOTHECIN\": []\n",
      "    },\n",
      "    \"NPEPL1\": {\n",
      "        \"TOSEDOSTAT\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"P2RX4\": {\n",
      "        \"ESLICARBAZEPINE ACETATE\": [\n",
      "            \"antagonist\"\n",
      "        ]\n",
      "    },\n",
      "    \"PMVK\": {\n",
      "        \"DIPHOSPHOMELAVONATE\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"PSMD8\": {\n",
      "        \"CARFILZOMIB\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"IXAZOMIB CITRATE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"BORTEZOMIB\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"OPROZOMIB\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for:  anesthesia_steroids_Yes_P_values\n",
      "{\n",
      "    \"CD38\": {\n",
      "        \"DARATUMUMAB\": [\n",
      "            \"antibody\",\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ISATUXIMAB\": [\n",
      "            \"antibody\"\n",
      "        ],\n",
      "        \"SAR-650984\": [],\n",
      "        \"HuMax-CD38\": [],\n",
      "        \"THROMBIN\": []\n",
      "    },\n",
      "    \"HSD17B11\": {\n",
      "        \"ETIOCHOLANOLONE\": []\n",
      "    },\n",
      "    \"MPI\": {\n",
      "        \"SULFOXONE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"SULFACETAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for:  tumor_status_at_12months_follow_up_With Tumor_P_values\n",
      "{\n",
      "    \"ASPH\": {\n",
      "        \"ASPARTIC ACID\": [],\n",
      "        \"SUCCINIC ACID\": []\n",
      "    },\n",
      "    \"CALR\": {\n",
      "        \"TRETINOIN\": [],\n",
      "        \"GENTAMICIN\": [],\n",
      "        \"TENECTEPLASE\": [],\n",
      "        \"ETRETINATE\": [],\n",
      "        \"MELATONIN\": [],\n",
      "        \"OLTIPRAZ\": []\n",
      "    },\n",
      "    \"GLS\": {\n",
      "        \"6-DIAZO-5-OXO-L-NORLEUCINE\": [],\n",
      "        \"METHOTREXATE\": [],\n",
      "        \"GLUTAMINE\": [],\n",
      "        \"DEXAMETHASONE\": [],\n",
      "        \"L-GLUTAMATE\": []\n",
      "    },\n",
      "    \"IRS2\": {\n",
      "        \"ASPIRIN\": [],\n",
      "        \"DEXAMETHASONE\": []\n",
      "    },\n",
      "    \"PYCR2\": {\n",
      "        \"CHEMBL1161866\": [],\n",
      "        \"L-PROLINE\": []\n",
      "    },\n",
      "    \"TARS\": {\n",
      "        \"THREONINE\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for:  tumor_status_at_24months_follow_up_With Tumor_P_values\n",
      "{\n",
      "    \"MARK2\": {\n",
      "        \"ACETAMINOPHEN\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for:  success_of_treatment_at_12months_follow_up_Persistent_Disease_or_Deceased_P_values\n",
      "{\n",
      "    \"CALR\": {\n",
      "        \"TRETINOIN\": [],\n",
      "        \"GENTAMICIN\": [],\n",
      "        \"TENECTEPLASE\": [],\n",
      "        \"ETRETINATE\": [],\n",
      "        \"MELATONIN\": [],\n",
      "        \"OLTIPRAZ\": []\n",
      "    },\n",
      "    \"CD44\": {\n",
      "        \"HYALURONIC ACID\": [],\n",
      "        \"STAUROSPORINE\": [],\n",
      "        \"INTERFERON GAMA-1B\": [],\n",
      "        \"MYCOPHENOLIC ACID\": [],\n",
      "        \"GENTAMICIN\": [],\n",
      "        \"MOMETASONE FUROATE\": []\n",
      "    },\n",
      "    \"GLS\": {\n",
      "        \"6-DIAZO-5-OXO-L-NORLEUCINE\": [],\n",
      "        \"METHOTREXATE\": [],\n",
      "        \"GLUTAMINE\": [],\n",
      "        \"DEXAMETHASONE\": [],\n",
      "        \"L-GLUTAMATE\": []\n",
      "    },\n",
      "    \"HSP90AB1\": {\n",
      "        \"RETASPIMYCIN\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"NVP-AUY922\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"GANETESPIB\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TANESPIMYCIN\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"RETASPIMYCIN HYDROCHLORIDE (CHEMBL377559)\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"ONALESPIB\": [],\n",
      "        \"CHEMBL399530\": [],\n",
      "        \"ALVESPIMYCIN\": [],\n",
      "        \"RADICICOL\": [],\n",
      "        \"GELDANAMYCIN\": [],\n",
      "        \"CHEMBL383189\": [],\n",
      "        \"CHEMBL2204502\": [],\n",
      "        \"CHEMBL553939\": [],\n",
      "        \"CHEMBL113690\": [],\n",
      "        \"CHEMBL2170470\": []\n",
      "    },\n",
      "    \"IRS2\": {\n",
      "        \"ASPIRIN\": [],\n",
      "        \"DEXAMETHASONE\": []\n",
      "    },\n",
      "    \"PYCR2\": {\n",
      "        \"CHEMBL1161866\": [],\n",
      "        \"L-PROLINE\": []\n",
      "    },\n",
      "    \"TFPI2\": {\n",
      "        \"HEPARIN\": []\n",
      "    }\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "} \n",
      "\n",
      "Genes and drugs for:  new_tumor_event_after_initial_treatment_at_24months_follow_up_Yes_P_values\n",
      "{\n",
      "    \"LNPEP\": {\n",
      "        \"TOSEDOSTAT\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"P2RX4\": {\n",
      "        \"ESLICARBAZEPINE ACETATE\": [\n",
      "            \"antagonist\"\n",
      "        ]\n",
      "    },\n",
      "    \"TXNRD1\": {\n",
      "        \"ARSENIC TRIOXIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"MOTEXAFIN GADOLINIUM\": [],\n",
      "        \"CHEMBL449269\": [],\n",
      "        \"FLAVIN ADENINE DINUCLEOTIDE\": [],\n",
      "        \"SPERMIDINE\": [],\n",
      "        \"FOTEMUSTINE\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for:  percent_necrotic_surface_area_Above_Mean(5.21)_P_values\n",
      "{\n",
      "    \"CPN1\": {\n",
      "        \"PYRAZINAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"F5\": {\n",
      "        \"DROTRECOGIN ALFA (ACTIVATED)\": [\n",
      "            \"multitarget\",\n",
      "            \"antagonist\",\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TAMOXIFEN\": [],\n",
      "        \"ESTRONE SODIUM SULFATE\": [],\n",
      "        \"THROMBOMODULIN ALFA\": [],\n",
      "        \"ELTROMBOPAG\": [],\n",
      "        \"THROMBIN\": []\n",
      "    },\n",
      "    \"SHBG\": {\n",
      "        \"SPIRONOLACTONE\": [\n",
      "            \"binder\"\n",
      "        ],\n",
      "        \"BUSULFAN\": [],\n",
      "        \"LISINOPRIL\": [],\n",
      "        \"NORGESTREL\": [],\n",
      "        \"DROLOXIFENE\": []\n",
      "    }\n",
      "} \n",
      "\n"
     ]
    }
   ],
   "source": [
    "print('UP-REGULATED:\\n')\n",
    "for i, request in enumerate(dgidb_requests_up):\n",
    "    print('Genes and drugs for: ', sig_cols_up[i].columns[0])\n",
    "    drug_dict_up = bf.dgidb_json_parse(request, genes=True)\n",
    "    print(json.dumps(drug_dict_up, indent=4), '\\n')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "DOWN-REGULATED:\n",
      "\n",
      "Genes and drugs for: tumor_focality_Multifocal_P_values:\n",
      "\n",
      "{\n",
      "    \"CPN1\": {\n",
      "        \"PYRAZINAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"F5\": {\n",
      "        \"DROTRECOGIN ALFA (ACTIVATED)\": [\n",
      "            \"multitarget\",\n",
      "            \"antagonist\",\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TAMOXIFEN\": [],\n",
      "        \"ESTRONE SODIUM SULFATE\": [],\n",
      "        \"THROMBOMODULIN ALFA\": [],\n",
      "        \"ELTROMBOPAG\": [],\n",
      "        \"THROMBIN\": []\n",
      "    },\n",
      "    \"SHBG\": {\n",
      "        \"SPIRONOLACTONE\": [\n",
      "            \"binder\"\n",
      "        ],\n",
      "        \"BUSULFAN\": [],\n",
      "        \"LISINOPRIL\": [],\n",
      "        \"NORGESTREL\": [],\n",
      "        \"DROLOXIFENE\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for: hemoglobin_Normal_P_values:\n",
      "\n",
      "No Gene/Drug interactions\n",
      "{\n",
      "    \"CPN1\": {\n",
      "        \"PYRAZINAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"F5\": {\n",
      "        \"DROTRECOGIN ALFA (ACTIVATED)\": [\n",
      "            \"multitarget\",\n",
      "            \"antagonist\",\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TAMOXIFEN\": [],\n",
      "        \"ESTRONE SODIUM SULFATE\": [],\n",
      "        \"THROMBOMODULIN ALFA\": [],\n",
      "        \"ELTROMBOPAG\": [],\n",
      "        \"THROMBIN\": []\n",
      "    },\n",
      "    \"SHBG\": {\n",
      "        \"SPIRONOLACTONE\": [\n",
      "            \"binder\"\n",
      "        ],\n",
      "        \"BUSULFAN\": [],\n",
      "        \"LISINOPRIL\": [],\n",
      "        \"NORGESTREL\": [],\n",
      "        \"DROLOXIFENE\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for: history_of_cancer_Yes_P_values:\n",
      "\n",
      "{\n",
      "    \"CPN1\": {\n",
      "        \"PYRAZINAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"F5\": {\n",
      "        \"DROTRECOGIN ALFA (ACTIVATED)\": [\n",
      "            \"multitarget\",\n",
      "            \"antagonist\",\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TAMOXIFEN\": [],\n",
      "        \"ESTRONE SODIUM SULFATE\": [],\n",
      "        \"THROMBOMODULIN ALFA\": [],\n",
      "        \"ELTROMBOPAG\": [],\n",
      "        \"THROMBIN\": []\n",
      "    },\n",
      "    \"SHBG\": {\n",
      "        \"SPIRONOLACTONE\": [\n",
      "            \"binder\"\n",
      "        ],\n",
      "        \"BUSULFAN\": [],\n",
      "        \"LISINOPRIL\": [],\n",
      "        \"NORGESTREL\": [],\n",
      "        \"DROLOXIFENE\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for: margin_status_Margin(s) involved by invasive carcinoma_P_values:\n",
      "\n",
      "No Gene/Drug interactions\n",
      "{\n",
      "    \"CPN1\": {\n",
      "        \"PYRAZINAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"F5\": {\n",
      "        \"DROTRECOGIN ALFA (ACTIVATED)\": [\n",
      "            \"multitarget\",\n",
      "            \"antagonist\",\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TAMOXIFEN\": [],\n",
      "        \"ESTRONE SODIUM SULFATE\": [],\n",
      "        \"THROMBOMODULIN ALFA\": [],\n",
      "        \"ELTROMBOPAG\": [],\n",
      "        \"THROMBIN\": []\n",
      "    },\n",
      "    \"SHBG\": {\n",
      "        \"SPIRONOLACTONE\": [\n",
      "            \"binder\"\n",
      "        ],\n",
      "        \"BUSULFAN\": [],\n",
      "        \"LISINOPRIL\": [],\n",
      "        \"NORGESTREL\": [],\n",
      "        \"DROLOXIFENE\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for: residual_tumor_R1:Microscopic residual tumor_P_values:\n",
      "\n",
      "{\n",
      "    \"CPN1\": {\n",
      "        \"PYRAZINAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"F5\": {\n",
      "        \"DROTRECOGIN ALFA (ACTIVATED)\": [\n",
      "            \"multitarget\",\n",
      "            \"antagonist\",\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TAMOXIFEN\": [],\n",
      "        \"ESTRONE SODIUM SULFATE\": [],\n",
      "        \"THROMBOMODULIN ALFA\": [],\n",
      "        \"ELTROMBOPAG\": [],\n",
      "        \"THROMBIN\": []\n",
      "    },\n",
      "    \"SHBG\": {\n",
      "        \"SPIRONOLACTONE\": [\n",
      "            \"binder\"\n",
      "        ],\n",
      "        \"BUSULFAN\": [],\n",
      "        \"LISINOPRIL\": [],\n",
      "        \"NORGESTREL\": [],\n",
      "        \"DROLOXIFENE\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for: anesthesia_insulin_Yes_P_values:\n",
      "\n",
      "No Gene/Drug interactions\n",
      "{\n",
      "    \"CPN1\": {\n",
      "        \"PYRAZINAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"F5\": {\n",
      "        \"DROTRECOGIN ALFA (ACTIVATED)\": [\n",
      "            \"multitarget\",\n",
      "            \"antagonist\",\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TAMOXIFEN\": [],\n",
      "        \"ESTRONE SODIUM SULFATE\": [],\n",
      "        \"THROMBOMODULIN ALFA\": [],\n",
      "        \"ELTROMBOPAG\": [],\n",
      "        \"THROMBIN\": []\n",
      "    },\n",
      "    \"SHBG\": {\n",
      "        \"SPIRONOLACTONE\": [\n",
      "            \"binder\"\n",
      "        ],\n",
      "        \"BUSULFAN\": [],\n",
      "        \"LISINOPRIL\": [],\n",
      "        \"NORGESTREL\": [],\n",
      "        \"DROLOXIFENE\": []\n",
      "    }\n",
      "} \n",
      "\n",
      "Genes and drugs for: new_tumor_event_after_initial_treatment_at_24months_follow_up_Yes_P_values:\n",
      "\n",
      "{\n",
      "    \"CPN1\": {\n",
      "        \"PYRAZINAMIDE\": [\n",
      "            \"inhibitor\"\n",
      "        ]\n",
      "    },\n",
      "    \"F5\": {\n",
      "        \"DROTRECOGIN ALFA (ACTIVATED)\": [\n",
      "            \"multitarget\",\n",
      "            \"antagonist\",\n",
      "            \"inhibitor\"\n",
      "        ],\n",
      "        \"TAMOXIFEN\": [],\n",
      "        \"ESTRONE SODIUM SULFATE\": [],\n",
      "        \"THROMBOMODULIN ALFA\": [],\n",
      "        \"ELTROMBOPAG\": [],\n",
      "        \"THROMBIN\": []\n",
      "    },\n",
      "    \"SHBG\": {\n",
      "        \"SPIRONOLACTONE\": [\n",
      "            \"binder\"\n",
      "        ],\n",
      "        \"BUSULFAN\": [],\n",
      "        \"LISINOPRIL\": [],\n",
      "        \"NORGESTREL\": [],\n",
      "        \"DROLOXIFENE\": []\n",
      "    }\n",
      "} \n",
      "\n"
     ]
    }
   ],
   "source": [
    "print('DOWN-REGULATED:\\n')\n",
    "for i, request in enumerate(dgidb_requests_down):\n",
    "    print('Genes and drugs for: ' + sig_cols_down[i].columns[0] +':\\n')\n",
    "    drug_dict_down = bf.dgidb_json_parse(request, genes=True)\n",
    "    print(json.dumps(drug_dict_up, indent=4), '\\n')"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
